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Chapter 1
General Introduction
Introduction
The activity of ribosomal RNA genes generates a distinct subnuclear structure, called the 
nucleolus, which is the site of ribosome biogenesis. Although the name was given almost 
two centuries ago, its primary function as ribosome synthesis and assembly factory has been 
known for only a couple of decades. In eukaryotes, the 5.8S, 18S and 25/28S ribosomal 
RNAs (rRNA) are transcribed by RNA polymerase I as a single precursor (pre-rRNA). 
These pre-rRNA molecules then associate with a large number of proteins, which together 
form a pre-ribosomal particle. By analogy to splicing, the pre-rRNA needs to be processed 
to obtain the mature rRNAs. The fully processed rRNAs assemble with ribosomal proteins 
into a small and large subunit that together constitute the mature ribosome.
Pre-rRNA processing requires a large number of trans-acting factors, among them the 
small nucleolar ribonucleoprotein particles (snoRNPs), which mediate the cleavage reac­
tions and nucleotide modifications in the pre-rRNA.
In this chapter the structural and functional organisation of the nucleolus will be briefly 
described first. Subsequently, the two major classes of snoRNPs, box C/D and box H/ACA 
snoRNPs, that function in pre-rRNA modification and/or processing will be discussed, with 
emphasis on the U3 snoRNP complex.
Structural and functional organisation of 
the nucleolus
The nucleolar structure in interphase cells is 
organised around tandemly repeated genes that code 
for ribosomal RNA. These genes are generally 
referred to as rDNA units and contain the sequences 
for the 18S, 5.8S and 25/28S rRNA. Nucleoli can be 
visualised by light and electron microscopy as sin­
gle or multiple nuclear structures that occupy a sig­
nificant portion of the nuclear compartment. Using 
refined electron microscopic techniques, three basic 
nucleolar substructures have been resolved: the fib­
rillar center, the dense fibrillar compartment, and the 
granular compartment (Figure 1A) (reviewed in 42, 
43, 52, 59). In mammalian cells, there is consider­
able diversity in the arrangement of these compo­
nents. This depends on the cell type, the physiolog­
ical state of the cell and the rDNA transcription 
activity. However, most nucleoli display a concen­
tric arrangement. A schematic representation of the 
organisation of nucleolar substructures is presented
in Figure 1B. In this model, the fibrillar center (FC) 
is surrounded by the dense fibrillar compartment 
(DFC). The latter is associated with the outermost 
granular compartment (GC). The FC contains the 
rDNA, whereas the nascent pre-rRNA is predomi­
nantly detected in the DFC (Figure 1) ((34, 40) and 
references therein). There is considerable discussion 
about where transcription of the rDNA actually 
takes place. Most data suggest that it occurs in the 
border region between the FC and the DFC (Figure 
1B) (for a recent commentary, see 21). For subse­
quent steps in pre-rRNA processing it is generally 
accepted that the pre-rRNA, already packaged into 
RNP (ribonucleoprotein) particles, migrates from 
the fibrillar compartments to the GC, where it is pre­
pared for transport to the nucleoplasm and cyto­
plasm (reviewed in 17). However, it remains unclear 
at what stage of processing this particle moves from 
the DFC to the GC and whether such specific com­
partments have specific functions in ribosome bio­
genesis.
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Figure 1. Structural and functional organisation of the nucleolus.
A) Image o f a section o f  a cell generated by electron microscopy showing a single nucleolus and its substructures. The positions of 
the nucleolar substructures in this section (GC, DFC and FC) are indicated. The regions corresponding to the cytoplasm, the nuclear 
envelope and the nucleoplasm are indicated on top o f  the picture.
B) Schematic representation o f  the nucleolar substructures. The FC is surrounded by the DFC, which contacts the outermost layer, 
the GC. The rDNA is located in the FC. Pre-rRNA synthesis takes place at the border between the FC and the DFC (shown in grey; 
tnx zone). Pre-ribosomal particles are formed in the DFC and, for subsequent processing steps, these particles move from the DFC 
to the GC (arrow). Finally, the (almost) mature ribosomal subunits are transported to compartments outside the nucleolus.
Small nucleolar ribonucleoprotein 
complexes
Chemical modification of pre-rRNA
The mature human 18S, 5.8S and 28S rRNAs 
together contain more than 200 modified 
nucleotides. These are introduced before the pre- 
rRNA is processed by nucleolytic cleavages and 
these post-transcriptional modifications are carried 
out by snoRNPs (46). Each snoRNP consists of sev­
eral protein components associated with a single 
small RNA molecule, called the snoRNA, which 
acts as a sequence specific guide to select the target 
nucleotide in the pre-rRNA. Based on structural 
similarity, conserved sequence elements and associ­
ated proteins, the snoRNAs can be divided into 2 
major groups: the box C/D snoRNAs and the box 
H/ACA snoRNAs. Other snoRNPs, which will not 
be discussed here, are the RNase MRP and RNase P 
endoribonucleases (reviewed in 67) and a recently
discovered snoRNA (U85) that contains a box C/D 
and a box H/ACA motif (23).
The box H/ACA snoRNAs guide the 
pseudouridylation (Figure 2A), whereas the box 
C/D snoRNAs guide 2’-O-methylation of rRNA 
(Figure 2B). In addition to modification of rRNA, 
snoRNAs have been shown to be involved in chem­
ical modification of spliceosomal RNAs (snRNAs) 
and in Archaea snoRNAs are also required for the 
modification of tRNA. (reviewed in 13).
The modifications are predominantly clustered 
in functionally important regions of the mature 
rRNA, suggesting that they contribute to the func­
tion of the ribosome (46, 56). The pseudouridine has 
increased potential to hydrogen bonding and may 
promote intramolecular and intermolecular base- 
pairing interactions (Figure 2C). The introduction of 
a methyl group at the 2’ hydroxyl of the ribose (2’- 
O-methylation) increases the hydrophobicity of the
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residue (Figure 2D). It is likely that this makes the 
phosphate backbone less susceptible to cleavage by 
ribonucleases.
The box H/ACA snoRNAs
The members of the box H/ACA snoRNA class 
are characterised by two hairpin structures, a hinge 
region, and a 3’ tail region (Figure 2A). The hinge 
and tail regions carry the conserved boxes H 
(ANANNA) and ACA, respectively. The guide 
sequences of the box H/ACA snoRNAs are located 
in the internal loops found in the 5’ and 3’ hairpin 
structures. These guide sequences base-pair with 
regions of the rRNA that flank the uridine residue 
destined to be modified (reviewed in 65).
Four proteins are associated with all box 
H/ACA snoRNAs: Nhp2, Gar1, Cbf5p (dyskerin in 
human) and Nop10 (13, 65). Cbf5p, Nhp2 and 
Nop 10 are essential for snoRNA stability and 
required for the assembly of Gar1 into the RNP 
complex (20, 36). Cbf5p/dyskerin exhibits signifi­
cant sequence similarity to known pseudouridine 
synthases and is very likely the modification 
enzyme (35-37, 75).
The box C/D snoRNAs
The box C/D snoRNAs are characterised by the 
conserved sequence elements box C (RUGANGA) 
and box D (CUGA) and contain regions of comple­
mentarity to rRNA (Figure 2D). Sequences located 
adjacent to box C and box D often form a stem 
structure, which brings the two boxes juxtaposed to 
each other. The box C/D snoRNAs often have a sec­
ond pair of box C/D like motifs referred to as box C’ 
and box D ’ (Figure 2B) (31, 32). Each methylation 
guide snoRNA contains one or two regions (10-21 
nucleotides) that mediate the base-pairing with spe­
cific rRNA regions. These guide elements are 
always located immediately upstream of box D or 
box D’. The rRNA nucleotide that is targeted for
modification in the snoRNA/rRNA duplex is always 
found 5 nucleotides upstream of box D or D’ and 
there is no base specificity to the reaction (31, 32).
The box C/D snoRNAs are associated with a 
common set of core proteins: Nop56, Nop58, fibril- 
larin/Nop1p and 15.5K/Snu13p (reviewed in ref. 65; 
discussed in more detail below).
The U3 snoRNP complex
There is a small group of box C/D snoRNAs 
that have regions of extensive complementarity to 
(pre-)rRNA but are not involved in 2’-O-methyla- 
tion of rRNA. These snoRNAs (U3, U8, U13, U22) 
are required for the cleavage reactions in pre-rRNA 
processing. The U3 snoRNP, one of the most abun­
dant small RNPs in mammalian cells, is essential for 
the processing of the small ribosomal subunit RNA 
(18S rRNA). In this section, the structural and func­
tional aspects of the U3 box C/D snoRNP are dis­
cussed in more detail.
The U3 snoRNP complex is required for early 
cleavage steps in pre-rRNA processing
Pre-rRNA processing has been extensively stud­
ied in Saccharomyces cerevisiae (reviewed in 68) 
(Figure 3A). The nascent pre-rRNA (35S pre-rRNA) 
contains internal (ITS1 and ITS2) and external tran­
scribed sequences (5’ETS and 3’ETS) that need to 
be removed to obtain the mature 18S, 5.8S and 25S 
rRNAs. Physiologically, the 35S pre-rRNA is first 
cleaved at site A0, yielding the 33S pre-rRNA. This 
precursor is then rapidly cleaved at sites A1 and A2, 
which results in the accumulation of 20S and 27SA2 
pre-rRNAs. The 20S precursor is subsequently 
transported as a pre-40S RNP particle to the cyto­
plasm where it is processed at site D to form the 
mature 18S rRNA (Figure 3A). The 27SA2 precur­
sor is either cleaved at site A3 by the endonuclease 
RNase MRP or processed at site B1(S), which, upon 
further processing, yields the 25S rRNA and two
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Figure 2. Stucture and function of box H/ACA snoRNAs and box C/D snoRNAs.
A) A  secondary structure model for a box H/ACA snoRNA base-paired to the pre-rRNA. The sequences flanking the rRNA 
nucleotide to be modified (NW) are base-paired with the snoRNA. The consensus sequences o f boxes H and ACA are indicated (R 
is a purine and N stands for any nucleotide).
B) A  secondary structure model for a box C/D snoRNA base-paired with pre-rRNA. The consensus sequences for boxes C, C’, D 
and D ’ are indicated. The box C/D or box C’/D ’ interaction with the pre-rRNA generates a conserved structure in which the boxes 
D and D ’ are positioned 5 nucleotides from the ribose moiety to be 2’-O-methylated (indicated by (m))
C) Pseudouridine formation by base rotation around the N3-C6 axis.
D) Methylation o f the 2’-hydroxyl in the ribose moiety.
The structure and the nucleotide conversion models were adopted from references (30, 37).
forms of 5.8S rRNA, the long form (5.8S(L)) and 
the short form (5.8S(S)). Genetic depletion experi­
ments in yeast have demonstrated that the U3 
snoRNP is required for cleavage at sites A0, A 1 and 
A2, and thus for 18S rRNA synthesis. Synthesis of 
5.8S rRNA and 25S rRNA is not affected by genet­
ic depletion of U3 because the pre-rRNA can still be 
cleaved at site A3.
The mechanism of pre-rRNA processing in 
human and mouse cells is similar to that in yeast, 
although much less is known about the role of the 
U3 snoRNP in this process (Figure 3B) (6, 10, 19).
General Introduction 11
A 5' E TS ITS1 ITS2Ao A í D
J_ i 18S i 5.8S 25S
A o
a2 a 3 b ,(L) c ^ c i ,  
B ^ S)
3'ETS
35S pre-rRNA
U3snoRNP
U3snoRNP
18S 5.8S(S) 25S 5.8S(L) 25S
Figure 3. Pre-rRNA processing in the yeast Saccharomyces cerevisiae and in human.
A) Schematical representation o f pre-rRNA processing in yeast. The 18S, 5.8S and 25S rRNAs are transcribed as a single precur­
sor, the 35S pre-rRNA. The pre-rRNA is subsequently cleaved at site A 0 in the 5 ’ external transcribed spacer (5’ ETS), followed by 
cleavages at the 5 ’ end o f the 18S rRNA (A!) and in the internal transcribed spacer 1 (ITS1). The U3 snoRNP complex is involved 
in cleavage at these sites, which is essential for 18S rRNA synthesis. The 2 7 SA2 precursor, can be cleaved at site A 3 by the RNase 
MRP endonuclease in ITS1, yielding the 2 7 SA3 precursor, or at site B 1(L), yielding the 27SB1(L) precursor. Upon further process­
ing, these pre-rRNAs are converted into the 5.8S molecules (5.8S(L) and 5.8S(S)) and the 25S rRNA.
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B) Pre-rRNA processing in human. Schematic representation of human pre-rRNA processing. The 18S, 5.8S and 28S rRNAs are 
transcribed as a single precursor (47S), which is rapidly cleaved at the primary processing site (PPS) in the 5 ’ external transcribed 
spacer (5’ETS) and the second processing site (SPS) in the 3 ’ external transcribed spacer (3 ’ETS), yielding the 45S pre-rRNA. 
Cleavage at the primary processing site is mediated by the U3 snoRNP. For subsequent processing steps, the pathway (indicated by 
arrows) depends on the temporal order o f  cleavages at sites 1 and 2. Based on experiments performed in yeast and Xenopus laevis 
oocytes (4, 68), the U3 snoRNP is predicted to play a role in processing at sites 1 and 3 (as indicated). The RNase MRP endonu­
clease might cleave at site 2.
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In human cells, the nascent pre-rRNA (47S) is 
rapidly cleaved at the primary processing site in the 
5’ETS and at the second processing site in the 
3’ETS (Figure 3B; PPS and SPS, respectively), 
yielding the 45S pre-rRNA. For subsequent process­
ing steps, the pathway depends on the temporal 
order of cleavages at sites 1 and 2 (Figure 3B), but 
there may be even other, alternative pathways (6,
19).
Cleavage at the primary processing site can be 
effectively reproduced in mouse cell extracts and 
this activity is mediated by processing complexes 
that include the U3 snoRNP (27, 29). These proces­
sing complexes are thought to represent the “termi­
nal balls” that assemble at the 5’ end of nascent pre- 
rRNA transcripts as seen in chromatin spreads (8, 
48, 49). Very little is known about how the U3 
snoRNP is incorporated into these processing com­
plexes. Interestingly, genetic depletion experiments 
performed in yeast show that the U3 snoRNA is 
essential for terminal ball formation on the pre- 
rRNA (8).
The mouse processing signal is highly con­
served in human and rat pre-rRNA (~85%), as well 
as in other mammals, and these sequence elements 
indeed are involved in processing (27, 28, 64, 66). In 
Xenopus laevis oocytes, the U3 snoRNP has been 
shown to be required for cleavages at the 5’ and 3’ 
termini of the 18S rRNA as well (4, 58). Thus, it is 
likely that the human U3 snoRNP is also required 
for cleavages at sites 1 and 3 in the 47S pre-rRNA 
(Figure 3B). It is, however, unclear whether sites 1 
and 3 are functional equivalents of the A1 and A2 
sites in yeast.
The U3 snoRNA
The RNA component of the U3 snoRNP com­
plex (U3 snoRNA) contains two distinct functional 
domains: the 5’ domain and the 3’ domain (Figure 
4). The 5’ domain contains sequence elements that
are important for base-pairing with the pre-rRNA: 
box GAC, box A, box A’, 5’hinge, and 3’hinge. The 
3’ domain of the U3 snoRNA contains four con­
served RNA sequence elements, namely boxes B, C, 
C’ and D, which are involved in protein binding (47,
54, 57). Boxes C’ and D are found close to to each 
other in the secondary structure at the base of the 3’ 
domain and correspond to the common box C/D 
motif. The highly conserved boxes B and C are 
located in the upper part of the 3’ domain and 
together constitute the box B/C motif, which is 
unique to the U3 snoRNA. Several studies suggest 
that the box B/C and box C’/D motifs are function­
ally distinct. In contrast to the box B/C motif, the 
box C’/D motif has been shown to be required for 
5’-cap hypermethylation, snoRNA stability and 
nucleolar localisation (57, 62, 63, 74).
In yeast, base-pairing between box A and the 5’ 
terminus of the 18S rRNA sequence in the pre- 
rRNA blocks the formation of an evolutionarily con­
served pseudoknot structure, a long-range interac­
tion that is important for the formation and the func­
tion o f the small ribosomal subunit (22, 60). 
Mutations that largely disrupt this base-pairing 
result in defects in processing at sites A1 and A2 
(Figure 3A). Similar base-pairing interactions can 
occur in vertebrates (22, 60), suggesting that not 
only the sequence but also the function of box A in 
pre-rRNA processing is evolutionarily conserved. 
Based on these and other observations it has been 
suggested that the U3 snoRNP functions as an RNA 
chaperone. Its interaction with the pre-rRNA might 
render the processing sites accessible to endonucle­
ases.
The role of boxes GAC and A’ of the yeast U3 
snoRNA is less clear. In Xenopus laevis oocytes 
these elements are required for cleavages at the 5’ 
and 3’ terminus of the 18S rRNA sequence (3, 5) 
(site 1 and 3 in the 47S pre-rRNA; Figure 3B).
The 5’ hinge and 3’ hinge elements have the
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Base-pairing with the pre-rRNA
Figure 4. Schematic representation of the human U3 snoRNA secondary structure.
The secondary structure for U3 snoRNA is based on chemical and enzymatic probing experiments and in vivo mutation analysis 
studies performed in a variety o f organisms (3, 25, 47, 54). The 5’ domain contains the sequence elements required for base-pair­
ing with the pre-rRNA (box A, box A’, box GAC, 5 ’ hinge and 3 ’ hinge). The position o f  boxes GAC, A  and A’ are indicated by 
brackets. The positions o f the 5 ’-and 3 ’ hinge are indicated by boxes. The positions o f  the conserved boxes B, C, C’ and D in the 
3 ’ domain o f  the U3 snoRNA are also indicated by boxes.
potential to base-pair with regions in the 5’ ETS of 
the pre-rRNA. It has been suggested that these
sequence elements function by correctly positioning 
the U3 snoRNA on to the pre-rRNA, thereby pro­
moting additional base-pairing interactions between 
the U3 snoRNA and 18S pre-rRNA sequences (3, 5). 
In yeast, the 5’ hinge is absolutely essential for
cleavages at sites A0, A 1 and A2, while the role of the 
3’ hinge in pre-rRNA processing is still obscure (1). 
In Xenopus leavis oocytes, the 3’ hinge is absolute­
ly essential for cleavages in the 5’ ETS and the 5’- 
and 3’ termini of the 18S rRNA (3). The spacing 
between the 5’ hinge and 3’ hinge is also important 
for 18S rRNA synthesis (3). Based on chemical and
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enzymatic probing experiments, this sequence ele­
ment is often drawn as part of a stem (Figure 4; here 
referred to as “hinge stem”) (3, 47, 79).
The common box C/D snoRNP proteins associat­
ed with the U3 snoRNP
Like other box C/D snoRNAs, the U3 snoRNA 
is associated with the common box C/D snoRNP 
proteins Nop56, Nop58, 15.5K/Snu13p and fibril- 
larin/Nop1p. In this section, these proteins and their 
interaction with the box C/D motif (box C’/D in the 
U3 snoRNA) will be discussed in more detail.
The 15.5K/Snu13p protein belongs to a family 
of RNA binding proteins that include the ribosomal 
proteins L7a, L32 and S12 and the box H/ACA core 
protein Nhp2 (33, 51). The human 15.5K protein 
was initially identified as a [U4/U6-U5] tri-snRNP- 
associated protein that is essential for pre-mRNA 
splicing and directly binds the 5’ stem-loop structure 
of the U4 snRNA (51). Surprisingly, the yeast 
Snu13p co-purified with the U3 snoRNP and genet­
ic depletion experiments in yeast showed that 
Snu13p is essential for box C/D snoRNA stability 
(76).
The crystal structure of 15.5K bound to a U4
snRNA 5’ stem-loop fragment has recently been 
solved (72). Binding of 15.5K to this RNA element 
induces a kink in the phosphodiester backbone that 
causes a sharp turn in the RNA helix. Other features 
of the 15.5K binding site are an asymmetrical inter­
nal loop, two sheared G-A base-pairs, a high degree 
of purine stacking and a flipped-out nucleotide in 
the internal loop. A schematic representation of the 
15.5K binding site in the U4 5’ stem-loop is shown 
in Figure 5A. Interestingly, both box C/D motifs and 
the U3-specific box B/C motif can adopt a second­
ary structure highly reminiscent of the 15.5K bind­
ing site in the U4 snRNA (Figure 5A) and it has 
been shown that 15.5K indeed directly binds to 
these motifs in vitro in the absence of other box C/D 
snoRNP proteins (76). Mutational analysis of the U4 
5’ stem structure, the U14 C/D motif, and the U3 
B/C and C’/D motifs has demonstrated that the con­
served G and A nucleotides in the internal loop 
(Figure 5A) are essential for 15.5K binding (51, 72, 
74, 76). These data strongly support the secondary 
structures of the box C’/D and box B/C motifs in the 
3’ domain of the U3 snoRNA depicted in Figure 5, 
B and C.
The fact that Snu13p/15.5K is associated with 
two different classes of RNP complexes raises the
Figure 5 (opposite side). The box C’/D and box B/C motifs of the human U3 snoRNA can be folded into a structure that 
resembles the 15.5K binding site in the U4 snRNA.
A) The sequence and secondary structure models for the 5 ’ stem-loop o f  the U4 snRNA, the U8 and U14 box C/D motifs and the 
U3 box B/C and box C’/D motifs. The highly conserved nucleotides that are essential for 15.5K binding to the U4 snRNA 5 ’ stem- 
loop are marked by a black box. The grey boxes indicate the remaining nucleotides that are conserved in the individual box ele­
ments (76)]. The positions o f  stem I, stem II and the box elements are indicated. The dots depict non-Watson-Crick base-pairing 
interactions. The sequences and structures were adopted from references 51 and 76.
B) Secondary structure model for a box C/D snoRNA base-paired to pre-rRNA. On the left, a part o f  the model depicted in Figure 
2B is shown. On the right a secondary structure model is shown o f  the same region in which the proposed secondary structure o f 
the box C/D motif is included. The positions o f stem I, stem II and the box elements are indicated. The dotted lines indicate non- 
Watson-Crick base-pairing interactions. The highly conserved nucleotides that are essential for 15.5K binding are marked by black 
boxes. The grey boxes indicate the highly conserved nucleotides o f  stem II in box C/D snoRNAs.
C) Secondary structure models o f  the U3 snoRNA specific box B/C motif with flanking stems. On the left the secondary structure 
model for the box B/C motif, as proposed by Parker and Steitz (54), is shown. On the right a model is shown in which the proposed 
secondary structure o f  the box B/C motif is included. The positions o f  stem I, stem II and the box elements are indicated. The dot­
ted lines indicate non-Watson-Crick base-pairing interactions. The highly conserved nucleotides that are essential for 15.5K bind­
ing are marked by black boxes. The grey boxes indicate the conserved nucleotides o f  boxes B and C. Note that the structure o f  the 
box B/C motif is a mirror-image of the box C/D motif depicted in B).
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interesting question how functionally distinct com­
plexes can assemble around the 15.5K-RNA com­
plex. Interestingly, the 15.5K protein primarily con­
tacts the nucleotides in the internal loop leaving the 
flanking stem structures accessible for other pro­
teins.
Nop56 and Nop58 are highly basic and struc­
turally related proteins that might originate from a 
common ancestor. Indeed, in Archaea only one 
homologue of Nop56 and Nop58 has been identified 
(Nop56/58) (16, 50) and it has recently been shown 
that Nop56/58 is a core component of Archaeal box 
C/D snoRNPs (53). However, in eukaryotes Nop56 
and Nop58 appear to have distinct functions. In con­
trast to Nop56, Nop58 is required for box C/D 
snoRNA stability (38, 39). Both proteins are associ­
ated with fibrillarin/Nop1p, and Nop58 can interact 
with box C/D snoRNAs independent of fibrillarin 
and Nop56 (38, 39).
Fibrillarin is one of the most highly conserved 
box C/D proteins and is probably the enzyme that 
catalyzes 2’-O-methylation since it exhibits struc­
tural homology with known methyl transferase 
enzymes (73). Indeed, the methyl transferase activi­
ty of fibrillarin with box C/D snoRNPs has recently 
been demonstrated in vitro using both native and 
reconstituted complexes (14, 53). However, since 
the U3 snoRNP is not involved in 2’-O-methylation 
it is unclear what the function of fibrillarin in this 
snoRNP might be.
The U3 snoRNP specific proteins
In addition to the common box C/D compo­
nents, immunoprecipitation experiments showed 
that the U3 snoRNA specifically interacts with 
Rrp9p (hU3-55K in human), Imp3p, Imp4p, Mpp10, 
Rcl1p, Sof1p, Lcp5p, Mrd1p and Dhr1p (2, 7, 9, 24, 
26, 41, 44, 69, 78). Genetic depletion experiments in 
yeast have demonstrated that all these proteins, like
the U3 snoRNA, are essential for viability and 
required for processing at sites A0, A 1 and A2, and 
thus for 18S rRNA synthesis. In contrast to Nop58 
and 15.5K/Snu13p, none of these proteins are essen­
tial for U3 snoRNA stability, suggesting that they 
are more important for U3 snoRNP function than for 
its biogenesis (reviewed in 65, 68).
Rrp9p/hU3-55K and Sof1p belong to the family 
of WD40 repeat proteins. WD40 repeat domains 
have been reported to mediate protein-protein inter­
actions (24, 55, 61). Sof1p was identified as a sup­
pressor of a yeast fibrillarin mutant, suggesting that 
these proteins physically interact in the U3 snoRNP 
complex (24).
The human Mpp10 protein was initally identi­
fied as a nucleolar protein that is phosphorylated 
during the M phase of the cell cycle (78). Co- 
immunoprecipitation experiments demonstrated that 
hMpp10 and its yeast counterpart (Mpp10p) specif­
ically associate with the U3 snoRNP complex (9, 
78). The yeast Imp3p and Imp4p proteins were iden­
tified in a two-hybrid screen using Mpp10p as a bait 
(41). Both Imp3p and Imp4p are predicted to be 
RNA binding proteins. Imp3p contains a putative S4 
RNA binding domain, a motif first identified in the 
ribosomal protein S4. Imp4p belongs to the Imp4 
superfamily of proteins, which are characterised by 
a so-called o 70-like RNA binding motif (41, 77). All 
the members of the Imp4 superfamily are involved 
in pre-rRNA processing, although Imp4 appears to 
be the only member that interacts with the U3 
snoRNP complex and is required for early pre- 
rRNA processing steps (11, 41, 77). Mpp10 contains 
several putative coiled-coil domains, which are 
often involved in inter-or intra-molecular interac­
tions (9, 45, 78). In addition, recent proteomic stud­
ies have identified a large number of novel proteins 
that associate with the U3 snoRNA in higher order 
processing complexes (8, 18). The purified yeast U3 
snoRNP monoparticle was shown to contain
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Nop56p, Nop58p, Nop1p, Snu13p and only one U3- 
specific protein, namely Rrp9p (69, 76), suggesting 
that the other proteins interact with the U3 snoRNA 
in pre-rRNA processing complexes (2, 12).
Nucleolar distribution of the human U3 snoRNA 
and pre-rRNA processing intermediates
It is generally accepted that the nascent pre- 
rRNA transcripts reside in the DFC region and that 
late processing steps take place in the GC. The 
mammalian U3 snoRNA is distributed throughout 
the nucleolus, but higher concentrations are found in 
regions of the nucleolus that resemble the FC and 
surrounding DFC (reviewed in 17). In contrast, fib- 
rillarin is predominantly found in the DFC region. 
Both the U3 snoRNA and fibrillarin are also present 
in a nuclear compartment called the Cajal body (15), 
which is involved in snoRNP biogenesis (13, 70,
71).
The localisation of the U3 snoRNA in the GC 
suggests that it remains associated with the pre- 
rRNA when it moves from the DFC to the GC. This 
leads to the question which processing event(s) trig­
gers this transition? Because it has not yet been 
established where in the nucleolus specific pre- 
rRNA processing steps take place, it is presently 
impossible to answer this question. The U3 snoRNP 
mediated cleavage at the primary processing sites 
may take place in the DFC since the nascent tran­
script was primarily detected in this compartment 
(40). Regions in the 5’ ETS downstream of the pri­
mary processing site are readily detected throughout 
the nucleolus, suggesting that U3 snoRNP mediated 
cleavage at site 1 may occur in the GC ((40) and ref­
erences therein) (Figure 3B).
Outline of this thesis
The aim of the project was to gain more insight 
into the assembly and architecture of the human U3 
snoRNP complex. How many proteins are associat­
ed with the U3 snoRNP complex? Which regions of 
the U3 snoRNA are required for the association of 
the individual proteins? And vice versa, which pro­
tein domains are required for the association with 
the U3 snoRNP? At the start of the project, a cDNA 
encoding the human U3-55K protein had already 
been cloned. We set out to further characterise this 
protein and to determine the regions that are impor­
tant for its association with the U3 snoRNA in vivo 
(Chapter 2). In C hapter 3, the development of a 
U3 snoRNP reconstitution assay in a HeLa nuclear 
extract is described as well as its application in stud­
ies addressing the way in which hU3-55K is assem­
bled into the U3 snoRNP complex. In this Chapter 
we also provide evidence that the proposed second­
ary structure for the box B/C motif shown in Figure 
5C indeed exists in the U3 snoRNA. In C hapter 4 
we describe the cloning and characterisation of the 
human Imp3 and Imp4 proteins and their interaction 
with Mpp10.
To gain more insight into how and where in the 
cell U3 snoRNP complexes are formed, we devel­
oped an in vivo system that allowed us to monitor 
the effect of mutations in conserved regions of the 
U3 snoRNA on U3 RNP formation and subnucleo- 
lar distribution (Chapter 5). C hapter 6 discusses 
the characterisation of another human homologue of 
a yeast U3 snoRNP protein. However, the results 
presented in this manuscript suggest that the human 
counterpart of the yeast Sof1p protein is not associ­
ated with the U3 snoRNA.
The results are discussed and summarised in 
C hapter 7.
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Abstract
U3 small nucleolar RNA (snoRNA) is a member of the box C/D family of snoRNAs 
that functions in ribosomal RNA processing. U3-55K is a protein that has been found to 
interact with U3 but not other members of the box C/D snoRNA family. We have found that 
interaction of the U3-55K protein with U3 RNA in vivo is mediated by the conserved box 
B/C motif which is unique to U3 snoRNA. Mutation of box B and box C, but not of other 
conserved sequence elements, disrupted interaction o f U3-55K with U3 RNA. Furthermore, 
a fragment of U3 containing only these two conserved elements was bound by U3-55K in 
vivo. RNA binding assays performed in vitro indicate that box C may be the primary deter­
minant of the interaction. We have cloned the cDNA encoding the Xenopus laevis U3-55K 
protein and find strong homology to the human sequence, including six WD40 repeats. 
Deletion of WD40 repeats or sequences near the carboxy terminus of U3-55K resulted in 
loss of association of the protein with U3 RNA and also loss of localisation of U3-55K to 
the nucleolus, suggesting that protein-protein interactions contribute to the localisation and 
RNA binding of U3-55K in vivo.
Introduction
Eukaryotic ribosome production requires the 
contribution of small nucleolar RNAs (snoRNAs) in 
the processing and modification of ribosomal RNA 
(rRNA). Involvement of snoRNAs in rRNA biogen­
esis includes the processing of the primary rRNA 
transcript into the mature 18S, 5.8S, and 28S 
rRNAs, the methylation of selected ribose moieties 
(2’ O-methylation), and the isomerisation of specif­
ic uridine residues (pseudouridylation) (3, 22, 39,
55, 59, 66). More than 150 snoRNAs have been 
identified and are divided into two major classes: 
the box C/D snoRNAs and the box H/ACA 
snoRNAs (4, 18). These two classes are distin­
guished by conserved sequence / secondary struc­
ture elements, and by associated proteins (4, 18). 
Both snoRNAs and their associated proteins are 
essential to the maturation of rRNA, indicating that 
the functional complexes in rRNA processing and 
modification are small nucleolar ribonucleoprotein 
particles (snoRNPs) (63).
The U3 snoRNA is a box C/D snoRNA essential 
for the processing of 18S rRNA from the pre-rRNA
transcript (7, 8, 14, 25, 29, 42, 52). Sequence analy­
sis of U3 snoRNA reveals six evolutionarily con­
served sequence elements, termed boxes A, A’, B, C, 
C’, and D (23, 26, 28, 30, 35, 40, 41, 46, 47, 49, 51). 
Box A and box A’ are located in the 5’ domain of U3 
snoRNA, and along with the “hinge” region, base- 
pair to sites within the pre-rRNA to direct the multi­
ple endonucleolytic cleavages necessary for the 
maturation of 18S rRNA (7, 8, 24, 41, 47). Boxes B, 
C, C’, and D are found in the 3’ domain of U3 and 
have been characterised as sequences required for 
protein association (23, 28, 37, 41, 47). The second­
ary structure of the 3’ domain positions boxes B and 
C, as well as boxes C’ and D into discrete loops 
flanked by base-paired stems to form the box B/C 
and box C’/D motifs respectively (41, 51, 58). The 
box C’/D motif of U3 is equivalent to the box C/D 
motifs of other members of this snoRNA family in 
sequence/structure and function (41, 51, 58). The 
box B/C motif is unique to U3 snoRNA. Both the 
box B/C and box C’/D motifs operate as independ­
ent units of U3 RNA nuclear retention in the 
Xenopus oocyte (58). The box C’/D motif of U3 also
26 Chapter 2
directs the localisation of the snoRNA to the nucle­
olus (43). The functions associated with the box B/C 
and box C’/D sequence motifs are very likely medi­
ated by proteins that bind at the sites.
The U3 snoRNA exists as a U3 snoRNP in vivo 
(15, 30, 61). The RNA is associated with proteins 
common to all box C/D snoRNAs, including fibril- 
larin/Nop1p (6, 54), Nop56p (32), and 
Nop58/Nop5p (31, 38, 69), and proteins specific to 
the U3 snoRNP including, Sof1p (27), Mpp10 (13, 
67), Lcp5p (68), Imp3p (36), Imp4p (36), and U3- 
55K (37, 48). Each of these proteins (like U3 RNA) 
are essential and have been shown to be specifically 
required for the maturation of 18S rRNA(13, 21, 27, 
36, 60, 68, 69). U3-55K, the focus of this work, was 
initially identified as part of a trimeric complex 
(p55, p50, and p15) that co-purified from CHO cells 
with U3 snoRNA. The co-purification of the trimer- 
ic complex with U3 snoRNA was carried out under 
conditions of high salt (650 mM KCl or 500 mM 
NaCl), suggesting that the three proteins are core 
components of the U3 snoRNP (37). Lübben et. al. 
analysed deletion mutants of human U3 RNA and 
determined that a central region of the RNA 
(nucleotides 97-204) was important for binding of a 
complex that included CHO U3-55K in vitro (37). 
The cDNA for the U3-55K protein was subsequent­
ly isolated from a human teratocarcinoma library 
and the protein was characterised in HeLa cells (48). 
Pluk et al. found that human U3-55K (hU3-55K) co­
localised with fibrillarin in nucleoli, and showed the 
association of hU3-55K with U3 in vivo (48). In 
addition, characterisation of several hU3-55K 
mutants revealed that replacement of 17 amino acids 
at the carboxy terminus disrupted localisation of the 
protein to nucleoli and the ability of U3-55K to 
associate with U3 snoRNA in vivo (48).
U3-55K belongs to the WD40 repeat family of 
proteins (48), characterised by the core sequence 
[GH]-(X23-41)-[WD] arranged in repeats of four to
eight units (44, 56, 62). Beta transducin (Gß), a 
member of the same family, has seven WD40 
repeats which fold into a propeller-like structure 
with each repeat motif forming a discrete blade of 
the propeller (33, 57, 65). Although Gß is the only 
WD40 repeat protein whose structure has been 
determined by crystallography, structural analysis 
and homology modeling of other WD40 proteins 
indicate that the propeller structure may be common 
to the members of the family (19, 20, 45, 53). The 
structure appears to provide a platform on which 
protein-protein interactions can occur, with the 
specificity of these interactions being directed by 
variable sequences within each WD40 repeat.
WD40 repeat proteins have been found to func­
tion in a variety of processes (44). Several WD40 
repeat proteins in addition to U3-55K (e.g. PRP4, 
PRP17, U5-40kD, and Sof1) have been found to be 
associated with specific RNAs (1, 2, 9-12, 17, 27). 
Like U3-55K, these proteins do not contain known 
RNA binding motifs and it remains to be determined 
whether these proteins interact directly with the 
associated RNAs.
We have isolated the Xenopus homologue of 
U3-55K (XlU3-55K) and characterised the 
sequences of Xenopus U3 RNA important for inter­
action with U3-55K both in vivo and in vitro. Our 
results indicate that the box B/C motif of U3 
snoRNA is both necessary and sufficient for U3- 
55K binding in vivo. In vitro analysis suggests that 
box C is of greater importance than box B in the 
interaction between U3 and U3-55K. In addition, we 
have examined the effects of deletion of regions of 
hU3-55K on nucleolar localisation of the protein 
and U3 snoRNP assembly. While nuclear localisa­
tion sequences and a glutamic acid rich region near 
the amino terminus are not required, our results indi­
cate that the WD40 repeats and specific sequences 
near the carboxy terminus of hU3-55K are required 
for localisation to the nucleolus and interaction with
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Figure 1. Alignment o f  Xenopus laevis U3-55K with human and yeast homologues.
An alignment between the predicted amino acid sequences o í  Xenopus laevis (XI), human (h), and Saccharomyces cerevisiae (Sc) U3-55K was generated using PILEUP from the GCG Wisconsin 
Sequence Analysis package (Version 10). Residues that are identical in 2 sequences are in black boxes; similar residues are in grey boxes. WD repeat motifs were identified using the Protein Structure 
Analysis server at the BioMolecular Engineering Research Center (http://BMERC-www.bu.edu/) and are indicated with brackets. The glutamic acid-rich region defined in Pluk et. al. 1998 (48) is indi­
cated with a bar (E-rich region).
U3 snoRNA.
Results
Isolation and characterisation of Xenopus U3- 
55K
U3-55K has been found to interact specifically 
with U3 snoRNA in hamster and human cells (37, 
48). In order to determine the U3 RNA sequences 
required for the association of U3-55K in vivo 
(using the Xenopus oocyte system), we cloned the 
cDNA encoding the Xenopus laevis homologue of 
U3-55K. The Xenopus clone was identified by RT- 
PCR using degenerate oligonucleotide primers 
based on alignments of the human U3-55K (48) 
with sequences from potential mouse and yeast 
homologues present in the GenEMBL sequence 
database (see Materials and Methods). The predict­
ed amino acid sequence of the Xenopus homologue, 
XlU3-55K, is shown with the human and yeast 
sequences in Figure 1. The Xenopus U3-55K protein 
is approximately 65% identical and 73% similar to 
the human, and 41% identical and 54% similar to 
the yeast homologue. The positions of each of 5 
WD40 repeats initially identified in hU3-55K (48) 
are conserved in XlU3-55K (Figure 1, WD1-5). In 
addition, we report the presence of a sixth WD40 
repeat in both human and Xenopus U3-55K (Figure 
1, WD6). The yeast U3-55K contains stretches of 
amino acids not found in the human and Xenopus 
proteins (e.g. between WD4 and WD5) and shares 5 
of the 6 WD40 repeats found in human and Xenopus 
(WD2-6) but lacks a WD40 consensus sequence at 
WD1. A Caenorhabdiditis elegans homologue of 
U3-55K (CE21137) contains 4 of the 6 WD40 
repeats corresponding to human/Xenopus WD3-6 
(R. Terns and M. Terns, unpublished data). Putative 
nuclear localisation signals were identified within 
the first 45 amino acids of U3-55K (48) and these 
signals appear to be conserved in Xenopus U3-55K. 
Xenopus U3-55K also contains a glutamic acid-rich
region near the N terminus (amino acids 60-65) that 
is found in the human and yeast homologues. The 
sequence analysis indicates that we have isolated the 
Xenopus laevis homologue of U3-55K, and that 
Xenopus and human U3-55K each contain six 
potential WD40 domains.
The XlU3-55K protein was expressed in E. coli 
and used to generate antibodies (see Materials and 
Methods). The affinity purified antibodies recognise 
a ~60 kDa protein by western blot analysis of 
Xenopus oocyte nuclear extract (Figure 2A, lane 2). 
We assessed the cellular localisation of XlU3-55K 
in nuclear spreads prepared from Xenopus oocytes 
and in a Xenopus somatic cell line using the aU3- 
55K antibodies (Figure 2B and 2C). The immuno­
fluorescence analysis revealed that XlU3-55K is 
present in the nucleoli of both cell types (Figure 2B, 
panel b; Figure 2C; panel b).
Analysis of U3 RNA sequences required for U3- 
55K association in vivo
We have used the antibodies against XlU3-55K 
to investigate the sequences in U3 snoRNA required 
for interaction with U3-55K in vivo. In these exper­
iments, radiolabeled Xenopus U3 and control RNAs 
(U1 and U6 snRNAs, U8 snoRNA, and 5S rRNA) 
were co-injected into Xenopus oocytes and allowed 
to incorporate into RNP complexes. Four hours after 
injection, RNP complexes containing U3-55K were 
immunoprecipitated from oocyte nuclear extracts. 
The aU3-55K antibodies specifically immunopre- 
cipitated a complex containing U3 RNA (Figure 3, 
lane 5). In order to determine which conserved U3 
RNA sequence elements are necessary for interac­
tion with U3-55K, we substituted the sequence of 
each of the phylogenetically conserved U3 box ele­
ments, A, A’, B, C, C’, and D as well as the hinge 
with complementary sequences (see Figure 3, A 
indicates substitution). Each of the radiolabeled U3 
mutant RNAs was co-injected with the control
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Figure 2. Antibodies against U3-55K recognise a nucleolar protein in Xenopus cells.
(A) Immunoblot analysis o f extract from 5 Xenopus oocyte nuclei was performed using pre-immune sera (NIS; lane 1) or affinity 
purified aU3-55K antibodies (lane 2). The arrow indicates the primary band corresponding to a ~60 kDa protein. 
Immunofluorescence analysis was carried out on Xenopus oocyte nuclear spreads (B) and Xenopus kidney cells (C). Differential 
interference contrast (DIC, panels a and c) and fluorescence (panels b and d) microscopy images are shown for each experiment. 
Representative nucleolar structures are indicated with arrowheads. Samples were analysed using pre-immune (panel d) and affin­
ity purified aU3-55K (panel b) antibodies.
RNAs and tested for interaction with the U3-55K 
protein by immunoprecipitation. We found that sub­
stitution of the box B or box C element of U3 RNA 
disrupted association with the U3-55K protein 
(Figure 3, U3AB and U3AC, lanes 19-24). 
Substitution of the other sequence elements did not 
prevent interaction (Figure 3, U3AA’, U3ADA, 
U3AH, U3AC’, and U3AD, lanes 7-18, 25-27). The 
results indicate that box B and box C of U3 snoRNA 
are necessary for interaction with U3-55K in vivo.
In order to assess whether the box B/C motif of 
U3 RNA is also sufficient for U3-55K binding, we 
tested the ability of stable fragments of U3 RNA to 
interact with U3-55K. Again, radiolabeled RNAs 
were injected and interaction was assessed by 
immunoprecipitation. A fragment consisting of the 
entire 3’ domain of U3 was bound by U3-55K in 
vivo (Figure 4, 3’ Domain, lanes 1-3), but as expect­
ed U3-55K did not interact with a sub-fragment con­
sisting of the box C/D motif (composed of U3 box 
C’, box D, and flanking stems; Figure 4, lanes 7-9). 
A sub-fragment containing box B, box C and the 
adjacent stem regions of U3 RNA was co-immuno-
precipitated with aU3-55K antibodies (Figure 4, 
lanes 4-6) indicating that the box B/C motif is suffi­
cient for interaction with U3-55K in vivo.
Interaction of U3-55K with U3 RNA in vitro
We have found that box B and box C are each 
necessary for interaction of U3-55K in vivo (Figure 
3). Lübben et. al. reported that interaction of a com­
plex of proteins that included U3-55K with U3 RNA 
in vitro required a region of the RNA containing 
both box B and box C (37). Interestingly, we found 
that box C is the primary determinant of U3-55K 
binding in an in vitro binding assay. In vitro translat­
ed, radiolabeled hU3-55K was incubated with 
biotinylated Xenopus U3 RNA, the RNA was select­
ed using streptavidin beads, and the association of 
U3-55K was assessed by fluorography. We found 
that U3-55K bound to U3 RNA (Figure 5A). While 
only a small fraction (~0.5%) of the U3-55K added 
to the reaction was co-precipitated, the interaction 
was reproducible and specific to U3. U3-55K did 
not interact with U8, another box C/D snoRNA 
(Figure 5A, lane 7, and 5B, lane 4). The amount of
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Figure 3. Box B and box C of U3 snoRNA are required for U3-55K association in vivo.
In vitro transcribed, 32P labeled U3 and U8 snoRNAs, U1 and U6 snRNAs, and 5S rRNA were co-injected into the nuclei o f 
Xenopus oocytes. After four hours complexes were immunoprecipitated using aU3-55K antibodies, and co-immunoprecipiated 
RNAs were isolated from both pellet (P) and supernatant (S) fractions and analysed by gel electrophoresis and autoradiography. 
For each experiment, 100% of the pellet (P) and 50% o f the total (T) and supernatant (S) samples were analysed. 
Immunoprecipitation using pre-immune serum (NIS) is shown in lanes 1-3. Immunoprecipitation, using aU3-55K antibodies with 
wildtype and variant U3 snoRNAs are shown in lanes 4-27. The positions o f the conserved sequence elements are indicated on the 
U3 RNA secondary structure model diagram.
U3-55K observed with U8 in Figure 5A (lane 7) was 
similar to that bound to streptavidin beads alone 
(data not shown).
Furthermore, we have found that the interaction 
of U3-55K with U3 RNA in vitro depends upon spe­
cific sequences in U3. Substitution of boxes A, C’, 
and D of U3 did not reduce the association of U3- 
55K with the RNA (Figure 5A). However, mutation 
of box C eliminated the interaction of U3-55K with 
the U3 RNA, reducing it to the background level 
observed with U8 RNA (Figure 5A). Disruption of 
box B did not prevent U3-55K binding in vitro, but 
did appear to reduce binding relative to wild-type 
and other mutants (Figure 5A). Our results indicate 
that interaction of U3-55K with U3 RNA in vitro 
depends predominantly on box C and to a lesser 
extent on box B of U3. While it is important to note 
that we cannot exclude the possibility that protein 
components present in the wheat germ extract used 
to generate the U3-55K protein contributed to the 
U3 RNA binding, our results may indicate that U3-
55K interacts directly with U3 RNA. Assessment of 
direct binding of purified, recombinant U3-55K 
expressed in E. coli to U3 RNA was not possible due 
to the insolubility of the protein under all tested con­
ditions.
We tested the ability of U3-55K to interact with 
fragments of U3 RNA containing the box B/C motif 
in vitro. Both the 3’ domain of U3 and a subfrag­
ment comprised of box B, box C, and flanking stem 
sequences were bound by the U3-55K protein in 
vitro (Figure 5B). The interactions with the frag­
ments appeared to be reduced relative to wildtype 
U3 but were substantially greater than the back­
ground observed with U8 RNA. In summary, our 
results suggest that the box B/C motif of U3 is nec­
essary and sufficient for interaction of U3-55K in 
vivo, but that box C may be a primary determinant 
of the interaction.
m
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Analysis of U3-55K sequences required for nucle­
olar localisation and association with U3 RNA
Previous work indicated that replacement of 17 
amino acids at the carboxy terminus of human U3- 
55K (with 15 vector-encoded amino acids) disrupt­
ed interaction of U3-55K with U3 RNA and result­
ed in loss of localisation of U3-55K to the nucleolus 
(48). Deletion of 45 amino acids from the amino ter­
minus of the protein, including a putative nuclear 
localisation sequence, did not prevent interaction 
with U3 or nucleolar localisation of the protein (48). 
We have further investigated the role of hU3-55K 
sequences in these two processes in experiments 
using VSV-tagged hU3-55K deletion mutants 
(Figure 6A) expressed in transfected cells.
We first assessed the level of expression of each 
of the VSV-tagged proteins by analysis of total 
extract of 1.0 x 106 transfected COS-1 cells using 
anti-VSV monoclonal antibodies. The various 
mutant proteins were found to be expressed at levels 
comparable to VSV-tagged wildtype human U3- 
55K (Figure 6B).
VSV-tagged wildtype U3-55K interacted with 
U3 RNA and localised to nucleoli in our experimen­
tal system. We have assessed the ability of hU3-55K 
proteins to interact with U3 RNA by precipitation of 
the VSV-tagged proteins from transfected cell 
extracts and northern analysis of co-precipitated 
RNAs (Figure 6C). While the VSV protein alone did 
not co-precipitate U3 RNA (Figure 6C, lane 5), 
wildtype VSV-tagged hU3-55K expressed in COS-1 
cells associated with U3 snoRNA as expected 
(Figure 6C, lane 2). Fibrillarin is also found associ­
ated with U3 RNA in these cells (Figure 6C), and 
fibrillarin immunoprecipitations were included as 
positive controls in each of the co-precipitation 
experiments that will be described. The cellular 
localisation of expressed U3-55K proteins was eval­
uated by immunofluorescence using anti-VSV anti­
bodies (Figure 6D). As expected, wildtype VSV-
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Figure 4. Fragment o f U3 snoRNA containing box B and 
box C is sufficient for U3-55K association in vivo.
32P-labeled U3 snoRNA fragments and U1 snRNA (negative 
control) were injected into the nuclei o f Xenopus oocytes and 
tested for co-immunoprecipitation with aU3-55K antibodies 
as described in Figure 3. The subfragments o f U3 snoRNA are 
shown schematically above each panel.
tagged hU3-55K expressed in HEp-2 cells localised 
to nucleoli similar to fibrillarin (Figure 6D, panels b 
and j).
In order to further assess the role of the C-termi­
nal domain of U3-55K in nucleolar localisation and 
U3 RNA association (48), two additional carboxy 
terminal mutant constructs were analysed (Figure 
6A). We found that deletion of 17 amino acids at the 
carboxy terminus of U3-55K also disrupted U3 
RNA binding and U3-55K nucleolar localisation 
(A459-475, Figure 6C, lanes 7-9, and 6D, panel d). 
Though we cannot exclude the possibility that this 
deletion had global effects on protein folding, the 
mutant protein was expressed (Figure 6B) and
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Figure 5. Box C of U3 snoRNAis required for U3-55K asso­
ciation in vitro.
In vitro translated, 35S-labeled hU3-55K was added to in vitro 
transcribed, UTP-21-biotin labled RNA. The mixture was incu­
bated for 1 hour, and biotinylated RNAs were selected from the 
mixture with streptavidin agarose beads. hU3-55K associated 
with the biotinylated RNA was eluted by boiling in SDS-load- 
ing buffer and analysed by SDS-PAGE and fluorography. 
Biotinylated RNAs used in each reaction are indicated above 
each lane.
(A) Evaluation o f U3-55K association with wildtype (lane 1) 
and mutant (AA, AC’, AB, AC, and AD, lanes 2-7, respective­
ly) U3 snoRNA as well as U8 (lane 8).
(B) Evaluation o f  U3-55K association with U3 snoRNA 3 ’ 
domain and box B/C subfragments (lanes 2 and 3). Wildtype 
U3 and U8 are shown in lanes 1 and 4.
appeared to accumulate in the nucleoplasm (Figure 
6D, panel d). Deletion of the last 9 amino acids did 
not prevent RNA binding or nucleolar localisation 
(A467-475, Figure 6C, lanes 10-12, and 6D, panel 
f). These results indicate that residues located with­
in amino acids 459-466 of hU3-55K are important 
for interaction with U3 RNA and localisation of U3- 
55K to the nucleolus.
A glutamic acid rich region was previously 
noted near the amino terminus of the human U3- 
55K protein sequence (48). This region appears to 
be conserved in the yeast and Xenopus proteins 
(Figure 1). However, we have found that deletion of 
these amino acids did not prevent the interaction of 
the protein with U3 RNA or the localisation of U3- 
55K to the nucleolus (A64-74, Figure 6C, lanes 13­
15, and 6B, panel h).
WD40 repeats like those found in U3-55K have 
been characterised to be important for dynamic pro­
tein-protein interactions (44). We were interested to 
assess whether the WD40 repeats of U3-55K are 
important for association of the protein with U3 
snoRNA and localisation of the protein to nucleoli. 
Three deletion mutants were tested: A193-352 lack­
ing WD40 repeats 2-5, A193-315 lacking WD40 
repeats 2-4, and A140-230 lacking WD40 repeats 1 
and 2 (Figure 6A). The effects of the deletions on 
the overall structure of the protein are not known but 
did not prevent accumulation or nuclear import of 
the mutant proteins. Though each of the WD40 dele­
tion mutants was expressed in the transfected cells, 
U3 RNA was not found in association with any of 
the 3 mutants (Figure 6B, lanes 6-8, and 6C, lanes 
16-24). Co-precipitation of U3 was not detected 
even upon a 20 fold increased exposure of the north­
ern blot (data not shown). In addition, the WD40 
deletion mutants accumulated in the nucleus but did 
not localise to nucleoli (Figure 6D, panels l, n, p). 
The results suggest that the WD40 repeats of U3- 
55K are required for association of U3-55K with U3 
snoRNA and for localisation of U3-55K to nucleoli 
in vivo.
Discussion
A detailed understanding of the composition 
and organisation of the U3 snoRNP complex is 
required in order to understand U3 RNP biogenesis, 
transport, and function. Little information is avail­
able regarding the nature of the association of either 
the common box C/D-associated proteins or the U3- 
specific proteins with U3 RNA. In this study, we 
have identified sequence domains in both the U3 
RNA and U3-55K protein that are required for their 
association.
The predominant sequence feature of U3-55K is 
a series of six WD40 repeats. WD40 repeats within 
a protein are generally thought to mediate dynamic
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Figure 6. U3-55K sequences required for association with U3 RNA and localisation of U3-55K to the nucleolus.
(A) Schematic representation o f  the human U3-55K protein. The positions the nuclear localisation signals (NLS), glutamic acid rich 
region (E-stretch), and WD40 repeats in the human U3-55K protein are represented with boxes. The WD40 repeats are represent­
ed as black boxes. The amino acid positions relevant to the deletions used in B, C and D) are indicated.
(B) Expression levels o f hU3-55K deletion mutants. Western blots using aVSV antibodies are shown for COS-1 cells expressing 
untagged human U3-55K (lane 2), VSV tagged wildtype U3-55K (lane 1), and deletion constructs A459-475 (lane 3), A467-475 
(lane 4), A64-74 (lane 5), A140-230 (lane 6), A193-315 (lane 7), and A193-352 (lane 8). Lanes 3 and 5 are taken from a different 
blot.
(C) The effect o f hU3-55K deletions on U3 snoRNP association. VSV-tagged human U3-55K wildtype and deletion constructs (as 
indicated) were expressed in COS-1 cells, and complexes containing the tagged proteins (or endogenous fibrillarin) were immuno- 
precipitated using aVSV (or aFib) antibodies. Co-immunoprecipitated U3 RNA was detected by northern blotting. Co-immuno- 
precipitation o f U3 with fibrillarin is shown for each experiment. The input lanes contain 10% o f RNAisolated from extracts pre­
pared for immunoprecipitation.
protein-protein interactions and to provide a plat­
form for the assembly of multicomponent complex­
es (44). We found that disruption of the WD40 
repeats of U3-55K resulted in loss of association of 
the protein with U3 RNA in vivo (Figure 6C) sug­
gesting that protein-protein interactions play an 
important role in the protein-RNA association in 
vivo. At the same time, our finding that recombinant 
U3-55K protein interacts with U3 RNA in vitro sug­
gests that U3-55K may interact directly with U3 
RNA. The U3-55K protein sequence does not pos­
sess any recognisable RNA binding motifs, but may 
contain an undefined RNA-binding domain (possi­
bly including the sequences in the carboxy terminus 
of U3-55K that we found to be required for U3
snoRNA binding (Figure 6C)). Conceivably, U3- 
55K interacts directly with U3 RNA and the interac­
tion is strengthened by association with other pro­
teins in vivo.
The interaction of the U3-55K protein with U3 
RNA in vivo and in vitro depends upon conserved 
sequences in an RNA motif that is specific to U3, 
the box B/C motif (Figures 3, 4 and 5). Our findings 
are in good agreement with a previous study which 
demonstrated that a region of human U3 
(nucleotides 97-204) including box B and box C 
supported the assembly of a complex which includ­
ed CHO U3-55K in vitro (37). We found that muta­
tion of box B disrupted the interaction of U3-55K 
with U3 RNA to a greater extent in vivo than in vitro
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Figure 6 continued
(D) Cellular localisation o f  hU3-55K wildtype and deletion mutants. VSV-tagged U3-55K wildtype and deletion constructs were 
expressed in HEp-2 cells, and the localisation o f  the tagged proteins (or endogenous fibrillarin) was assessed by immuno­
fluorescence using aVSV (panels c-p) or aFib (panels a,b) antibodies. Phase contrast (panels a, c, e, g, I, k, m, o) and fluorescence 
(panels b, d, f, h, j, l, n, p) microscopy images are shown for each experiment. Fibrillarin is found primarily in the phase-dark nucle­
oli o f HEp-2 cells (panels a and b). VSV-tagged wildtype U3-55K (panels i and j), and deletion constructs A467-475 (panels e and 
f) and A64-74 (panels g and h) were localised to nucleoli. Deletion mutants A459-475 (panels c and d), A140-230 (panels k and l), 
A193-315 (panels m and n), and A193-352 (panels o and p) did not localise to nucleoli but accumulated in the nucleoplasm.
(Figures 3 and 5). The greater importance of box B 
in vivo may reflect the importance of another protein 
located at box B (which is absent or limited in the in 
vitro assay) in the interaction of U3-55K with U3. 
One model consistent with our results is that U3- 
55K interacts primarily with box C of U3 RNA and 
that the interaction is stabilised by association with 
other proteins (mediated by the WD40 repeats of 
U3-55K) that bind box B.
It is noteworthy that U3 snoRNA associates 
with two WD40 repeat proteins, U3-55K and Sof1. 
Sof1 (supressor of fibrillarin) was identified as a 
high copy supressor that overcomes the temperature 
sensitive phenotype of yeast expressing human 
rather than yeast fibrillarin, and like U3-55K inter­
acts specifically with U3 RNA (27). We have cloned 
the Xenopus (A. A. Lukowiak, S. Mattox, R. Terns, 
and M. P. Terns, unpublished data) and human (S. 
Granneman and W. J. van Venrooij, unpublished
data) Sof1 homologues and also plan to characterise 
the manner in which this WD40 repeat protein is 
recruited into U3 snoRNP complexes.
There is evidence that fibrillarin also requires 
box C for association with U3 RNA in vitro and in 
vivo (5, 6). It is possible that fibrillarin interacts with 
U3 RNA through association with U3-55K (or 
another associated protein). On the other hand, a 
recent study indicates that fibrillarin interacts direct­
ly, and in the absence of other proteins, with anoth­
er box C/D snoRNA, U16 (16), raising the interest­
ing question whether U3-55K and fibrillarin interact 
simultaneously or exclusively with U3 RNA. This 
work and another study indicate that U3-55K can 
associate with U3 RNA in the absence of fibrillarin 
(37).
U3 RNA is predominantly found within the 
nucleoli of various cell types where it functions in
2
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rRNA processing. It is now clear that U3-55K is also 
localised in the nucleoli of multiple cell types (48). 
The sequence elements involved in the localisation 
of U3 RNA to nucleoli have been investigated (34, 
43, 51). We have found that while the box B/C motif 
of U3 is involved in the retention of the RNA in the 
nucleus, it is neither required nor sufficient for 
nucleolar localisation (43, 58). Thus, U3-55K may 
function as part of the redundant mechanisms for 
nuclear retention of U3, but does not likely play a 
role in the targeting of U3 RNA to nucleoli. And 
indeed, U3-55K probably relies on interaction with 
U3 for its own localisation to the nucleolus. We 
observed a correlation between the ability of U3- 
55K variants to interact with U3 RNA and to be 
localised to nucleoli (Figure 6). Mutants that were 
not able to interact with U3 also did not localise to 
nucleoli. Thus, U3-55K may be targeted to nucleoli 
via interaction with the U3 snoRNP.
It will be important to determine the role of U3- 
55K in U3 snoRNP biogenesis and function. Studies 
in yeast have indicated that the box B/C motif (i.e. 
the U3-55K binding site) is not essential for stabili­
ty of U3 RNA but is essential for viability, indicat­
ing an important role for the box B/C motif in U3 
snoRNP function (41, 51). Correspondingly, it has 
been found that the yeast U3-55K homologue 
(Rrp9p) is also not required for the stability of U3 
RNA, but is essential for viability and 18S rRNA 
production (J. Venema and H. A. Raué, personal 
communication). Future work will further investi­
gate the role of U3-55K in rRNA proccessing by the 
U3 snoRNP.
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Materials and Methods
Cloning of the Xenopus laevis U3-55K  
The oligonucleotides used in the cloning o f XlU3-55K were: 
84,GAGCTGGARGARACYGCACAGGAAAAGAA; 85, 
TTCTCCACCATCGGCCAAGCCTGTGCTC; 111, CAATG- 
GCATCCT GAT CCTCG; 124, CT GGGATCCT CT GAC ATG; 
1 6 6 .G G A A T T C CAT A T G G A A T T C  A TG  T C C G G C -  
CTTTTCATCAAAAAGAAATCAGG;167,GAAGATCT- 
GAATTCGTGCAACAGGGTCAACAAAATATGTCTAT- 
GTGG.
The Xenopus homologue o f  hU3-55K was isolated using a 
combination o f RT-PCR and RACE (Rapid Amplification o f 
cDNA Ends) against mRNA isolated from stage V and VI 
Xenopus laevis oocytes (mRNA Separator Kit, Clontech, CA, 
USA). Degenerate oligonucleotides, 84 and 85, were designed 
based on sequences conserved between human (accession num­
ber AJ001340) and potential mouse (accession number 
AA170033), or yeast (accession number U40829, ORF: 
YPR137W) U3-55K sequences respectively, and used in RT- 
PCR (Boehringer Mannheim, IN, USA) to amplify an internal 
fragment (1090 bps) o f  the Xenopus U3-55K cDNA. Primers 
111 and 124 were used in RACE to isolate the 5 ’ and 3 ’ ends o f 
the cDNA, respectively (Marathon-Ready cDNA, Clontech, 
CA, USA, and 3 ’ RACE System, Gibco BRL, MD, USA). 
Primers 166 (start codon in bold) and 167 (3’ UTR) were 
designed with incorporated EcoRI sites (underlined) immedi­
ately flanking the predicted protein coding region. Using these 
primers, RT-PCR was used to isolate the full length (1451 bp) 
cDNA from purified Xenopus oocyte mRNA and the product 
was subcloned and sequenced.
Expression o f recombinant Xenopus U3-55K and produc­
tion of antibodies
The Xenopus U3-55K cDNA was excised by digestion at
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2the engineered EcoRI sites flanking the encoding cDNA, and 
cloned in frame into the EcoRI site o f the pET32a expression 
vector (Novagen, WI, USA). The fusion protein was expressed 
in E.coli BL21(DE3) and isolated by nickel chelation affinity 
chromatography under denaturing conditions (His-Bind Resin 
and Buffer Kit, Novagen, WI, USA) and gel purification. One 
New Zealand White rabbit was immunised with 250 ^g o f  the 
purified recombinant protein (Animal Resources, University of 
Georgia, GA, USA). Antibodies were affinity purified using 
purified XlU3-55K protein coupled to a N-hydroxysuccin- 
imide-activated sepharose column (HiTrap, Amersham 
Pharmacia Biotech, NJ, USA).
U3 snoRNA mutant constructs
Construction o f the Xenopus U3 snoRNA single box sub­
stitutions A, A’, B, C, C’, and D, the 3 ’ domain subfragment 
(nts. 75-220), the C’/D subfragment (nts. 75-104, tetraloop 
GCUU nts., 198-220) and B/C subfragment (nts. 93-208) has 
been detailed (43).
Injection of RNAs into Xenopus Oocytes
The procedure for microinjection of Xenopus oocyte 
nuclei has been described in detail (43, 58). In short, a mixture 
o f 32P-labeled RNAs was resuspended in 20 mg/ml o f  blue dex­
tran (at a final concentration o f 100 fmol o f U3 snoRNA/^l). 
Nuclear injections o f  Xenopus laevis oocytes (stages V and VI) 
delivered 10 nl (1 fmol o f  U3) o f sample, and cells were incu­
bated for 4 hours at 18°C in MBSH buffer. After incubation, 
nuclear extracts were prepared by manual enucleation o f  inject­
ed oocytes and homogenisation in Ipp100-T buffer (100 mM 
NaCl, 50 mM Tris-HCl pH 7.5, and 0.05% Triton X-100).
Construction o f hU3-55K deletion mutants
The oligonucleotides used to generate hU3-55K deletion 
mutants were:
55K140-For, GCCTCAGCTGACATTCGGATCC-
TACGGGGGCACCAGC; 55K140-Rev, GCTGGTGCCCC- 
CGTAGGATCCGATGTCAGCTGAGGC; 55K193-For, 
GAAGGGTGCCGAGGGATCCCCCCCTGGCCACAGC; 
55K193-Rev, GCT GT GGCC A GGGGGGG ATCCCTCG-
GCACCCTTC;55K230-For,CATTTGGGAGGCCCAGAG- 
GATCCAGCACTTGTACACCTTC; 55K230-Rev, GAAGGT- 
G TA CA G TG CTG GATCCTCTGGGCCTCCCAAATG; 
55K315-For, GGAAGATCCCCGAGGGATCCCAGCTTGTC 
TTCTATG;55K315-Rev, CATAGAAGACAAGCTGGATCC- 
CTCGGGGATCTTCC; 55K352-For, GTGGC- 
C TTG TG G G G TG G A TC C A A G A A G C G A C C A C T TG ; 
55K352-Rev, CAAGTGGTCGCTTCTTGGATCC 
ACCCCACAAGGCCAC; 55KAE-For, GCCTAGCTCCAAG- 
GAAGCCTACTGCACAGGAAAAGAAGCTG; 55KAE-Rev, 
CAGCTTCTTTTCCTGTGCAGTAGGCTTCCTTGGAGC- 
TAGGC; 55KA, GCAGCCCTTCTGATATCGTCGG;
55KB, AGAATCAAAGAGGCTCGGAATTCTTGATCTA- 
GAGCG; and 55KC, TGCATCATCCCACTCCGCAGGT- 
GATCTAGAGCG.
pCI-neo VSV-55K was constructed as described (48). The 
original hU3-55K cDNA was modified by PCR to introduce an 
Xhol site before the translational start codon (pGEM3Zf(+)- 
hU3-55K (48)).
The hU3-55K deletion mutants A459-475, A467-475, and 
A64-74 were generated via mutagenic PCR using pGEM 
3Zf(+)-hU3-55K as template. Deletion mutant A459-475 was 
made using oligonucleotides 55KA and 55KB which incorpo­
rate a stop codon (indicated in bold) at amino acid position 458 
followed by an in-frame XbaI restriction site (underlined). 
Deletion mutant A467-475 was made using oligonucleotides 
55KA and 55KC which incorporate a stop codon (bold) at 
amino acid position 466, followed by an in-frame XbaI site 
(underlined). The A459-475 and A467-475 PCR products were 
digested with EcoRV and XbaI and cloned into wildtype pCI- 
neo VSV-55K digested with EcoRV and XbaI. Deletion mutant 
A64-74 was generated by PCR (Quickchange site-directed 
mutagenesis kit, Stratagene, The Netherlands) using oligonu­
cleotides 55KAE-For and 55KAE-Rev and pGEM3Zf(+)-hU3- 
55K as template. The PCR product was digested with BglII and 
NarI and the 180 bp product, which lacked the E-stretch, was 
cloned into the wild-type pGEM3Zf(+)-hU3-55K vector digest­
ed with BglII and NarI, thereby replacing the wildtype 
sequence. The resulting construct, pGEM3Zf(+)-hU3-55KAE, 
was subsequently digested with HindIII, made blunt with
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Klenow polymerase and partially digested with XhoI. The 
resulting hU3-55K AE fragment was ligated into an XhoI and 
SmaI-digested pCI-neo vector that contains a 5 ’ VSV-G tag 
(MEIYTDIEMNRLGK). The resulting construct contained a 5 ’ 
VSV tag in-frame with the coding sequence o f  hU3-55K.
To construct the hU3-55K WD40 deletion mutants, PCR 
mutagenesis was performed on the pGEM3Zf(+)-hU3-55K 
cDNA using appropriate combinations o f the oligonucleotides 
listed above (QuickChange site directed mutagenesis kit, 
Stratagene, The Netherlands). In-frame deletions o f  WD40 
repeats were generated from five pGEM3Zf(+)-55K constructs 
that contain a BamHI site (underlined) at nucleotide positions 
452 (55K452), 610 (55K610), 723 (55K723), 977 (55K977) or 
1087 (55K1087), corresponding to amino acids 140, 193, 230, 
315, or 352. 55K A140-230 was made by combining the Xhol- 
BamHI fragment o f  55K452 with the BamHI-HindIII fragment 
o f 55K723. 55KA193-315 was created by combining the XhoI- 
BamHI fragment o f  55K610 with the BamHI-HindIII fragment 
o f 55K977. 55KA193-352 was created by combining the XhoI- 
BamHI fragment o f  55K610 with the BamHI-HindIII fragment 
o f 55K1087.
Finally, all pGEM3Zf(+) 55K deletion mutant constructs 
were digested with HindIII, made blunt with Klenow poly­
merase, and partially digested with XhoI. The resulting hU3- 
55K fragments were ligated into an XhoI and SmaI-digested 
pCI-neo vector. The resulting constructs contained a 5 ’ VSV tag 
in-frame with the coding sequence o f  hU3-55K. The correct­
ness o f each construct was confirmed by sequence analysis.
Expression of hU3-55K constructs in COS-1 and HEp-2 
cells
hU3-55K constructs were transiently transfected into cul­
tured cells. Monolayers o f cells were grown to 80% confluence. 
4-5 x 106 COS-1 cells were transfected in 400 ^l PBS with 20 
^g o f  DNA. Electroporation was performed at 300 V  and a 
capacity o f 125 ^Fa with Gene Pulser II (Bio-Rad, CA, USA). 
2.5 x 106 HEp-2 cells were transfected in 800 ^l o f Dulbecco’s 
modified Eagles’s medium with 10 ^g of DNA. Electroporation 
was performed at 260 V and a capacity o f 950 ^Fa with Gene 
Pulser II (Bio-Rad, CA, USA). After electroporation, cells were
resuspended in 5 or 10 ml o f Dulbecco’s modified Eagle’s 
medium supplemented with 10% fetal calf serum and grown for 
18 hours before use.
Immunoblot analysis
Analysis o f  Xenopus nuclear proteins with antibodies against 
XIU3-55K
Nuclear samples were prepared by manual dissection o f  
nuclei from stage VI Xenopus oocytes and were elec- 
trophoresed on a 10% SDS-polyacrylamide gel with 5 nuclear 
equivalents per lane. Proteins were transferred to nitrocellulose 
(BioRad, CA, USA). Immobilised proteins were blocked for 1 
hour with 5% Non-fat milk in TBS (100 mM Tris, 0.9% NaCl, 
pH 7.5) and washed three times in TBS. Pre-immune serum 
was diluted 1:100 and affinity purified aXlU3-55K antibodies 
(~2 mg/ ml) were diluted 1:2000 in TTBS (0.5% Tween-20 in 
TBS), and incubated with membranes for 1 hour at room tem­
perature. Membranes were washed and incubated with anti-rab­
bit IgG (whole molecule) alkaline phosphatase conjugated anti­
bodies (Sigma, MO, USA) at a dilution o f 1:5000 in TTBS for 
1 hour at room temperature. After washing, immunoreactive 
proteins were visualised by incubation with NBT/BCIP (Sigma, 
MO, USA) for 10 minutes.
Analysis o f  expression o f  VSV-hU3-55K constructs in COS-1 
cells
Extract prepared from 1.0 x 106 COS-1 cells was acetone 
precipitated, the proteins resolved by 10% SDS-PAGE, and 
blotted to a nitrocellulose membrane (Protan, Schleicher & 
Schuell, Dassel, Germany). After one hour incubation in block­
ing buffer (5% non-fat milk, 0.1% NP-40, in PBS), the blot was 
incubated with anti-VSV antibodies (Boehringer-Mannheim, 
Almere, The Netherlands) diluted 1:50 in buffer B (3% non-fat 
milk, 0.1% NP-40, in PBS) supplemented with 1% normal rab­
bit serum for one hour at room temperature. The blot was 
washed in buffer B, and then incubated with horseradish perox­
idase-conjugated, goat anti-mouse antibodies (Dako, Denmark) 
for 1 hour at room temperature. After washing bound secondary 
antibodies were visualised via chemiluminescence.
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2Immunofluorescence analysis 
Analysis o f  XIU3-55K in Xenopus cells
Indirect immunofluorescence analysis was carried out on 
Xenopus oocyte nuclear spreads as described (43). Briefly, 
Xenopus nuclear contents were centrifuged onto a slide (5140 x 
g for 1 hour), fixed with 1% paraformaldehyde in PBS for 1 
hour, and blocked with 10% horse serum (Hyclone, UT, USA) 
in PBS for 15 minutes at 37°C. Slides were washed and incu­
bated with pre-immune serum (diluted 1:1000 in PBS) or affin­
ity purified aXlU3-55K antibodies (diluted 1:1000 in PBS) for 
1 hour at 37°C. Slides were washed and incubated with FITC- 
conjugated anti-rabbit antibody (Jackson ImmunoResearch, 
PA, USA) at 1:50 dilution in PBS for 1 hour at 37°C. Slides 
were washed and mounted with 50% glycerol in PBS contain­
ing 1 mg/ml phenylenediamine, pH 9.0.
For indirect immunofluorescence o f Xenopus somatic 
cells, XlK2 cells were grown on autoclaved glass slides to 
approximately 80% confluence. Slides were rinsed in PBS and 
fixed for 10 minutes in 5% paraformaldehyde in PBS at 25°C. 
Cells were permeabilised in acetone (pre-chilled at -20°C) for 5 
minutes, rinsed, and blocked in 3% BSA in PBS for 1 hour at 
room temperature. Slides were rinsed and incubated with pre­
immune serum (diluted 1:1,000) or affinity purified antibodies 
(diluted 1:20,000) in 3% BSA in PBS for 1 hour at 37°C. Slides 
were washed and Texas Red-conjugated anti-rabbit antibodies 
(Jackson Immunoresearch, PA, USA) were added at 1:50 dilu­
tion in 3% BSA in PBS and incubated for 45 minutes at room 
temperature. Slides were washed and mounted as described 
above.
Analysis o f  Xenopus oocyte nuclear spreads and kidney 
cells was carried out on a Zeiss Axiovert S 100 inverted fluo­
rescence microscope equipped with differential interference 
contrast optics (Thornwood, NY, USA). Images were acquired 
at 63x magnification using a cooled charge-coupled device 
camera (Quantix-Photometrix, AZ, USA) and IP Lab Spectrum 
software (Signal Analytics, VA, USA).
Analysis o f  VSV-hU3-55K proteins in HEp-2 cells
Transiently transfected HEp-2 cells were grown for 18 
hours. The slides were washed with PBS, placed in methanol
for 5 minutes at -20°C and permeabilised with acetone for 1 
minute at room temperature. Indirect immunofluorescence was 
performed using monoclonal anti-fibrillarin antibody 72B9 
(50) and monoclonal aVSV  antibody (Boehringer-Mannheim, 
Almere, The Netherlands) diluted 1:2 and 1:50, respectively in 
PBS supplemented with 1% normal rabbit serum. Fixed cells 
were incubated with monoclonal antibodies for 1 hour, fol­
lowed by goat anti-mouse antibodies coupled to fluorescein 
isothiocyanate (Dako, Denmark; diluted 1:50 in PBS) for 1 
hour.
Images were acquired using an Olympus BH2 microscope 
(Hamburg, Germany) in combination with an Olympus DP10 
microscope digital camera system (Hamburg, Germany) and 
analySIS sofware (Soft Imaging System GMBH, Münster, 
Germany)
Immunoprecipitations
Xenopus U3-55K
Antiserum against XlU3-55K (10 ^l / immunoprecipita- 
tion) was coupled to protein A-Sepharose CL-4C beads (Sigma, 
MO, USA) in 0.5 ml o f Ipp 500 buffer (500 mM NaCl, 50 mM 
Tris-HCl pH 7.5, and 0.1% NP-40) at 4°C overnight. 
Immunoprecipitations were performed with nuclear extracts 
isolated from injected oocytes (3 nuclei / immunoprecipitation) 
in Ipp100-T. Samples were incubated overnight at 4°C in the 
presence o f  40U RNasin (Promega, WI, USA) and 2 mM DTT. 
RNA from supernatants and pellets was isolated by proteinase 
K digestion, phenol extraction, and ethanol precipitation. 
Precipitated RNAs were separated by 8% urea-PAGE and visu­
alised by autoradiography.
Human U3-55K
After 18 hours o f growth, transfected COS-1 cells were 
washed with PBS and resuspended in buffer A  (25 mM Tris- 
HCl pH 7.5, 100 mM KCl, 1 mM DTE, 2 mM EDTA, 0.5 mM 
PMSF, 0.05% NP-40) to approximately 1000 cells per ^l. The 
cell suspension was sonicated with a Branson microtip (3 times 
for 20 sec each), insoluble material was pelleted (12,000 x g, 15 
min) and the supernatants were used for immunoprecipitation. 
Rabbit anti-mouse antibodies (Dako, Denmark) were coupled
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to 10 ^l o f  protein A  agarose beads (Biozym, Landgraaf, The 
Netherlands) in IPB500 (500 mM NaCl, 10 mM Tris-Cl pH 8.0, 
0.05% NP-40). The beads were washed with IPB500 and then 
incubated with monoclonal anti-VSV and anti-fibrillarin anti­
bodies for one hour at room temperature. The beads were sub­
sequently washed twice with IPB500 and once with IPB150 
(150 mM NaCl, 10 mM Tris-Cl pH 8.0, 0.05% NP-40), and 250 
^l o f cell extract (~ 2.5 x 105 cells) was added and incubated for 
1 hour at 4°C. After washing 3 times with IPB150, RNA was 
isolated from the beads by phenol-chloroform extraction and 
ethanol precipitation. RNA was resolved on an 8% denaturing 
polyacrylamide gel and blotted onto a Hybond-N+ membrane 
(Amersham, Buckinghamshire, England). Northern analysis 
performed with anti-sense radiolabled U3 RNA probes was 
done essentially as previously described (48, 64).
Analysis of U3-55K association with U3 snoRNA in vitro
Biotinylated RNAs were synthesised using a 10:1 ratio of 
UTP to UTP-21-biotin (Clontech, CA, USA) and the yield esti­
mated by ethidum bromide staining (to allow addition o f  com­
parable amounts o f  each RNA to reactions). In vitro translated, 
35S-labeled hU3-55K was synthesised using wheat germ extract 
(TNT Coupled Wheat Germ Extract System, Promega, WI, 
USA) in the presence o f translation grade 35S methionine 
(1,000 Ci/mmol; Amersham, NJ, USA). Approximately 5% of 
the biotinylated RNA made in a 25 ^l transcription reaction was 
added to 10 ^l o f in vitro translated hU3-55K, 40U RNasin 
(Promega, WI, USA), 2 ^g non-specific competitor yeast tRNA 
(Boehringer Mannheim, IN, USA), and 2 ^l o f  10x Binding 
Assay Buffer (100 mM Tris pH 8.0, 1 M KCl, and 0.5% NP- 
40). Reactions were brought to a final volume o f  20 ^l with 
water and allowed to incubate for 1 hour at 4°C. After incuba­
tion, 10 ^l o f  streptavidin agarose beads (Gibco BRL, NY, 
USA) were added and the final volume was brought to 500 ^l 
with 1x Binding Assay Buffer. Samples were incubated for 1 
hour at 4°C. After incubation, pellets were washed 3 times with 
1 ml ice cold 1x Binding Assay Buffer and resuspended in SDS- 
PAGE loading buffer. Samples were boiled and resolved by 
12% SDS-PAGE. Gels were fixed in water: isopropanol: glacial 
acetic acid (65:25:10) for 30 minutes, incubated in Amplify
(Amersham, NJ, USA) for an additional 30 minutes, dried and 
exposed to film at -80°C.
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Abstract
The 15.5K protein directly binds to the 5’ stem-loop of the U4 snRNA, the snoRNA box 
C/D motif, and the U3 snoRNA-specific box B/C motif. The box B/C motif has also been 
shown to be essential for the association of the U3 snoRNP-specific protein hU3-55K. We 
therefore set out to determine how 15.5K and hU3-55K recognise the box B/C motif. Using 
an in vitro assembly assay we show that hU3-55K effectively binds a sub-fragment of the 
U3 snoRNA surrounding the B/C motif that we have named the U3BC RNA. The associa­
tion of hU3-55K with the U3BC RNA is dependent on the binding of 15.5K to the box B/C 
motif. The association o f hU3-55K with the U3BC RNA was found to be also dependent on 
a conserved RNA structure that flanks the box B/C motif. Furthermore, we show that hU3- 
55K, a WD40 repeat containing protein, directly crosslinks to the U3BC RNA. Our data 
support a new structural model of the box B/C region of the U3 snoRNA in which the box 
B/C motif is base-paired to form a structure highly similar to that of both the U4 5’ stem- 
loop and the box C/D motif.
Introduction
The U3 small nucleolar RNA (snoRNA) is 
essential for the processing of the small subunit 
ribosomal RNA (rRNA) in both vertebrates and 
fungi (11, 13, 27). This box C/D type snoRNA func­
tions by base-paring with the 5’ETS of the 35S pre- 
rRNA and the 5’-terminal region of the 18S rRNA 
sequence. The latter interaction blocks the formation 
of a universally conserved central pseudoknot; a 
long-range interaction essential for the formation 
and function of the small subunit rRNA (11, 30). 
Based on these observations, the U3 snoRNP has 
been proposed to function as an RNA chaperone in 
the assembly of the small subunit of the ribosome.
The U3 snoRNP contains the core proteins com­
mon to all box C/D snoRNPs, namely fibrillarin 
(Nop1p in yeast), NOP56, NOP58 (Nop5p), and 
15.5K (Snu13p in yeast) (14, 15, 18, 21, 28, 35, 43, 
45). These proteins are essential for the biogenesis, 
stability, and nucleolar localisation of the box C/D 
snoRNPs. In addition the U3 snoRNA has been 
shown to be associated with several U3-specific 
proteins in yeast, namely Rrp9p (hU3-55K in 
human), Imp3p, Imp4p, Mpp10p, Dhr1p, Rcl1p, 
Sof1p, and Lcp5p (2, 5, 6, 8, 25, 36, 37). However,
the purified yeast U3 snoRNP mono-particle was 
shown to contain only one U3-specific protein, 
namely Rrp9p (43), suggesting that many of the 
other U3 snoRNA associated proteins may be part of 
a larger processing complex (2, 6, 9, 10). Genetic 
studies in yeast have shown that all of the U3 
snoRNP specific proteins are essential for U3 
snoRNP function but not for its biogenesis (2, 5, 16, 
36, 37).
The 3’ domain of the U3 snoRNA can be folded 
into a stem-rich structure which contains four con­
served RNA sequence elements, namely boxes C’, 
B, C, and D. Boxes C’ and D are found opposite 
each other at the base of the 3’ domain and form the 
common core box C/D motif (previously termed the 
box C’/D motif but referred to here as the box C/D 
motif for clarity) (12, 19, 24). The box C/D motif is 
required for the biogenesis of the box C/D snoRNAs 
and has been shown to be essential for nucleolar 
localisation, cap hypermethylation, and accumula­
tion/stability of the transcript (reviewed in 34). This 
motif is also responsible for the association of the 
core box C/D proteins (4, 21, 40-43). The U3 
snoRNA also contains a U3-specific RNA element, 
termed the box B/C motif. This RNA element is a
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protein-binding site that is essential for the associa­
tion of Rrp9p in yeast and U3-55K in vertebrates 
(17, 37). However, unlike the box C/D motif, the 
box B/C motif is not essential for biogenesis of the 
U3 snoRNA (26, 32).
The 15.5K protein was initially identified as a 
U4/U6.U5 tri-snRNP component that directly binds 
to the 5’ stem-loop structure of the U4 snRNA (22). 
We have recently shown that the 15.5K protein is 
associated with the box C/D snoRNAs in vivo and 
that it directly binds to both the box C/D motif and 
the U3 snoRNA-specific box B/C motif in vitro 
(43). Both the box C/D and the box B/C motifs are 
capable of forming stem-internal loop-stem struc­
tures that are strikingly similar to the U4 5’ stem- 
loop. The discovery that 15.5K can bind three simi­
lar RNA motifs raises the interesting question of 
how 15.5K functions in the assembly of these dis­
tinct RNP complexes. In this study we have 
analysed the binding of 15.5K and hU3-55K to the 
box B/C motif. These two proteins have been shown 
to require the B/C motif in the U3 snoRNA for their 
association (17, 37, 43). To determine how these 
two proteins associate with the U3 snoRNA we 
made use of a HeLa nuclear extract assembly sys­
tem. Our results show that the interaction between 
hU3-55K and the U3 snoRNA is dependent on 
15.5K binding to the box B/C motif. Moreover, we 
show that hU3-55K requires not only the box B/C 
motif but also sequences flanking this RNA element 
for its association with the U3 snoRNA. Our data 
suggest that hU3-55K recognises structural, rather 
than sequence-specific, RNA elements within the 
15.5K-bound U3 box B/C snoRNA complex.
Results
The box B/C is essential for the binding of both 
15.5K and hU3-55K to the B/C fragment of the 
U3 snoRNA
The 15.5K and hU3-55K proteins have both 
been proposed to bind to the conserved box B/C 
region of the U3 snoRNA (17, 43). We therefore 
used an in vitro reconstitution assay, using HeLa 
nuclear extract, in order to analyse the binding of 
these two proteins to the U3 snoRNA. This system 
has been previously used to study the assembly of 
the box C/D and H/ACA snoRNPs (7, 21, 40, 42). 
In order to analyse assembly, 32P-labeled U3 
snoRNA transcripts were incubated in nuclear 
extract and the association of hU3-55K determined 
by immunoprecipitation with anti-hU3-55K anti­
bodies. The co-precipitated RNA was then analysed 
by polyacrylamide gel electrophoresis. In order to 
show that each of the RNAs used in this investiga­
tion was not degraded during our experiments, after 
incubation in nuclear extract 5% of the material was 
isolated and also analysed (Figure 1B, 5% I).
The U3 snoRNA was co-precipitated with anti- 
hU3-55K antibodies (Figure 1B, lanes 1 and 3) but 
not with the normal rabbit serum (NRS) (lane 2). 
Under the same conditions no U14 snoRNA was co­
precipitated with anti-hU3-55K antibodies demon­
strating the specificity of our assay. (Figure 1B, lane 
6) as hU3-55K is a U3-specific protein (17, 25). 
Previous studies have mapped the sequences 
required for hU3-55K association to a region of the 
U3 snoRNA that consists of the box B/C motif and 
its flanking stems (17). We could also show that an 
RNA comprising just the B/C motif region of the U3 
snoRNA (U3BC RNA, Figure 1A), was effectively 
co-precipitated by anti-hU3-55K antibodies after 
incubation in nuclear extract (Figure 1B, lane 9). In 
contrast, the U3CD region of the U3 snoRNA 
(Figure 1A) was not precipitated by the anti-hU3- 
U55K antibodies. This confirmed that all of the
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Figure 1. The box BC fragm ent of the U3 snoRNA associates with 15.5K and hU3-55K in vitro
A) Sequence and proposed secondary structure of the U3 box B/C and C/D motifs in the 3 ’ domain o f the U3 snoRNA. This model 
includes the new structural organisation o f the box B/C motif (39). The secondary structure of the box C/D motif (containing the 
C ’ and D sequences) was drawn according as described previously (24, 39). The highly conserved nucleotides in either the box C/D 
or box B/C motifs are depicted in white on a black background. The dotted line indicates non-Watson-Crick base-pair interactions 
predicted from the crystal structure o f the U4 5 ’ stem-loop bound by 15.5K (38). The dashed line dissecting the 3 ’ domain o f the 
U3 snoRNA indicates how this region of the RNA was sub-divided to generate the BC (upper part) and CD (lower part) fragments 
o f the U3 snoRNA. In the U3CD RNA, the BC fragment is replaced by the tetra-loop sequence UUGA. The asterisks in the U3BC 
fragment mark the nucleotides mutated in box C and box B in order to generate mutC and mutB, respectively.
B) The U3BC RNA is sufficient for the association of hU3-55K. In vitro reconstitution assays were performed using 32P-radiola- 
beled RNAs incubated in HeLa nuclear extract. RNP complexes formed during this reaction were then immunoprecipitated and the 
co-purifying RNAs analysed on an 8 % polyacrylamide/7 M urea gel. The RNA used is indicated above each panel. NRS: normal 
rabbit serum; a55K: anti-hU3-55K antibodies; 5% I: 5% o f the input material after incubation in nuclear extract; 10% I: 10% of 
the input material after incubation in nuclear extract.
C) Binding of hU3-55K to the U3BC RNA is dependent on an intact box B and box C. In vitro reconstitution experiments using 
HeLa nuclear extract were performed as described in B) using the mutB and mutC RNAs. The RNAused is indicated at the top and 
the antibodies used are as described in B).
D) Binding of 15.5K to the U3BC RNA is dependent on an intact box B and box C. GST pull down experiments, using either recom­
binant GST or GST15.5K, with the U3BC, mutB, and mutC RNAs, were performed as described in the Materials and Methods. 
The bound RNAs were then resolved on an 8 % polyacrylamide/7 M urea gel (indicated by pellet). The use o f GST or GST15.5K 
is indicated. The RNA used is indicated above each lane. Input represents 10% o f the starting material.
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essential sequences necessary for hU3-55K binding 
are contained within the box B/C region of the U3 
snoRNA. The U3BC RNA was therefore used as the 
substrate RNA in our investigations as the analysis 
of protein binding to this fragment most likely 
reflects what is observed with the full-length 
snoRNA. In addition, the physical separation of the 
two 15.5K binding sites facilitates the direct analy­
sis of 15.5K binding to the box BC motif in the 
absence of the box C/D motif.
We have previously shown that the GA di­
nucleotides present in the U4 5’ stem-loop, box C/D 
motif, and the box B/C motif are essential for the 
binding of 15.5K in vitro (22, 43). Therefore, we 
next addressed the role these highly conserved 
nucleotides play in hU3-55K binding. Constructs 
were generated with point mutations in either box B 
or box C of the U3BC RNA (Figure 1A; nucleotides 
marked by an asterisk). Mutation of either A113 
(mutB) or G162 (mutC) (numbers refer to the posi­
tion in the intact U3 snoRNA) in the U3BC RNA 
abolished the binding of hU3-55K in HeLa nuclear 
extract (Figure 1C, lanes 6, and 8). However, neither 
mutation affects the stability of the RNA in nuclear 
extract (Figure 1C, lanes 5, and 7).
We next wanted to address whether the 15.5K 
protein specifically binds to the U3BC RNA in 
HeLa nuclear extract. However, anti-15.5K antibod­
ies co-precipitated only very low amounts of the 
U3BC RNA in this assay (data not shown). The 
analysis of the interaction of 15.5K with the RNA by 
immunoprecipitation was therefore not possible. 
The 15.5K antibodies also fail to immunoprecipitate 
the U4/U6.U5 tri-snRNP suggesting that in certain 
complexes this protein is not accessible for antibody 
binding (22). As the anti-15.5K antibodies could not 
be readily used to study the binding of 15.5K to the 
U3BC RNA, an alternative means of analysing 
15.5K binding to the box B/C motif was required. 
We therefore analysed the ability of recombinant
GST-tagged 15.5K protein to bind the mutant and 
wild-type RNAs. The RNA bound to GST15.5K 
was co-precipitated using glutathione sepharose 
beads. The results show that GST15.5K efficiently 
bound to the U3BC RNA, but not to either of the 
mutant transcripts (Figure 1D, lanes 2-4). When the 
GST-tag alone was used, no wild-type RNA was co­
precipitated (Figure 1D, lane 1). These results show 
that mutations that inhibit 15.5K binding to the box 
B/C motif also block the association of hU3-55K. 
However, a more direct analysis of the role 15.5K 
plays in hU3-55K binding was required before any 
further conclusions could be made about the assem­
bly pathway of this RNP complex.
Binding of 15.5K to the B/C motif is essential for 
the association of hU3-55K with the U3 snoRNA
The fact that the 15.5K protein can bind the B/C 
motif in the absence of hU3-55K suggests that this 
protein may indeed be the primary RNA binding 
protein. We therefore next addressed whether bind­
ing of the 15.5K protein to the box B/C motif was an 
essential pre-requisite for the association of hU3- 
55K. In order to investigate this, competition exper­
iments were performed with a chemically synthe­
sised oligonucleotide corresponding to the 5’ stem- 
loop of the U4 snRNA (Figure 2A; U4 SL1) that 
specifically binds 15.5K (22). Nuclear extract was 
pre-incubated with U4 SL1 oligonucleotide, in order 
to sequester 15.5K binding, prior to the addition of 
U3BC RNA, and then assayed for hU3-55K bind­
ing.
As seen in Figure 2B, the addition of 400 pmol 
of U4SL1 oligonucleotide inhibited the co-precipi­
tation of the U3BC RNA with anti-hU3-55K anti­
bodies (Figure 2B, lane 7). As a control, oligonu­
cleotide U4 SL17 (Figure 2A), containing a point 
mutation that abolishes 15.5K binding (22), was 
also used. The addition of up to 800 pmol of the U4 
SL17 RNA oligonucleotide had no effect on the
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Figure 2. The 15.5K protein is required for the binding of hU3-55K to the U3 snoRNA
A) Sequence and structure of the two U4 5’ stem-loop oligonucleotides used to block 15.5K binding. The conserved internal loop 
nucleotides are shown in white on a black background. U4 SL1 is the wild-type sequence while U4 SL17 contains a point mutation 
in the internal loop that inhibits 15.5K binding (22).
B) An excess of a U4 5 ’ stem-loop oligonucleotide can specifically block the assembly o f the box C/D snoRNP. Radiolabeled U3BC 
RNA was incubated in HeLa nuclear extract that had been pre-incubated with increasing amounts o f either U4 SL1 or U4 SL17 
RNA oligonucleotides. The binding o f hU3-55K was then assayed by immunoprecipitation with anti-hU3-55K antibodies. Bound 
RNA was recovered and then separated on an 8 % polyacrylamide/7 M urea gel. The amount of oligonucleotide used was as fol­
lows: no oligonucleotide in lanes 1 to 4, and 9; 100 pmoles in lanes 5 and 10; 200 pmoles, lanes 6  and 11; 400 pmoles, lanes 7 and 
12; 800 pmoles, lanes 8  and 13. NRS: normal rabbit serum; a55K: positive immunoprecipitation using anti-hU3-55K antibodies in 
the absence of U4 oligonucleotides; 5% I: 5% o f the input material after incubation in nuclear extract. The identity o f the RNA 
oligonucleotide used is indicated at the top of the panel.
C) Rescue o f U4 SL1-oligonucleotide blocked extract by the addition of recombinant 15.5K. HeLa nuclear extract was pre-incu- 
bated with either 400 pmoles of U4 SL1 RNA oligonucleotide (lane 5) or buffer (lanes 2 to 4). Radiolabeled U3BC RNA was sub­
sequently added in the absence or presence o f increasing amounts of recombinant 15.5K (lanes 6  to 10). The inclusion of the U4 
SL1 oligonucleotide and the amount of recombinant 15.5K used is indicated above each lane. The binding o f hU3-55K was deter­
mined as described in B).
D) The 15.5K protein is required for the binding o f in vitro translated hU3-55K to the U3BC RNA. 35S labeled-hU3-55K was incu­
bated with 6  pmoles o f wild type m7G-capped U3BC RNA (lanes 2 to 5) or 6  pmoles o f m7G-capped U3BC mutB RNA (lanes 6  to 
9) in the presence or absence o f recombinant 15.5K. Bound, radiolabeled proteins were precipitated with anti-cap antibodies (H20) 
and analysed on a 13% polyacrylamide SDS gel. The amount of recombinant 15.5K used is indicated above each lane. 10%I; 10% 
o f the input in vitro translated hU3-55K protein.
association of hU3-55K with the U3BC RNA 
(Figure 2B, lane 13). Therefore, inhibiting the bind­
ing of 15.5K to the box B/C motif effectively 
blocked the association of hU3-55K with the U3BC 
RNA transcript. We next asked whether we could 
restore hU3-55K binding to the U3BC RNA, in the 
15.5K-sequestered extract, by the addition of
recombinant 15.5K. The 15.5K protein was first pre­
bound to U3BC RNA and then added to the oligonu­
cleotide-inhibited extract. As seen in Figure 2C 
(lanes 6-10) the addition of recombinant 15.5K 
effectively restored hU3-55K binding. This there­
fore clearly demonstrates that 15.5K binding to the 
box B/C RNA is an essential step in the hierarchical
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assembly of the U3 box B/C RNP complex.
It was previously reported that hU3-55K, in 
vitro translated in wheat germ extract, binds to the 
U3 snoRNA in vitro without the addition of exoge­
nous proteins (17). We therefore performed similar 
experiments in order to determine whether our 
results are in contradiction to this earlier publica­
tion. In vitro translated hU3-55K was incubated 
with m7G capped U3BC RNA in either the absence 
or presence of recombinant 15.5K. The complexes 
were then isolated using the H20 antibody, which 
specifically recognises the m2,2,7G and m7G cap 
structures. The bound protein was then analysed on 
a 12% polyacrylamide SDS gel. Efficient binding of 
hU3-55K to the U3BC RNA was only observed in 
the presence of 15.5K (Figure 2D). Importantly, this 
binding was not observed when the U3BC mutB 
transcript was used. This therefore confirms that 
15.5K binding to the snoRNA is essential for the 
subsequent association of hU3-55K. The hU3-55K 
protein used in the previously reported experiments 
was in vitro translated in wheat germ extract, while 
the protein used in these experiments was produced 
in reticulocyte lysate. It is therefore possible that 
factors in the wheat germ extract, such as endoge­
nous 15.5K, mediate hU3-55K binding to the U3 
snoRNA.
hU3-55K requires additional RNA elements 
flanking the box B/C motif for its association 
with the U3 snoRNA
We next decided to analyse whether RNA 
sequences flanking the box B/C motif were also 
necessary for the association of hU3-55K. In order 
to achieve this four deletion mutants were generated 
in the U3BC RNA (Figure 3A). The ability of 15.5K 
to bind to the various RNAs was determined by 
pull-down experiments using GST-tagged 15.5K. As 
seen in Figure 3B, each of the deletion mutants 
bound 15.5K with approximately the same efficien­
cy confirming that the binding of this protein to the 
U3BC RNA is solely dependent on the central box 
B/C motif.
The binding of hU3-55K to the mutant tran­
scripts was next analysed in nuclear extract by 
immunoprecipitation with anti-hU3-55K antibodies, 
as described above. Importantly, none of the muta­
tions had any affect on the stability of the RNAs in 
nuclear extract (Figure 3C, lanes 1, 3, 5, 7, 9, and
11). Interestingly, the removal of both stems V and 
IV (U3BCAstem IV+V) abolished the association of 
hU3-55K (Figure 3C, lane 8), whereas deletion of 
stem I and stem-loop VI (U3BCAstem I+VI) or 
deletion of stem V (U3BCAstem V) only reduced 
the binding of hU3-55K (Figure 3C lanes 6 and 12). 
In contrast, deletion of stem VI (U3BCAstem VI) 
did not affect the association of hU3-55K (Figure 
3C, lane 10). These results show that in addition to 
the box B/C motif, other regions of the U3BC RNA, 
most notably stems IV and V, are important for the 
stable association of hU3-55K with the U3 snoRNA.
The association of hU3-55K with the U3BC RNA 
requires an internal loop structure adjacent to 
the box B/C motif
Since the deletion of stems IV and V abolished 
the binding of the hU3-55K protein to the U3BC 
RNA, we decided to determine the sequence and/or 
structural elements in this region that are essential 
for hU3-55K binding. Phylogenetic analysis of the 
U3BC domain from a wide range of eukaryotes 
revealed no clear sequence conservation in this 
region of the RNA (Figure 4A; bracketed area). 
However, in all cases examined, stem IV is separat­
ed from the flanking helices by small internal loop 
structures. Indeed, the upper loop between stem IV 
and stem V is pyrimidine rich (Figure 4A). We 
therefore constructed a series of mutants in order to 
define the nucleotides in this region required for 
hU3-55K association (Figure 4B). Since the
15.5K mediates hU3-55K binding to the U3 snoRNA 51
A U3BC
Stem III 
box B
Astern VI
Uc-gU- 140
> - ü
CG--CGU 
c1-!  - 150
L i- î  
CG--C
Astem V
CUG 
C A
Astem IV+V
GC 
C A
|  . - jr.#  box C l a p .
f í 70
G . 1 G U
r g i j i i ^ . A
'U Stem VI
B 190
a-Ucuu cucucc1
U.||u.uG^.^n
UC-GA
UAU
UG- A
UG- A
G-G.
CUG- G
U C
GCU-GA
A-A
UC-GG
U-GA
Astem I+VI
B GST GST15.5K  I—II------ >-----1
> > > ±
Input
1 2 3 4 5 6
ni m ir
•  • •
1 2 3 4 5 6 7 8 9 10 11 12
Figure 3. RNA elements flanking the box B/C m otif are involved in the binding of hU3-55K
A) Schematic representation o f U3BC RNA deletion mutants. The conserved nucleotides of the box B/C motif are represented as 
in Figure 1A.
B) Binding of GST15.5K to U3BC deletion mutants. GST pull-down experiments were performed with either recombinant GST 
or GST15.5K using the RNAs outlined in A). The bound RNAs were then resolved on an 8 % polyacrylamide/7 M urea gel (indi­
cated by pellet). The use o f GST or GST15.5K is indicated. The RNA used is indicated above each lane. Input represents 10% of 
the material used for binding.
C) In vitro reconstitution experiments performed in HeLa nuclear extract with the U3BC RNA and the deletion mutants. The U3BC 
as well as the mutant transcripts outlined in A) were incubated in HeLa nuclear extract and the binding o f hU3-55K was assayed 
by immunoprecipitation with anti-hU3-55K antibodies (a55K) with the bound RNAs being separated on an 8 % polyacrylamide/7 
M urea gel. The RNAs used are indicated above the respective lanes. NRS: normal rabbit serum; 5% I: 5% of the input material 
after incubation in nuclear extract.
U3BCAstem VI mutant bound hU3-55K as well as 
the full length U3BC we decided to use the 
U3BCAstem VI as template for this analysis.
We first analysed the effect of these mutations 
on the binding of GST15.5K in pull-down experi­
ments. This demonstrated that changing the 
sequence of the upper internal loop (mutpyrloop), 
closing this loop to join stems IV and V (mutloop- 
stem), or altering the sequence of a section of stem
IV (mutstem IV), had no noticeable effect on 15.5K 
binding (Figure 4C, lanes 3-5). In contrast, disrup­
tion of stem IV (mutGG-AA) or disruption of the 
AU base-pair in stem III (mutAU-AA) abolished the 
binding of 15.5K (Figure 4C, lanes 6 and 8). This 
effect is likely due to the destabilisation of the sec­
ondary structure in this region of the RNA inhibiting 
the correct folding of the box B/C motif for 15.5K 
binding. This hypothesis is enforced by the fact that
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mutations that stabilise the structure of this region of 
the RNA, i.e. by either closing the internal loop join­
ing stem III and IV (mutloopA-GG) or the exchange 
of a AU base-pair in stem III for a GC base-pair 
(mutstem III), significantly enhanced the binding of 
15.5K (Figure 4C, lanes 7 and 9).
We next analysed the effect of these mutations 
on hU3-55K binding in nuclear extract. Importantly, 
none of the mutations affected the stability of the 
RNA in nuclear extract (Figure 4D, lanes 1, 3, 5, 7, 
9, 11, 13, 15, and 17). Consistent with the fact that 
15.5K binding is essential for the association of the 
U3-specific protein, mutations that block 15.5K 
binding by destabilising stem III (mutAU-AA) or IV 
(mutG-AA) also inhibited the association of hU3- 
55K (Figure 4D, lanes 12, 16). Interestingly, the A­
GG mutation, which closes the internal loop 
between stem III and IV, completely blocked the 
binding of hU3-55K (Figure 4D, lane 14). This point 
is even more striking considering the fact that this 
mutation significantly enhanced the binding of 
15.5K (Figure 4C, lane 7). In contrast, mutations 
that altered the upper internal loop (mutpyrloop and 
mutloop-stem) or that changed the sequence of stem 
IV (mutstem IV) had no visible effect on hU3-55K 
binding (Figure 4D, lanes 6, 8, and 10). In addition, 
the exchange of the AU base-pair for a GC base-pair 
in stem III (mutstem III) did not noticeably affect 
the binding of hU3-55K (Figure 4D, lane 18). Taken 
together, these data clearly show that the internal 
loop structure joining stem III and stem IV is 
absolutely essential for the binding of hU3-55K and 
probably helps to provide the structural platform 
necessary for the binding of this protein.
The structure but not the sequence of stem II in 
the U3BC RNA is essential for the association of 
both hU3-55K and 15.5K
The crystal structure of the U4 5’ stem-loop 
bound to 15.5K demonstrated that this protein pri­
marily contacts the internal-loop and makes mini­
mal contact to the two stem structures (38). Our data 
suggests that 15.5K binds the box B/C motif in a 
manner analogous to the U4 snRNA and primarily 
contacts the internal-loop nucleotides (22, 38, 43) 
The nucleotides of stem II in the U3BC RNA that 
are part of the conserved box B/C motif sequence, 
are likely not bound by 15.5K, and could therefore 
provide a sequence specific binding site for U3-spe- 
cific proteins such as hU3-55K. In order to confirm 
the role of stem II in 15.5K binding, as well as to 
determine the role of the conserved nucleotides in 
U3 snoRNP assembly, a series of mutations were 
generated in stem II (Figure 5A) and analysed for 
15.5K and hU3-55K binding as described above.
We first analysed the effect of these mutations 
on the binding of GST15.5K. As can be seen in 
Figure 5B, all of the mutations that disrupted the 
base-pairing in stem II, whether conserved or non­
conserved nucleotides, either severely reduced or 
abolished 15.5K binding to the U3BC RNA (lanes 3, 
4, 7 and 8). In contrast, all mutations that altered the 
sequence of stem II but retained the base-pairing 
potential (Figure 5B, stemCG and stemCCGCGG, 
lanes 5 and 9, respectively) bound 15.5K as well as 
the wild-type RNA. This strongly supports the fact 
that stem II exists in the U3 snoRNA and confirms 
its involvement in the formation of the stem-internal 
loop-stem structure necessary for 15.5K binding. 
Interestingly, substitution of the UU pair with a GC 
base-pair (mutUU-GC) reduced the association of 
15.5K at least two-fold (Figure 5B, lane 6). This is 
somewhat surprising considering that a GC base- 
pair is present at the equivalent position in the U4 5’ 
stem-loop. However, it is entirely possible that some 
differences exist in the binding of 15.5K between 
the box B/C motif and the U4 5’ stem-loop and that 
in the context of the U3 snoRNA the UU pair is 
more favourable for protein binding.
We next analysed the effect of these mutations
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on the binding of hU3-55K in nuclear extract. 
Consistent with previous data, none of the mutations 
affected RNA stability in nuclear extract (Figure 5C, 
lanes 1, 3, 5, 7, 9, 11, 13, 15, and 17). As seen in 
Figure 5C, mutations that inhibiting 15.5K binding, 
either by disrupting stem II or mutating the potential 
UU base-pair, also inhibit the association of hU3- 
55K to an equivalent degree (lanes 8, 10, 14, 16). In 
contrast, mutations that change the sequence but do 
not disrupt the structure of stem II, thus retaining 
15.5K binding, do not effect hU3-55K association 
(lanes 12, 18). Therefore, the structure but not the 
sequence of stem II is important for both 15.5K and 
hU3-55K association. This means that the conserved 
sequence of stem II is not essential for 15.5K and 
hU3-55K association and may therefore function in 
the recruitment of other U3-associated proteins (see 
Discussion).
hU3-55K directly binds the U3BC RNA
The association of hU3-55K with the box B/C 
motif is dependent on the binding of 15.5K as well 
as the conserved structure of the flanking RNA. This 
implies that hU3-55K, or an additional protein other 
than 15.5K, directly contacts the U3BC RNA. We 
therefore performed UV crosslinking experiments in
order to determine whether hU3-55K indeed direct­
ly contacts the U3 snoRNA. To achieve this we used 
U3BC wild-type and U3BC mutB transcripts 
(Figure 1C) synthesised in the presence of 4-thio- 
UTP. Following incubation of the RNA in nuclear 
extract, the reaction was UV irradiated and subse­
quently digested with RNAse T1 (see Materials and 
Methods). Crosslinked proteins were then analysed 
by SDS-PAGE.
Analysis of the crosslinked products revealed 
that one specific product of about 65kDa was 
observed when U3BC RNA was used as a substrate 
(Figure 6A). This product was dependent on both 
UV irradiation and the presence of 4-thio-UTP in 
the transcript. Importantly, this crosslink was not 
observed when the mutB RNA (Figure 1C) was 
used, suggesting that the interaction of this protein 
with the U3BC RNA is specific and dependent on 
15.5K binding to the box B/C motif. We next 
analysed the crosslink products by immunoprecipi- 
tation in order to determine whether hU3-55K is 
specifically crosslinked to the U3BC RNA. To 
achieve this, the complexes were immunoprecipitat- 
ed under semi-denaturing conditions with anti-hU3- 
55K antibodies (see Materials and Methods). Under 
these conditions, complexes present within the bind-
Figure 4 (opposite side). A short internal loop between stem III and stem IV of the U3BC RNA is essential for hU3-55K 
binding to the U3 snoRNA
A) The proposed secondary structure o f U3BC RNA fragments derived from the Homo sapiens (Hs. BC), Rattus norvegicus (Rn. 
BC), Xenopus laevis (Xl. BC), Dyctiostelium discoideum (Dd. BC), Bombix mori (Bm. BC) and Saccharomyces cerevisiae (Sc. 
BC). The conserved nucleotides o f the box B/C motif are represented as in Figure 1A. The bracket indicates the conserved stem 
structures found above the box B/C m otif that are essential for the binding o f hU3-55K to human U3 snoRNA.
B) Schematic representation of the mutations generated in the upper region o f the U3BC RNA mutant U3BCAstem VI. The muta­
tions, and their likely effect on the secondary structure o f the RNA are depicted. The conserved nucleotides o f the box B/C motif 
are represented as in Figure 1A.
C) Binding o f GST15.5K to mutations in U3BCAstem VI. GST pull-down experiments were performed with either recombinant 
GST or GST15.5K using the RNAs outlined in B). The bound RNAs were then resolved on an 8 % polyacrylamide/7 M urea gel 
(indicated by pellet). The use of GST or GST15.5K is indicated. The RNA used is indicated above each lane. Input represents 10% 
of the starting material.
D) In vitro reconstitution experiments performed in HeLa nuclear extract with the U3BCAstem VI RNA and mutants. The 
U3BCAstem VI as well as the mutant transcripts outlined in B) were incubated in HeLa nuclear extract and the binding o f hU3- 
55K was assayed by immunoprecipitation with the bound RNAs being separated on an 8 % polyacrylamide/7 M urea gel. The RNA 
mutants used are indicated above the respective lanes. NRS: normal rabbit serum; a55K: anti-hU3-55K antibodies; 5% I: 5% of 
the input material after incubation in nuclear extract.
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ing reaction are disrupted and therefore only RNA 
covalently attached to the hU3-55K protein, by a 
UV induced crosslink, will be co-precipitated by the 
anti-hU3-55K antibodies. Precipitated complexes 
were subsequently treated with proteinase K and the 
extracted RNAs were resolved on an 8% polyacry­
lamide/7 M urea gel. As seen in Figure 6B, hU3- 
55K specifically crosslinks to the U3BC RNA. The 
co-precipitation of the U3BC RNA was only 
observed with the wild-type RNA and not with the 
box B mutant (Figure 6B, lanes 5 and 6). In addi­
tion, this signal was dependent on UV irradiation 
and the presence of 4-thio-UTP in the transcript 
(Figure 6B, lanes 1 to 4). This therefore clearly 
demonstrates that the WD40 protein, hU3-55K, 
specifically binds the U3BC RNA.
The WD40 repeats alone are sufficient for the 
15.5K dependent binding of hU3-55K to the 
U3BC RNA
It was initially reported that hU3-55K contained 
six WD40 repeats, located between amino acids 144 
and 405 (17). In re-examining its amino acid 
sequence we have recently observed a seventh 
WD40 repeat located between amino acids 419 and 
461 in the C-terminus of the protein. An alignment 
of the seven WD40 repeats is shown in Figure 7A. It 
was previously demonstrated that deletions in the 
region of amino acids 140-460, the seven WD40 
repeats, inhibited the association of hU3-55K with 
the U3 snoRNA (17). We therefore decided to re­
examine the role the WD40 repeats play in 15.5K- 
dependent binding of hU3-55K to the U3BC RNA.
Radiolabeled hU3-55K, or one of the mutant 
proteins, was incubated with U3BC RNA and 
recombinant GST-tagged 15.5K. The resulting com­
plex was isolated using GST-beads and the associa­
tion of the in  vitro translated protein analysed by 
SDS polyacrylamide gel electrophoresis. As seen in 
Figure 7C, the binding of hU3-55K to the
GST15.5K requires the presence of the U3BC RNA 
(lanes 1 and 2). Analysis of the previously published 
hU3-55K deletion mutants clarifies that, as with the 
previous experiments, mutations in the WD40 
domain abolish binding to the 15.5K-bound U3BC 
RNA, while mutations in the N-terminal domain 
have little or no effect (Figure 7C, lanes 3, 4, 6, 7, 8, 
9, and 10) (17, 25). In order to further refine this 
analysis, we generated a new mutant, in which the 
complete N-teminus of this protein is deleted (A1- 
136), effectively leaving just the seven WD40 
repeats of hU3-55K. This mutation still efficiently 
binds the 15.5K-U3BC complex (Figure 7C, lane 5) 
demonstrating that the WD40 motifs alone are suffi­
cient for this interaction. We next analysed whether 
the binding of A1-136 is dependent on the flanking 
RNA sequences. The use of the U3BC RNA muta­
tion, which blocks the binding of hU3-55K in 
nuclear extract, instead of the wild-type RNA, com­
pletely inhibits the binding of the in vitro translated 
WD40 domain of hU3-55K (Figure 7D) although 
this mutant still binds the 15.5K protein. Therefore, 
these data are highly suggestive that the WD40 
domain of hU3-55K makes specific contacts to the 
U3BC RNA.
Discussion
The 15.5K protein is essential for the binding of 
hU3-55K to the U3 snoRNA
In this manuscript, we have shown that the bind­
ing of 15.5K to the box B/C motif is essential for the 
subsequent association of hU3-55K in either nuclear 
extract or using in vitro translated protein. This 
demonstrates a hierarchical assembly of the U3 
snoRNP in which 15.5K binds first to the box B/C 
motif in order to recruit hU3-55K. The binding of 
15.5K to the box B/C motif functions to direct the 
specific association of hU3-55K to the U3 snoRNA. 
The association of hU3-55K is also dependent on 
the RNA elements surrounding the box B/C motif.
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Figure 5. The structure but not the sequence of stem II  in the box B/C m otif is essential for both 15.5K and hU3-55K bind­
ing to the U3 snoRNA
A) Schematic representation o f the U3BC RNA stem II mutants. Conserved nucleotides of the box B/C motif are represented as in 
Figure 1A.
B) Binding of GST15.5K to U3BC stem II mutants. GST pull-down experiments were performed with either recombinant GST or 
GST15.5K using the RNAs outlined in A). The bound RNAs were then resolved on an 8 % polyacrylamide/7 M urea gel (indicated 
by pellet). The use o f GST or GST15.5K is indicated. The RNAused is indicated above each lane. Input represents 10% of the start­
ing material.
C) In vitro reconstitution experiments performed in HeLa nuclear extract with the U3BC stem II mutants. The U3BC as well as the 
mutant transcripts outlined in A) were incubated in HeLa nuclear extract and the binding o f hU3-55K was assayed by immunopre- 
cipitation. The bound RNAs were then separated on an 8 % polyacrylamide/7 M urea gel. The RNAmutants used are indicated above 
the respective lanes. NRS: normal rabbit serum; a55K: anti-hU3-55K antibodies; 5% I: 5% of the input material after incubation 
in nuclear extract.
This therefore suggests that 15.5K binding to the 
box B/C motif results in the creation of a highly spe­
cific binding site for hU3-55K. The crystal structure 
of 15.5K bound to the U4 5’ stem-loop clearly 
showed that the binding of this protein has a dramat­
ic effect on the folding of the RNA (38). The data 
presented in this manuscript strongly suggest that 
the box B/C motif probably folds into a stem-inter­
nal loop-stem structure very similar to that of the U4 
5’ stem-loop. It is therefore likely that 15.5K binds
the box B/C motif in a similar manner. The binding 
of this protein to the snoRNA will have a profound 
effect on the structure of this region of the U3 
snoRNA (see later). Thus, we believe that 15.5K 
binding to the box B/C motif functions to nucleate 
the assembly of the U3 box B/C motif RNP by the 
specific creation of the hU3-55K binding site.
The 15.5K protein has now been shown to func­
tion as a nucleation factor in the hierarchical assem­
bly of three distinct RNP complexes, namely the
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U3-specific box B/C RNP (this work), the box C/D 
core snoRNP (40) and the spliceosomal U4/U6 
snRNP (23). In the box C/D core complex, 15.5K 
binding is essential for the association of NOP56, 
NOP58, fibrillarin, TIP48 and TIP49. In addition, in 
the U4/U6 snRNP 15.5K binding is essential for the 
association of 61K (hPrp31), and the heteromeric 
20/60/90K complex. Interestingly, hU3-55K and the 
60K protein are both WD40 repeat proteins suggest­
ing that there may be some similarity in the way 
they bind their respective 15.5K/RNA complexes.
hU3-55K is a WD40 protein that directly binds 
RNA
The results presented in this manuscript clearly 
show that there are two equally important elements 
required for the binding of hU3-55K to the U3 
snoRNA. These are the 15.5K protein bound to the 
box B/C motif as well as the flanking RNA struc­
tures, in particular an internal loop structure 
(nucleotides 115-118/155-157) adjacent to the box 
B/C motif. Indeed, disruption of the secondary 
structure of the loop joining stem III and stem IV 
specifically disrupted the association of hU3-55K. 
The structure, but not the primary sequence of the 
U3 snoRNA elements important for hU3-55K asso­
ciation appears to be conserved amongst the various 
U3 snoRNAs. This suggests that the specific struc­
tural arrangement of the U3 snoRNA, after the bind­
ing of 15.5K, is the essential requirement for hU3- 
55K binding. It has been previously shown in yeast 
that the stem-loops surrounding the box B/C motif 
are not essential for U3 function. While the data pre­
sented in this manuscript would predict, in the case 
of the human U3 snoRNP, that hU3-55K binding 
would be abolished, it is entirely possible that the 
association of the yeast protein is not affected by 
these changes or compensated by protein-protein 
interactions.
Due to the solubility problems experienced
expressing hU3-55K in E. coli, we were not able to 
study the direct interaction between hU3-55K and 
the 15.5K/U3BC RNA complex using recombinant 
proteins. However, several points suggest that the 
hU3-55K interaction with the 15.5K-bound U3B/C 
RNA complex is direct and not mediated by an addi­
tional protein(s). Firstly, the binding of in vitro- 
translated hU3-55K to the U3 snoRNA is complete­
ly dependent on the presence of recombinant 15.5K 
(Figure 2D). Secondly, the purified yeast U3 
snoRNP monoparticle contained just one U3-specif- 
ic protein, namely Rrp9p (yeast homologue of hU3- 
55K; (37, 43)). This suggests that, at least in yeast, 
no other U3-specific protein is required for the sta­
ble association of Rrp9p with the U3 snoRNA. 
Thirdly, the hU3-55K protein specifically crosslinks 
to the U3BC RNA, and finally, we have partially 
purified the U3BC RNP complex assembled in 
nuclear extract. This complex was shown, by west­
ern blot of the recovered material, not to contain the 
human homologues of the U3-specific proteins 
Mpp10, Sof1, and Imp4. In addition, the core box 
C/D proteins NOP58, NOP56, and fibrillarin were 
also not associated with this RNA (data not shown). 
It was previously shown that an intact box C, of the 
box B/C motif, was important for fibrillarin binding 
to the U3 snoRNA in HeLa total cell extracts (1). We 
did not observe fibrillarin binding to the U3BC 
RNA in our HeLa nuclear extract, however, under 
the same conditions we could observe fibrillarin 
binding to the box C/D motif (40). Furthermore, it 
has since been shown that the box B/C motif is not 
required for fibrillarin association with either the 
yeast or human U3 snoRNAs in vivo (44) 1. We 
therefore believe that the hU3-55K interacts direct­
ly with the 15.5K-bound U3BC RNA complex.
The main structural feature of the hU3-55K pro­
tein is the presence of seven WD40 repeats (this 
work; (17, 25)) which are generally thought to play 
a role in protein-protein interactions. Crosslink
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experiments demonstrated that the hU3-55K protein 
directly contacts the U3 snoRNA in our in vitro 
assembly reaction. Furthermore, we have shown 
that the WD40 repeats of hU3-55K are sufficient for 
the RNA-dependent interaction with the 15.5K- 
bound U3BC RNA. There was no observable inter­
action between hU3-55K and 15.5K in the absence 
of RNA suggesting that protein-RNA contacts play 
a significant role in the binding of the WD40 repeats 
to the U3BC RNA. To our knowledge, we believe 
that this is the first example of a WD40 repeat pro­
tein directly interacting with RNA and it is likely 
that the hU3-55K interaction with the U3 snoRNA is 
mediated by one or more of the WD40 repeats.
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Figure 6 . A direct contact between hU3-55K and the U3BC
RNA
A) A single protein specifically crosslinks to the U3BC RNA 
in HeLa nuclear extract. In vitro reconstitution experiments 
were performed in HeLa nuclear extracts using 4-thio-UTP 
containing 32P-labeled U3BC transcripts. The extracts were 
then UV irradiated, RNAse T1 digested and then resolved on 
a 13% polyacrylamide/SDS gel. The RNA used, the inclusion 
of 4-thio-UTP in the transcript, and whether the sample was 
UV irradiated is indicated above each lane. NRS: normal rab­
bit serum; a55K: anti-hU3-55K antibodies.
B) hU3-55K specifically crosslinks to the U3BC RNA. In vitro 
reconstitution and UV crosslinking experiments were per­
formed as in A). After UV irradiation, the samples were 
immunoprecipitated either under semi-denaturing conditions 
(lanes 1-6) or normal native conditions (lanes 7-9) with either 
anti-hU3-55K antibodies (a55K) or normal rabbit serum 
(NRS). The bound RNA was then separated on an 8 % poly­
acrylamide/7 M urea gel. The RNA used, the inclusion o f 4- 
thio-UTP in the transcript and whether the sample was UV 
irradiated is indicated above each lane.
The U3 snoRNP contains two independent 15.5K 
containing RNP complexes
The 3’ domain of the U3 snoRNA contains two 
15.5K binding sites, namely the C/D and B/C 
motifs. Several studies have shown that in the U3 
snoRNA, the box B/C and box C/D motifs are func­
tionally distinct. Mutations in box B/C motif appear 
not to affect the stability of the RNA in vivo where­
as mutations in the box C/D motif render the RNA 
unstable 1 (26). The box B/C motif alone was found 
to be sufficient for targeting the RNA to Cajal bod­
ies, whereas, the box C/D motif is essential for 
nucleolar localisation (20). Furthermore, in contrast 
to the box B/C, the box C/D is essential for 5’ cap 
hypermethylation (33). This functional distinctive­
ness between the box B/C and C/D motifs is likely 
due to the distinct sets of proteins that bind these 
two RNA elements.
The B/C motif is associated with hU3-55K and 
15.5K, while the core box C/D motif is associated 
with 15.5K, NOP56, NOP58, and fibrillarin. How 
do these two RNA motifs, which are very similar in 
structure and both bound by 15.5K, direct the spe­
cific assembly of two distinct RNP complexes? In 
this manuscript, we show that a specific structural
25
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element, present between boxes B and C in the pri­
mary sequence, is essential for the recruitment of 
hU3-55K to the 15.5K-bound U3BC RNA. In con­
trast, recent work has shown that the association of 
the core snoRNP proteins with the box C/D 
snoRNA/15.5K complex is dependent on the con­
served sequence of stem II in the box C/D motif 
(corresponds to stem II in the U3BC RNA, (40)). 
Interestingly, the sequence of this stem is different 
in the B/C motif explaining why the core box C/D 
snoRNP proteins do not associate with the U3BC 
RNA. In addition, the structure but not the sequence 
of this stem in the box B/C motif is essential for both 
15.5K and hU3-55K protein binding. Likewise, the 
conserved structural element found between boxes 
B and C in the U3 snoRNA, is not present in the core 
box C/D motif. Therefore, the distinct flanking 
sequences/structures, surrounding the highly similar 
15.5K binding sites, provide the specificity for the 
recruitment of the additional, complex-specific pro­
teins.
The structure of the 3’ domain of the U3 snoRNA
The results presented in this manuscript provide 
a significant insight into the structure of the 3’ 
domain of the U3 snoRNA. While all the work pre­
sented here was performed with a sub-fragment of 
the U3 snoRNA, the U3BC RNA contained all of 
the sequences necessary for the binding of hU3-55K 
and we, therefore, believe that this reflects what 
occurs in the full length RNA. This approach has 
been previously used in the systematic analysis of 
the U3 snoRNA in vitro and in vivo (17, 20, 32, 33). 
Furthermore, since there are two 15.5K binding sites 
in the U3 snoRNA, it is essential to physically sep­
arate these two motifs in order to enable the clear 
analysis of the binding requirements of this protein 
in the BC region of the U3 snoRNA.
The mutational analysis of the U3BC RNA has 
not only resulted in the definition of the binding
sites for the 15.5K and hU3-55K proteins, it has also 
provided convincing functional evidence for our 
model of the U3 snoRNA. In this model, we have 
brought together the boxes B and C to form stems II 
and III in the 3’ domain of the U3 snoRNA. Stem III 
is only two base-pairs in length, however, this inter­
action is feasible in all U3 snoRNAs examined even 
though in some cases only one potential base-pair is 
found. Our mutational analysis has shown the 
importance of base-pairing in stem II for 15.5K 
binding. Furthermore, stem IV appears to be neces­
sary to assist in the formation or stabilisation of 
stem III. This point is emphasised by the dramatic 
increase in 15.5K binding that was observed upon 
closing the small internal loop between stems III 
and IV. These data are therefore highly suggestive 
that the short stem III, which is probably stable only 
upon 15.5K binding, is found in the U3 snoRNP. 
The short nature of this stem is probably necessary 
to form the correct structure for hU3-55K binding. 
Base-pairing in stem II of the B/C RNA is also 
required for 15.5K binding. This stem contains a G- 
C base-pair that is found in all of the available U3 
snoRNA sequences. While the structure, but not the 
sequence of this base-pair is essential for 15.5K 
binding, it is possible that this conserved element 
may play a role, perhaps along with the hU3-55K 
protein, in the sequence specific recruitment of addi­
tional U3-specific proteins.
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Figure 7. The WD40 domain of hU3-55K is necessary and sufficient for the interaction with the 15.5K-U3BC RNA complex.
A) Alignment o f the seven putative WD40 repeats identified in hU3-55K. Using a m otif search program (http://www.embl-heidel- 
berg.de/~andrade/papers/rep/search.html) the seven WD40 repeats were identified in the amino acid sequence of hU3-55K. Highly 
conserved amino acids are shown in white on a black background. Conserved amino acids are represented in white on a grey back­
ground and are grouped according to (29). The WD40 repeat profiles used for these studies have been described (31) (http://bmerc- 
www.bu.edu/bioinformatics /wdrepeat.html).
B) Schematic representation of the hU3-55K protein. The putative nuclear localisation signal (NLS) and the glutamic acid stretch 
(E-stretch; grey box) have been described previously (17,31). The WD40 repeats are represented as black boxes. The amino acid 
positions relevant to the deletions used in C) are indicated.
C) In vitro translated wild-type or mutant 35S-labeled hU3-55K protein was incubated with GST15.5K in the absence or presence 
of U3BC RNA. Reconstituted complexes were precipitated using glutathione-sepharose beads and the co-precipitated proteins 
resolved on a 13% polyacrylamide SDS gel. The identity of the in vitro translated protein used is indicated above each lane. The 
designation of the mutants indicates which regions of hU3-55K were deleted, as described previously (17, 25). Ten percent of the 
input for each 35S-labeled protein is shown in the lower panel.
D) The WD40 domain of hU3-55K requires RNA elements flanking the 15.5K binding site for its association with the U3BC RNA. 
The binding o f the hU3-55K mutant A1-136 to the GST15.5K/RNA complex was performed as described above using either the 
U3BC wild-type or mutloopA-GG RNAs (see Figure 4B). The RNA transcript used is indicated above each lane. Lane 1; 10% of 
the in vitro translated protein used in each reconstitution.
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Materials and Methods
Generation of U3 snoRNA constructs
The U3 construct pSP6U3 (41) was kindly provided by 
Stuart Maxwell. Constructs encoding human U3 snoRNA 
mutants were generated by PCR using pSP6U3 as a substrate, 
with the oligonucleotides listed in Table I. The PCR products, 
which contain a T7 promoter upstream of the U3 sequence, 
were cloned into the EcoRI and BamHI sites of pUC19. Primer 
sets for each mutant were as follows: U3BC, oligonucleotides 2 
and 3; U3BCAstem V, 2 and 6 ; U3BCAstem IV+V, 7 and 8 ; 
U3BCAstem VI, 2 and 9; U3BCAstem I+VI, 10 and 11; 
U3BCmutB, 3 and 4; U3BCmutC, 2 and 5; U3BCstemC, 24 
and 3; U3BCstemG, 2 and 25; U3BCstemCG, 24 and 25; 
U3BCstemCCG, 26 and 3; U3BCstemCGG, 2 and 27; 
U3BCstemCCGCGG, 26 and 27; U3BCmutUU-GC, 22 and 23; 
U3BCmutloopA-GG, 2 and 28. The U3 snoRNA mutants 
U3BCmutstem III and U3BCmutAU-AA were generated using 
the pUC19-U3BCAstem VI construct as template with oligonu­
cleotides 14 and 15, and 1 and 12, respectively. U3BCmutGG- 
AA and U3BCmutloop-stem were generated via a two-step 
PCR method using pUC19-U3BCAstem VI as template. In the 
first round of PCR, oligonucleotides 16 and 19, and 13 and 19 
were used for U3BCmutGG-AA and U3BCmutloop-stem, 
respectively. PCR products were gel purified and used as 
primers for a second PCR amplification in combination with 
oligonucleotide 1. To generate the U3BCmutpyrloop and 
U3BCmutstem IV constructs, oligonucleotides 17 and 19 were 
used as a templates, respectively, and amplified using primers 1 
and 19 in a PCR reaction. RNA encoded by U3CD PCR prod­
uct, generated using oligonucleotides 2 1  and 2 2 , contains a 
tetraloop (UUCG) in order to join the two sides of the U3 
snoRNA. This PCR product was cloned into the KpnI and 
EcoRI sites of pUC19. The integrity of each construct was ver­
ified by DNA sequencing.
In  vitro transcription
For in vitro transcription all pUC19-U3BC constructs 
were linearised with BamHI, while pUC19-U3CD was cleaved 
with KpnI. All transcriptions were performed with T7 RNA 
polymerase in the presence of 32P-UTP (Amersham) as previ­
ously described (25). For crosslinking experiments 4-thio-UTP 
labeled RNAs were generated via in vitro transcription in the 
presence of 32P-CTP (Amersham) using a final concentration of 
1 mM UTP and 1 mM 4-thio-UTP. The 4-thio-UTP was a gen­
erous gift from Heiko Manninga. The m7G-capped U3BC and 
mutB transcripts were generated as described previously (22).
Construction and in vitro translation of recom binant pro­
teins
The hU3-55KA1-136 deletion mutation was generated by 
PCR using pCI-neo VSVhU3-55K as a substrate (25) with 
oligonucleotides 55Kdelta1-136For and 55KRev (Table I). The 
remaining pCI-neo VSVhU3-55K deletion mutants were 
described previously (17, 25). 35S-labeled proteins were gener­
ated using the TnT reticulate lysate coupled transcription/trans­
lation kit (Promega) according to the manufacturers directions.
In  vitro reconstitution experiments
The hU3-55K antibodies were generated by immunising 
rabbits with a peptide derived from the hU3-55K sequence 
(EEELEETAQEKKLRLAK). The resulting antiserum specifi­
cally recognises hU3-55K in western blots and co-immunopre- 
cipitates only the U3 snoRNA from HeLa total cell extract (data 
not shown). HeLa nuclear extract was prepared essentially as 
described (22). For each 20 ^l reconstitution experiment 10 ^l 
HeLa nuclear extract, 10 Mg tRNA, and 50 fmoles 32P labeled 
RNA were incubated in a buffer containing 20 mM HEPES 
KOH (pH 7.9), 150 mM NaCl, 3 mM MgCl2, 0.1% (v/v) Triton 
X-100, 0.5 mM DTT, and 10% (v/v) glycerol for 30 minutes at 
30°C. In order to control for the stability of the RNA in nuclear 
extract RNA was extracted from 5% of the assembly reaction. 
The reconstituted complex was then immunoprecipitated using 
anti-hU3-55K antibodies coupled to protein A-sepharose in 300 
M-l o f IPP150 (20 mM Tris (pH 7.5), 150 mM NaCl, 0.2% Triton
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Table I: oligonucleotides used in this study 
Oligonucleotide Sequence
3
5 ’-GCGGAATTCTAATACGACTC-3’
5 ’-GCGGAATTCTAATACGACTCACTATAGGGCCCGGGCTCCTGAGCGTGAAGC
CG-3’
5 ’-GCGGATCCCTCCCTCTCACTCCCCAAT-3’
5 ’-GCGGAATTCTAATACGACTCACTATAGGGCCCGGGCTCCTGAGCGTGCAGC
CGGCTTTCTGGCGT-3’
5 ’-GCGGATCCCTCCCTCTCACTCCCCAATACGGAGAGAAGAACGATGATCAA-3’
5 ’-GCGGAATTCTAATACGACTCACTATAGGGCCCGGGCTCCTGAGCGTGAAGC
CGGCTTTCTGTCAGCCATTGATGATCGTTCTT-3’
5 ’-GCGGAATTCTAATACGACTCACTATAGGGCCCGGGCTCCTGAGCGTGAAGC
CGCATTGATGATCGTTTCTTCTCTCCGTATTGGGGAGTGAGAGGGAG-3’
5 ’-GCGGATCCCTCCCTCTCACTCCCCAATACGGAGAG-3’
5 ’-GCGGATCCCTCCCTAACGATCATCAATGGCTGACGG
5 ’-GCGGAATTCTAATACGACTCACTATAGGGCCCGGGAGCGTGAAGCCG
GCTTTCTG-3’
5 ’-GCGGATCCAACGATCATCAATGGCTGA-3’
5 ’-GCGGATCCTCCCTAACGATCATCTATGGCTGACGGCAGTTGCA-3’
5 ’-GAAGCCGGCTGACGGCGTTGCTTGGCTGCAACGAAGCCGGCTGACG
GCGTTGCTTGGCTGCAAC-3’
5 ’-GCGGAATTCTAATACGACTCACTATAGGGCCCGGGCTCCTGAGCGTGAGGC
CGGCTTTCTGGCGTTGC3-3’
5 ’-GCGGATCCTCCCTAACGATCATCGATGGCTGACGGCAGTTGCA-3’
5 ’-GAGCGTGAAGCCAACTTTCGGCGTTGCTTGGCTGC-3’
5 ’-CTCCTGAGCGTGAAGCCGCGTTTCTGGCGTTGCTTGGCTG
CAACTGCCGTCACGCATTGATGATCGTTAGGGAG-3’
5 ’-CTCCTGAGCGTGAAGCCGGCTAAGTGGCGTTGCTTGGCTGCAACTGCCGA
GAGCCATTGATGATCGTTAGGGAG-3’
5 ’-GCGGATCCTCCCTAACGATCATCAATG-3’
5 ’-GCGGAATTCTAATACGACTCACTATAGGGACCACGAGGAAGAGAG
GTAGCGTTTTTTCGAGAACGCGGTCTGAGTGGT-3’
5 ’-GCGGTACCACTCAGACCGCGTTCT-3’
5 ’-GCGGAATTCTAATACGACTCACTATAGGGCCCGGGCTCCTGAGCGGGAAGC
CGGCTTTCTGGCGT-3’
5 ’-GCGGATCCCTCCCTCTCACTCCCCAATACGGAGAGAAGAACGGTCATCAATG
GC-3’
5 ’-GCGGAATTCTAATACGACTCACTATAGGGCCCGGGCTCCTGAGCCTGAAGC
CGGCTTTCTGGC-3’
5 ’-GCGGATCCCTCCCTCTCACTCCC CAATACGGAGAGAAGAACCTCATCAATG 
GC-3’
5 ’-GCGGAATTCTAATACGACTCACTATAGGGCCCGGGCTCCTGCCG
GTGAAGCCGGCTTTCTGGC-3’
5 ’-GCGGATCCCTCCCTCTCACTCCC CAATACGGAGAGAAGCCGGTCATCAATG 
GC-3’
5 ’-GCGGATCCTCCCTAACGATCATCAACCGGCTGACGGCAGTTGCA-3’
5 ’-GCGGAATTCTAATACGACTCACTATAGGGAGCCTCGAGGCCACCATGTCAG
CTGACATTCGCGTTTTAC-3’
5 ’-GCGGGATCCCCCGGGTCAGGAACCAGCAGCTGGGGGTA-3’
1) U3BCT7Forw
2) U3BCForw
3) U3BCRev
4) U3BCmutB
5) U3BCmutC
6 ) U3BCForAstem V
7) U3BCForAstem IV+V
8 ) U3BCRevAstem IV+V
9) U3BCStemII Rev
10) U3BCForAstem I+VI
11) U3BCRevAstem I+VI
12) U3BCmutAU-AA Rev
13) U3BCmutloop-stem For
14) U3BCmutstem III For2
15) U3BCmutstem III Rev
16) U3BCmutGG-AAFor
17) U3BCmutstem IV
18) U3BCmutpyrloop
19) U3BCAstem VI Rev
20) U3C’DFor
21) U3C’DRev
22) U3BCmutUU-GC For
23) U3BCmutUU-GC Rev
24) U3BCstemC
25) U3BCstemG
26) U3BCstemCCG
27) U3BCstemCGG
28) U3BCmutloopA-GG
29) 55Kdelta1-136For
30) 55KRev
X-100). The bound material was washed four times in IPP150 
and the co-immunoprecipitated and control RNAs were isolat­
ed via phenol:chloroform:isoamylalcohol extraction and 
ethanol precipitation. The recovered RNAs were resolved on an 
8 % polyacrylamide/7 M urea gel.
Competition experiments using U4 SL1 and U4 SL17 
RNA oligonucleotides (22, 40) were performed by pre-incubat- 
ing nuclear extracts with either 100, 200, 400, or 800 pmoles of
the competitor for 30 minutes at 30°C. U3BC RNA was added 
(100 fmol) and the mixture was incubated for another 30 min­
utes at 30°C. For the add-back experiment shown in Figure 6 C, 
the U3BCwt RNA was first pre-incubated with recombinant 
15.5K protein (2.5 to 40 pmoles) for one hour on ice in buffer 
A (20 mM HEPES KOH (pH 7.9), 150 mM KCl, 1.5 mM 
MgCl2, 0.2 mM EDTA (pH 8.0), 0.5 mM DTT, 0.1% Triton X-
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The in vitro reconstitution experiment shown in Figure 2D 
was performed as described previously (22). Basically, 6  
pmoles of m7G-capped U3BC or m7G-capped mutB RNA was 
incubated with 35S-hU3-55K in vitro translate and increasing 
concentrations of recombinant 15.5K protein (0.3, 0.6 and 1.2 
pmoles) in Buffer A in a final volume o f 20 m1. After one hour 
o f incubation on ice, 240 m1 o f Buffer A was added to the reac­
tion and the reconstituted complex was immunoprecipitated 
using the H20 monoclonal antibody (specific for m2,2,7G and 
m7G cap structures (3). The bound material then separated on a 
12% SDS polyacrylamide gel.
GST pull-down assays
Recombinant GST15.5K was expressed and purified as 
described previously (22). Binding studies with mutant U3BC 
RNAs were performed using 1 Mg o f GST15.5K with 50 fmol 
o f 32P-labeled RNA and 1 Mg o f yeast total RNA in Buffer A in 
a final reaction volume o f 10 m1. After one hour o f incubation 
on ice, 240 m1 of Buffer B (20 mM HEPES KOH (pH 7.9), 1.5 
mM MgCl2, 0.2 mM EDTA (pH 8.0), 0.2% Triton X-100, 150 
mM KCl) and 10 M l of glutathione-sepharose beads 
(Pharmacia) were added and the samples were rotated for 2 
hours at 4°C. The beads were washed four times with Buffer B. 
Co-precipitated RNAs were isolated by 
phenol:chloroform:isoamylalcohol extraction and ethanol pre­
cipitation. RNAs were resolved on 8 % polyacrylamide/7 M 
urea gels.
In order to analyse the binding of mutant hU3-55K in vitro 
translates, 10 ng of GST15.5K was incubated with 0.6 pmoles 
of U3BC transcript and the radiolabeled-protein in a final reac­
tion volume of 20 m1 Buffer A. After one hour of incubation on 
ice, reconstituted complexes were bound to GST beads, washed 
four times in buffer B, and the proteins separated on a 12% SDS 
polyacylamide gel.
UV crosslinking experiments
For UV crosslinking experiments, 500 fmol modified 
RNA was used in a standard reconstitution reaction with a final 
volume o f 50 m1. Samples were then subjected to UV light (365
100). nm) for 15 minutes on ice. For direct analysis of proteins 
crosslinked to the RNA (Figure 6 A) 15 M g of RNAse T1 was 
added to the samples followed by a 1 hour incubation at 50°C 
and the resultant crosslinks were analysed by SDS-PAGE. For 
immunoprecipitation, reconstitution reactions were first disso­
ciated by the addition of SDS to 1% (w/v) and incubated at 
75°C for 15 minutes. Triton X-100 was then added to a final 
concentration of 5% (v/v) and the reaction diluted to 350 Ml 
with IPP150. Immunoprecipitations were then performed as 
described earlier. Precipitated complexes were subsequently 
treated with proteinase K and the extracted RNAs were 
resolved on an 8 % polyacrylamide/7 M urea gel.
Footnote
1 Sander Granneman, Nicholas J. Watkins, 
Judith Vogelzangs, Reinhard Lührmann, 
Walther J. van Venrooij, and Ger J.M. Pruijn. 
Manuscript in preparation.
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Abstract
Ribosome biogenesis requires a vast number o f trans-acting factors many o f which are 
required for the chemical modification and processing o f the pre-rRNA component. The U3 
snoRNP complex is required for the early cleavage steps in pre-rRNA processing. We have 
cloned cDNAs encoding the human homologues o f the yeast U3 snoRNP associated pro­
teins Imp3 and Imp4. Both human proteins localise to nucleoli and interact with the U3 
snoRNA. The results o f density gradient centrifugation experiments show that, in contrast 
to hU3-55K, hImp3 and hImp4 predominantly interact with the U3 snoRNA in 60-80S 
ribonucleoprotein complexes. Furthermore, we have found that hImp3, hImp4 and hMpp10 
can form a stable hetero-trimeric complex in vitro, which is generated by direct interactions 
o f both hImp3 and hImp4 with hMpp10. The analysis o f hImp3 and hImp4 mutants indicat­
ed that their binding to hMpp10 correlates with their nucleolar accumulation, strongly sug­
gesting that the formation o f the ternary complex o f hImp3, hImp4 and hMpp10 is required 
for their association with nucleolar components.
Introduction
The U3-small nucleolar RNA (snoRNA), a box 
C/D type snoRNA, is required for the early cleavage 
steps in pre-rRNA processing, which are essential 
for the formation of the small ribosomal subunit 
RNA(18S rRNA) in both fungi and vertebrates (15, 
16, 34). In yeast, the U3 snoRNA is essential for 
processing at sites A0, A1 and A2 (reviewed by 39). 
Base-pairing interactions of the U3 snoRNA with 
the 5’ external transcribed spacer (5’ETS) of the pre­
cursor ribosomal RNA (pre-rRNA) and the 5’ termi­
nal region of the 18S rRNA have been demonstrated 
to play an essential role in this process.
The U3 snoRNA contains several evolutionarily 
conserved sequence elements, designated box GAC, 
A, A’, B, C, C’ and D. The box GAC, box A and Box 
A’ display sequence complementarity to regions of 
the 5’ETS and 18S rRNA sequences within the pre- 
rRNA (1, 2, 4-6, 26, 33, 37). The boxes B/C and 
C’/D are located in the 3’ part of the U3 snoRNA 
and function as protein binding sites (13, 26, 30, 
41).
The U3 snoRNA interacts with proteins that are 
common to all box C/D snoRNPs: 15.5K (Snu13p in 
yeast), Nop56, Nop58, and fibrillarin (Nop1p) (18,
19, 24, 29, 35, 41, 47). In addition, a number of pro­
teins have been identified in a yeast system that 
specifically associate with the U3 snoRNA: Rrp9p 
(hU3-55K in human), Dhr1p, Lcp5p, Rcl1p, Sof1p, 
Imp3p, Imp4p and Mpp10p (hMpp10 in human) 
(reviewed in 36).
Recently, preribosomal particles have been puri­
fied using affinity-purification tags from yeast (7,
12). With the exception of Rcl1p and Lcp5p, these 
complexes contained all U3 snoRNA associated 
proteins mentioned above and a large number of 
other non-ribosomal proteins which are associated 
with the U3 snoRNA. It has been proposed that the 
U3 snoRNA, together with the proteins that are 
associated with U3 in preribosomal particles, are 
required to assist in the proper folding of the pre- 
rRNA.
The human U3 snoRNA is associated with both 
12S and 60-80S complexes (9, 38). Nop56, Nop58, 
15.5K, fibrillarin and hU3-55K are most likely the 
first proteins to interact with the U3 snoRNA during 
its assembly and together may constitute the 12S U3 
complex (18, 19, 41). Base-pairing interactions of 
the U3 snoRNA with pre-rRNA, which may require 
a number of auxiliary factors, may lead to the for-
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Figure 1. Amino acid sequence alignment of Imp3 and Imp4.
Amino acid sequences derived from cDNAs encoding Imp3 (A) and Imp4 (B) o f Homo sapiens (hs), Mus musculus (mm), 
Drosophila melanogaster (dm), Caenorhabditis elegans (ce), Arabidopsis thaliana (at) and Saccharomyces cerevisiae (sc) were 
aligned by ClustalW and shaded using Boxshade. Identical amino acids (in at least three o f the sequences) are marked by black 
boxes and similar amino acids are marked by gray boxes. The boxed regions mark the predicted coiled-coil domains. The black bar 
in A underlines the putative S4 RNA binding domain o f Imp3. The black bar in B underlines the putative a 70-like RNA binding 
domain o f Imp4. The broken line in B indicates the position o f the Imp4 domain. Accession numbers: dmImp3, AAL49156; ceImp3, 
NM_059571, atImp3, NM_121580; mmImp3, BC009145; hsImp3, BAB54955 and NP_060755; scImp3p, AA184637; dmImp4, 
AE003750; ceImp4, AF334609; atImp4, AC011622; hsImp4, AF054996; mmImp4, XP_129730 scImp4p, AA404192.
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Figure 2. hImp3 and hImp4 localise to nucleoli in HEp-2 cells and interact with the U3 snoRNA in vivo.
A) HEp-2 cells were transfected with constructs encoding GFPhImp3 and GFPhImp4 fusion proteins and after 16 hours cells were 
fixed and the subcellular localisation of the fusion proteins was determined by fluorescence microscopy (left panels). The corre­
sponding phase-contrast images are shown in the right panels.
B) HEp-2 total cell extracts were subjected to immunoprecipitation using antibodies against hImp3, hImp4, hMpp10, hU3-55K, fib­
rillarin (27B9) and anti-cap antibodies (H20) (lanes 2-7). Co-precipitated RNAs were separated on denaturing polyacrylamide gels 
and analysed by northern blot hybridisation using riboprobes specific for the U3, U 8  and U17 snoRNAs. In lane 1, RNA isolated 
from the total cell extract was loaded (5% o f the amount used for immunoprecipitation) and as a negative control an immunopre- 
cipitation was performed in the absence o f antibodies (beads, lane 8 ).
mation of 60-80S complexes, equivalent to the SSU 
processome/ 90S preribosomal complex described 
in yeast (7, 12).
Imp3p and Imp4p were identified in a yeast 
two-hybrid screen using yeast Mpp10p as a bait 
(21). Both the human and yeast Mpp10 proteins 
contain several putative coiled-coil regions that 
have been suggested to mediate intramolecular 
and/or intermolecular interactions (8, 23, 45). Imp3p 
contains a putative S4 RNA binding domain (21). 
Imp4p is a member of the Imp4 superfamily of pro­
teins, which are characterised by the a 70-like motif, 
a sequence motif first identified in the a 70 family of 
prokaryotic transcription factors (43). Interestingly, 
the a 70-like motif in the eukaryotic Imp4 superfam­
ily confers binding to RNA and all the proteins in 
this family interact with pre-rRNA processing inter­
mediates (10, 43). In contrast to other members of 
this family, Imp4p associates with the U3 snoRNA
and is required for the early cleavage steps in pre- 
rRNA processing (21, 43). In this study we have 
addressed the question whether the Mpp10-Imp3- 
Imp4 complex also exists in human cells and we 
have investigated its association with the human U3 
snoRNP. For these studies cDNAs encoding the 
human homologues of the yeast Imp3 and Imp4 pro­
teins were cloned and characterised. Besides data on 
their association with U3 snoRNA containing com­
plexes, details on their interactions with the human 
Mpp10 protein will be presented.
Results
Cloning of the human Imp3 and Imp4 ortho- 
logues
Database searches performed with the yeast 
Imp3 and Imp4 sequences led to the identification of 
putative Imp3p and Imp4p homologues in a number 
of species, several of which have been reported
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before (10, 21, 25, 43). The sequences of the puta­
tive human homologues were used to design 
oligonucleotides to isolate human cDNAs from a 
teratocarcinoma cDNA library. The resulting 
cDNAs were cloned and sequenced. The amino acid 
sequence derived from the cloned human Imp4 
cDNA (hImp4) was identical to the putative human 
Imp4p orthologue recently described (25) (acces­
sion number: AF054996). While this work was in 
progress, a protein designated MRPS4, the sequence 
of which is identical to the sequence derived from 
the cloned Imp3 cDNA (hImp3), was described as a 
mitochondrial ribosomal subunit component (acces­
sion numbers: BAB54955 and NP_060755), 
although no experimental evidence for its associa­
tion with the mitochondrial ribosome was presented 
(17). Figure 1 shows an alignment of the hImp3 and 
hImp4 amino acid sequences with homologous 
sequences from several species. The hImp3 protein 
has a predicted molecular mass of 21.8 kDa and a pI 
of 10.0; the hImp4 protein has a predicted molecu­
lar mass of 33.7 kDa and a pI of 9.7. Both human 
proteins show 51% identity and 68% similarity to 
their yeast counterparts.
Besides a putative S4 domain in hImp3 and a 
a 70-like motif in hImp4, coiled-coil regions are pre­
dicted to reside in both human proteins (Figure 1). 
The Interproscan program
(http://www.ebi.ac.uk/interpro/scan.html) revealed 
the so-called Imp4 domain (InterProScan 
ID:Q96G21) that was recently identified in Imp4 
homologues from several species (25).
The hImp3 and hImp4 proteins localise to nucle­
oli and interact with the human U3 snoRNP com­
plex
To investigate whether the hImp3 and hImp4 
cDNAs encoded the functional counterparts of the 
yeast Imp3p and Imp4p proteins, their subcellular 
localisation and association with the U3 snoRNP
were determined. HEp-2 cells were transfected with 
constructs encoding GFP-fusion proteins of hImp3 
and hImp4 and after 18 hours the subcellular locali­
sation of the GFP-tagged proteins was examined by 
fluorescence microscopy. The results show that both 
fusion proteins accumulate in the nucleoli (Figure 
2A). Thus, the subcellular localisation of hImp3 and 
hImp4 is consistent with U3 snoRNP association 
and a role in ribosomal RNA maturation. To investi­
gate whether these proteins indeed associate with 
U3, immunoprecipitations were peformed with anti- 
hImp3 and anti-hImp4 antibodies on HEp-2 total 
cell extracts (Figure 2B, lanes 3,4). As controls anti- 
hMpp10, anti-hU3-55K, anti-fibrillarin and anti- 
(tri)methylguanosine cap antibodies were used 
(Figure 2B, lanes 4-7). After immunoprecipitation, 
co-precipiated RNAs were analysed by northern 
blot hybridisation using various riboprobes. We 
observed U3 snoRNA co-precipitation with both the 
anti-hImp3 and anti-hImp4 antibodies, although the 
amounts were reproducibly low (Figure 2B, lanes 
2,3). Co-precipitation of U3 with the anti-hImp4 
antibodies was always more efficient than with anti- 
hImp3 antibodies. No significant co-precipitation of 
the box C/D U8 snoRNA, the U17 box H/ACA 
snoRNA was observed (Figure 2C). As expected, 
both box C/D snoRNAs, U3 and U8, were efficient­
ly co-precipitated by the anti-fibrillarin and anti-cap 
antibodies (Figure 2B, lanes 6 and 7).
hImp3, hImp4 and hMpp10 sediment at 60-80S 
in glycerol gradients
The human U3 snoRNA is associated with 12S 
and 60-80S complexes of which the latter probably 
represent the U3 snoRNA associated with pre-rRNA 
processing complexes (7, 9, 12, 38). Since most of 
the yeast U3 snoRNA associated proteins have been 
reported to interact with the RNA in higher order 
complexes (3, 7, 12), the association of hImp3 and 
hImp4 with the U3 snoRNP was further studied by
4
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Figure 3. hImp3, hImp4 and hM pp10 predom inantly sediment a t 60-80S in glycerol gradients.
A) HEp-2 cell lysates were loaded on a 10-30% (v/v) glycerol gradient, and the sedimentation o f U3 snoRNA, hU3-55K, hMpp10, 
hImp3 and hImp4 was analysed by northern blot hybridisation and immunoblotting, respectively. The sedimentation o f the large 
ribosomal RNAs was determined by agarose gel electrophoresis and ethidium bromide staining and these were used as markers for 
40S and 60S particles in the gradient. The U1 snRNA was used as a marker for 12S complexes. The arrow marks the hImp3 band.
B) The fractions containing either the 12S or 60-80S U3 snoRNP complexes (4-7 and 16-20) were pooled and used for immuno- 
precipitation experiments with anti-hU3-55K (lanes 2 and 7), anti-hMpp10 (lanes 3 and 8 ) and anti-hImp4 (lanes 4 and 9) antibod­
ies. RNAs isolated from the pooled fractions (5% Input, lanes 1 and 6 ) and co-precipitated RNAs were separated on denaturing 
polyacrylamide gels and analysed by northern blot hybridisation using a U3 snoRNA specific probe. As a negative control an 
immunoprecipitation was performed in the absence of antibodies (beads, lanes 5 and 10).
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density gradient sedimentation. Since yeast Imp3p 
and Imp4p interact with Mpp10p (45), we included 
the human Mpp10 protein in these analyses. In addi­
tion, the sedimentation of hU3-55K, a U3 snoRNP 
specific protein, was investigated (22, 31). HEp-2 
cells were disrupted by sonication and after the 
removal of insoluble material the extract was sepa­
rated on a 10-30% glycerol gradient. The fractions 
were analysed by agarose gel electrophoresis to 
monitor the distribution of rRNA, northern blot 
hybridisation to visualise the U3 snoRNA and the 
U1 snRNA and western blotting to detect the pro­
teins. (Figure 3A and data not shown). The U1 
snRNA was used as marker for 12S complexes, 
whereas the large ribosomal RNAs were used to 
monitor the sedimentation of the 40S and 60S ribo- 
somal subunits (data not shown). Northern blotting 
revealed that the bulk of the U3 snoRNA sediment- 
ed at 12S and 60-80S, in agreement with previous 
observations (9, 38). The U3-specific protein hU3- 
55K co-sedimented with the U3 snoRNA, and 
peaked with the U3 snoRNA in fractions 5-6 (~12S) 
and fractions 17-19 (~70S). Interestingly, the bulk of 
hImp3, hImp4 and hMpp10, co-sedimented with the 
U3 snoRNA at 60-80S (Figure 3A, fractions 17-19), 
whereas only very small amounts sedimented near 
12S (Figure 3A, fractions 4-7). These results sug­
gested that, in contrast to hU3-55K, the hImp3, 
hImp4 and Mpp10 proteins are not associated with 
the 12S U3 complex, but that they only interact with 
the larger, 60-80S U3 snoRNA containing complex­
es. Immunoprecipitation experiments performed 
with anti-hU3-55K, anti-hMpp10 and anti-hImp4 
antibodies (Figure 3B, lanes 7-9) confirmed the 
interaction between these proteins and the U3 
snoRNA in the fractions corresponding to the 60­
80S region (fractions 16-20). Furthermore, only 
very low amounts of U3 snoRNA were co-precipi­
tated by anti-hImp4 and anti-hMpp10 antibodies 
from the fractions corresponding to 12S (Figure 3B,
lanes 3-5).
hMpp10, hImp3 and hImp4 form a heterotrimer- 
ic complex in vitro
In yeast, the Imp3p and Imp4p proteins were 
identified by virtue of their interaction with Mpp10p 
(21). To study whether also the human proteins 
directly bind to each other, GST pull-down experi­
ments were performed using GSThImp3, 
GSThImp4 and 35S-labeled, in vitro translated 
hImp3, hImp4 and hMpp10 proteins. The GST- 
fusion proteins and radiolabeled proteins were incu­
bated and the complexes that were formed were pre­
cipitated using glutathione-sepharose beads. The 
results in Figure 4 show that GSThImp3 and 
GSThImp4 efficiently interacted with hMpp10 
(lanes 4,5). In contrast, no detectable interaction was 
observed between GSThImp3 and hImp4 and 
between GSThImp4 and hImp3 (Figure 4, lanes 
6,7). These results suggest that like their yeast coun­
terparts hImp3 and hImp4 interact with Mpp10 but 
not with each other. In agreement with these interac­
tions, hetero-trimeric complexes could be reconsti­
tuted in vitro when either GSThImp3 was incubated 
with radiolabeled hMpp10 and hImp4 (Figure 4, 
lane 8) or when GSThImp4 was incubated with radi­
olabeled hMpp10 and hImp3. (Figure 4, lane 9). 
When GST15.5K was used in these experiments, no 
detectable co-precipitation of radiolabeled hImp3, 
hImp4 or hMpp10 (Figure 4, lane 10) was observed.
Domains of hImp3, hImp4, and hMpp10 
involved in mutual interactions
The efficient interactions between hImp3, 
hImp4 and hMpp10 prompted us to examine the 
regions involved in their mutual interactions. Five 
hMpp10 deletion mutants were generated, three C- 
terminal truncations (Figure 5A, hMpp10AC565, 
hMpp10AC456, hMpp10AC325), one N-terminal 
truncation (Figure 5A, hMpp!0AN58) and one
4
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Figure 4. hImp3 and hImp4 in teract with hMpp10 but not w ith each other in vitro.
Radiolabeled hMpp10, hImp3 and hImp4 were expressed in an in vitro translation system (lanes 1 - 3). These polypeptides were 
incubated with GST-tagged hImp3 or hImp4 as indicated, followed by precipitation with immobilised glutathione (lanes 4 - 9). A 
GST15.5K fusion protein was used as a control (lane 10). Note that hImp4 is only co-precipitated with GSThImp3 in the presence 
of hMpp10 and that, vice versa, hImp3 is only co-precipitated with GSThImp4 in the presence of hMpp10. The positions of radi­
olabeled hMpp10, hImp3 and hImp4 in the gel are indicated on the right. On the left o f each panel the positions of molecular mass 
markers is shown.
internal deletion mutant (Figure 5A, hMpp10A103- 
326). The results show that GSThImp3 efficiently 
bound to hMpp10AN58, hMpp10A103-326 and 
hMpp10AC565, but not to hMpp10AC456 and 
hMpp10AC325 (Figure 5B, lanes 8-12). GSThImp4 
bound to all mutants (Figure 5B, lanes 14-18) with 
exception of hMpp10AC325. These results suggest 
that the region of Mpp10 bordered by amino acids 
457 and 565 is required for its interaction with 
hImp3, whereas the region bordered by amino acids 
327-456 is involved in the binding to hImp4 (Figure 
5C). In addition, our results show that large portions 
of hMpp10 can be deleted, without significantly 
affecting the interaction with hImp3 or hImp4 
(Figure 5A; hMpp10 mutants AN58, A103-325, and 
AC565; Figure 5B, lanes 8-10, 14-16).
To investigate the regions of hImp3 and hImp4 
involved in the interaction with hMpp10, the in vitro 
reconstitution of the hetero-trimeric complex of
hImp3, hImp4 and Mpp10 (see above) was used. 
The capacity of hImp3 and hImp4 deletion mutants 
(Figure 6A) to interact with in vitro translated 
hMpp10 bound to GSThImp4 and GSThImp3, 
respectively, was determined. Deletion of either the 
putative coiled-coil domain of hImp3 or the C-ter­
minal region including part of the S4 domain abro­
gated the interaction with hMpp10 (Figure 6A, 
hImp3ACC and hImp3AS4; Figure 6B, lanes 6 and 
7), suggesting that amino acids in both regions of 
hImp3 are important for the interaction with 
hMpp10. Deletion of the putative coiled-coil region 
of hImp4 did not affect its interaction with hMpp10 
(Figure 6A, hImp4ACC; Figure 6C, lane 6). 
However, deletion of the o 70-like motif, (Figure 6A, 
hImp4Ao70) abrogated its interaction with hMpp10 
(Figure 6C, lane 7). These data indicate that the 
deletion of spatially separated regions of hImp3 
interfere with its binding to hMpp10 and that the
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Figure 5. Regions of hMpp10 involved in its interaction with hImp3 and hImp4.
A) Schematic representation of the hMpp10 deletion mutants. The black boxes represent putative coiled-coil regions in hMpp10
(45).
B) Binding o f GSThImp3 and GSThImp4 to hMpp10 deletion mutants. GST pull-down experiments were performed with 
GSThImp3, GSThImp4 and GST15.5K. Lanes 1 to 6  show 10% of the input material. Precipitation o f hMpp10 mutants by 
GSThImp3 is shown in lanes 7-12, by GSThImp4 in lanes 13-18 and precipitation of wild type hMpp10 by GST15.5K in lane 19. 
On the left of the panel the positions of molecular mass markers is shown.
C) Schematic representation o f the results shown in B)
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Figure 6 . Regions of hImp3 and hImp4 required for their interaction with hMpp10 in vitro.
A) Schematic representation of the hImp3 and hImp4 deletion and substitution mutants. The black boxes indicate the putative 
coiled-coil regions in hImp3 and hImp4. The putative RNA binding domains in hImp3 (S4) and hImp4 (a 70-like) are depicted as 
grey boxes. The Imp4 domain is marked with a white box. The asterisks indicate the positions in hImp4 that were changed in the 
substitution mutants.
B) Binding of hImp3 deletion mutants to hMpp10. Reconstituted complexes were precipitated using glutathione-sepharose beads 
as described in Materials and Methods and analysed by SDS-PAGE. The hImp3 (mutant) translates are indicated above the respec­
tive lanes and radiolabeled hMpp10 was added to all reconstitution reactions. The GST-fusion proteins used in this experiment are 
indicated on top of the panels. Lanes 1-4 show 10% of the input material used in the pull-down experiments. Lanes 5-8 show the 
precipitates (in lane 8  GST15.5K was used as a negative control). On the left o f each panel the positions of molecular mass mark­
ers is shown. On the right the position of hMpp10 in the gel is indicated.
C) Binding of hImp4 deletion mutants to hMpp10. Reconstituted complexes were precipitated using glutathione-sepharose beads 
as described in Materials and Methods and analysed by SDS-PAGE. The hImp4 (mutant) translates are indicated above the respec­
tive lanes and radiolabeled hMpp10 was added to all reconstitution reactions. The GST-fusion proteins used in this experiment are 
indicated on top of the panels. Lanes 1-4 show 10% of the input material used in the pull-down experiments. Lanes 5-8 show the 
precipitates (in lane 8  GST15.5K was used as a negative control). On the left o f each panel the positions of molecular mass mark­
ers is shown.
D) Binding of hImp4 substitution mutants to hMpp10. The hImp4 (mutant) translates are indicated above the respective lanes and 
radiolabeled hMpp10 was added to all reconstitution reactions. The GST-fusion proteins used in this experiment are indicated on 
top of the panels. Lanes 1-4 show 10% of the input material used in the pull-down experiments. Lanes 5-8 show the precipitates 
(in lane 8  GST15.5K was used as a negative control. On the left of each panel the positions o f molecular mass markers is shown.
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o 70-like motif of hImp4 is required for its associa­
tion with hMpp10. To substantiate the importance of 
the o 70-like motif for this interaction and to investi­
gate the possibility that (also) the Imp4 domain 
plays a role in this interaction, we generated mutants 
containing point mutations in these motifs. Two 
amino acids in the o 70-like motif, which are highly 
conserved among the proteins in the Imp4 super­
family (43), were substituted by alanines (Figure 
6A, hImp4o70ERAA; Figure 1, amino acids E246 
and R250). In addition, two amino acids in the Imp4 
domain that are highly conserved in the Imp4 super­
family were substituted by alanines (Figure 6A, 
hImp4TFAA; Figure 1, amino acids T159 and F162) 
(25, 43). The results show that both mutant proteins 
did not efficiently interact with hMpp10 (Figure 6D, 
lanes 6-8), suggesting that the o 70-like motif and 
conserved amino acids in the hImp4 domain are 
important for binding to hMpp10 in vitro.
Complex formation deficient hImp3, hImp4 and 
hMpp10 mutants fail to localise to nucleoli in 
HEp-2 cells
To determine the effects of the deletions and 
substitutions in the hImp3, hImp4 and hMpp10 pro­
teins on their nucleolar accumulation, HEp-2 cells 
were transiently transfected with constructs encod­
ing GFP-fusion proteins o f these mutants. 
Interestingly, all hImp3 and hImp4 mutants that 
failed to interact with hMpp10 in vitro predominant­
ly accumulated in the nucleoplasm (Figure 7C, D, 
G, H, I), whereas the hImp4 mutant that retained the 
ability to interact with hMpp10 accumulated in the 
nucleoli like the wild type proteins (Figure 7B, E, 
F). These results suggest that the interaction of 
hImp3 and hImp4 with hMpp10 is required for their 
entry into the nucleolus.
The analysis of the GFPhMpp10 fusion proteins 
suggested that also hMpp10 requires the interaction 
with hImp3, and possibly hImp4, for nucleolar
localisation. The wild-type protein (GFPhMpp10), 
the N-terminal deletion mutant (GFPhMpp10AN58) 
and the internal deletion mutant (GFPhMpp10A103- 
326) accumulated in nucleoli (Figure 7J-L). Thus a 
large portion of the N-terminal part of hMpp10 can 
be deleted without affecting its subcellular distribu­
tion. Interestingly, a C-terminal deletion of 116 
amino acids (GFPhMp10AC565) resulted in both 
nucleolar and cytoplasmic accumulation, while only 
weak staining was observed in the nucleoplasm 
(Figure 7M). The most pronounced nucleolar accu­
mulation with this mutant was observed in cells 
expressing relatively low levels of the fusion protein 
(Figure 7M; indicated by an arrow). The cytoplas­
mic accumulation might be related to the amino acid 
composition of the region that was deleted, which 
contains clusters of basic amino acids that might be 
involved in nuclear import (45). The larger C-termi­
nal deletion mutant GFPhMpp10AC456 predomi­
nantly accumulated in the cytoplasm (Figure 7N), 
whereas only very small amounts appeared to reside 
in the nucleoplasm. Similar observations were made 
with the GFPhMpp10AC325 mutant (data not 
shown). With these mutants no significant staining 
was observed in the nucleoli. Taken together, these 
results suggest that the region in hMpp10 that is 
important for binding hImp3 (amino acids 456-565) 
is also required for nucleolar localisation, while the 
C-terminal region comprising amino acids 565-681 
is required for nuclear import.
Discussion
In this paper we describe the cloning and char­
acterisation of the human Imp3 and Imp4 proteins. 
Our data show that like in the yeast S. cerevisiae the 
hImp3 and hImp4 proteins both interact with 
hMpp10, but not with each other. Our data suggest 
that hImp3, hImp4 and hMpp10 predominantly 
associate with the U3 snoRNA in 60S-80S complex­
es, which are likely to represent preribosomal com-
4
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Figure 7. Effect of m utations in hImp3, hImp4 and hM pp10 on their subcellular localisation.
HEp-2 cells were transiently transfected with constructs encoding GFP fusion proteins of hImp3, hImp4, hMpp10 and mutants 
thereof and the localisation of the fusion proteins was determined by fluorescence microscopy. The mutants used in these experi­
ments are outlined in Figure 4B and Figure 5A. The corresponding phase contrast image is shown on the left of each fluorescence 
image. Panel Ashows the results for GFP alone; panels B-D GFP-tagged hImp3 and hImp3 mutants; panels E-I GFP-tagged hImp4 
and hImp4 mutants; panels J-N GFP-tagged hMpp10 and hMpp10 mutants. The arrow indicates the nucleolar accumulation of 
GFPhMpp10A565 in a cell expressing relatively low levels o f this protein.
plexes. The results obtained with hImp3, hImp4 and 
hMpp10 mutants suggest that the nucleolar accumu­
lation of these proteins is dependent on formation of 
the ternary complex.
hImp3 and hImp4 interact with the U3 snoRNA 
in 60-80S U3 snoRNA containing particles
Previously it has been shown that the yeast 
Imp3p and Imp4p proteins specifically interact with 
the U3 snoRNP complex (21). Our immunoprecipi- 
tation data indicate that this also occurs in the
human system. Despite the fact that a considerable 
amount of U3 snoRNA co-sedimented with hImp3 
and hImp4 in glycerol gradients, we reproducibly 
observed a relatively inefficient U3 snoRNA co-pre­
cipitation, indicating that only a small amount of U3 
snoRNA is stably associated with these proteins in 
HEp-2 cells. We obtained similar results with anti- 
GFP immunoprecipitations using extracts prepared 
from transiently transfected HEp-2 cells expressing 
GFP-tagged hImp3 or hImp4 (data not shown). The 
possibility that the inefficient co-precipitation was
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due to a poor accessibility of the hImp3 and hImp4 
proteins for the antibodies in the 60-80S U3 com­
plexes cannot be excluded. The absence of the U8 
box C/D snoRNA or the U17 box H/ACA snoRNA 
in the precipitates indicates that, like their yeast 
counterparts (20), hImp3 and hImp4 are not com­
mon snoRNP proteins.
The results of gradient sedimentation analyses 
suggested that hImp3, hImp4 and hMpp10 are effi­
ciently associated with 60-80S complexes, at least 
portion of which also contain the U3 snoRNA. U3 
containing complexes with a similar sedimentation 
behaviour have been reported by Tyc and Steitz 
using HeLa cell extracts (38). Components of the 
yeast SSU processome/ 90S preribosomal complex­
es are associated with pre-rRNA (11, 12) and these 
complexes have been suggested to represent the ter­
minal balls seen on nascent pre-rRNA transcripts (7,
12, 27, 28). Attempts to demonstrate the association 
of pre-rRNA by immunoprecipitation with anti- 
hImp and anti-hMpp10 antibodies from 60-80S gra­
dient fractions were not successful. This is most 
likely due to the low abundance of these precursors 
in the cell and low stability o f these RNAs. 
However, based on recent studies performed in 
yeast (7, 12), it is conceivable that the human U3 
complexes sedimenting at 60-80S are associated 
with pre-rRNA precursors.
Our results are consistent with the formation of 
a relatively stable trimeric complex of Imp3, Imp4 
and Mpp10, which interacts with the U3 snoRNA 
only when it is associated with higher order com­
plexes. The efficient association of hImp3, hImp4 
and hMpp10 with large complexes suggests a model 
in which U3 is recruited to the pre-rRNA by virtue 
of its interaction with this trimeric complex. 
Alternatively, the association of U3 with pre-rRNA 
may create or expose the binding site for the hImp3- 
hImp4-hMpp10 complex. Mpp10 association with 
U3 snoRNA requires sequence elements that are
important for base pairing with the 5’ ETS of the 
pre-rRNA (13, 46). In addition, a C-terminal trunc- 
tion of the yeast Mpp10p led to cold-sensitivity and 
pre-rRNA processing defects at A 1 and A2 (20, 44). 
A similar processing defect and growth phenotype 
has been observed in a yeast strain bearing muta­
tions in box A that block base-pairing with 18S 
rRNA sequences (14). Thus hMpp10, together with 
hImp3 and hImp4, might function by fascilitating or 
stabilising base-pairing interactions between U3 
snoRNA and the pre-rRNA. In addition, genetic 
depletion experiments have demonstrated that Imp3 
mediates the association of the hetero-trimeric com­
plex with the U3 snoRNA (44). Thus, Imp3 binding 
to the hinge region of the U3 snoRNA may correct­
ly position Mpp10 and Imp4 to fascilitate or sta­
bilise base-pairing interactions between U3 
snoRNA and 18S pre-rRNA sequences..
The presence of the U3 snoRNA in both 12S 
and 60-80S complexes raises the question whether 
the label U3 snoRNP is entirely accurate. The yeast 
12S U3 complex was shown to contain the common 
box C/D proteins and the yeast orthologue of hU3- 
55K (Rrp9p) (40, 41). Indeed, hU3-55K and the 
common box C/D snoRNP proteins are also associ­
ated with the human 12S U3 complex (this work; 
Granneman, Watkins, Vogelzangs, Lührmann, van 
Venrooij and Pruijn, manuscript in preparation). The 
majority of the U3-specific proteins in yeast, includ­
ing Imp3p, Imp4p and Mpp10p, seem to be prefer­
entially or exclusively associated with the U3 
snoRNA in higher order complexes (3, 7, 12, 42). 
Therefore, we propose to refer to the 12S U3 com­
plex as U3 snoRNP and the 60-80S U3 containing 
complexes as the U3 snoRNP associated with preri- 
bosomal particles.
4
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Formation of the hImp3-hMpp10-hImp4 com­
plex correlates with the nucleolar localisation of 
these proteins
Surprisingly, the analysis of deletion mutants 
showed that the putative RNA binding domains of 
hImp3 (S4 domain) and hImp4 (a70-like motif) are 
required for their binding to hMpp10 in vitro. 
Although it is possible that the observed effects are 
(in part) due to conformational changes in the 
mutant proteins caused by the deletions or substitu­
tions, the correlation between the observed interac­
tions in vitro and subcellular localisation is intrigu­
ing and strongly suggests that the entry of hImp3, 
hImp4 and hMpp10 into the nucleolus is dependent 
on formation of the ternary complex. Deletion of 
116 amino acids from the C-terminus of hMpp10 
(hMpp10AC565) resulted in both nucleolar and 
cytoplasmic accumulation of the protein. The 
human Mpp10 protein contains 5 putative nuclear 
localisation signals of which four are located in the 
region comprising amino acids 574-671 (45). While 
this region is not required for binding hImp3 and 
hImp4, it apparently is important for nuclear import. 
The larger C-terminal deletion mutants that did not 
bind hImp3 and/or hImp4 in vitro (hMpp10AC456 
and AC325) also failed to localise to nucleoli. Thus, 
our results are consistent with a model in which 
hImp3, hImp4 and hMpp10 need to interact with 
each other in order to accumulate in nucleoli.
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Materials and Methods
DNA m anipulations
The human Imp3 and Imp4 cDNAs were cloned by PCR 
using a teratocarcinoma cDNA library and oligonucleotides 
mImp3a and hImp3, hImp4a and hImp4b, respectively (Table
I). The PCR products were cloned into the pCR4-TOPO vector 
according to manufacturer’s procedure (Invitrogen). The result­
ing constructs contain in-frame BglII restriction sites at both the 
5 ’ and 3’ end, a XhoI restriction site upstream o f the translation­
al startcodon and an NheI and StuI site at the 3 ’ end in-frame 
with the coding sequence. The integrity of each construct was 
verified by DNA sequencing.
The pEGFPhImp3 and pEGFPhImp4 constructs were gen­
erated by inserting XhoI-BgK\ fragments o f the cDNA con­
structs into the pEGFP-C3 vector (Clontech) digested with 
XhoI and BamHI. The pCINeoVSVhImp constructs were gen­
erated by insertion o f the XhoI-StuI fragments in plasmid pCI- 
neo5’VSV (31) digested with XhoI and SmaI. The resulting 
constructs contained a VSV-G sequence in-frame with the 
translational start codon. The pGEX-2T GST-fusion constructs 
were generated using the BglII and StuI digested cDNA plas­
mids. hImp3AS4 mutant was generated by PCR using oligonu­
cleotides hImp3DS4 and mImp3a (Table I). The PCR product 
was gel purified and cloned into pCR4-TOPO (Invitrogen). The 
hImp3ACC mutant was generated by two sequential PCR reac­
tions. In the first round o f PCR, oligonucleotide 
hImp3DCCRev was used in combination with oligonucleotide 
mImp3a. The PCR product was gel purified and used as a 
primer in a second reaction in combination with oligonu­
cleotide hImp3. The resulting PCR product was cloned into 
pCR4-TOPO (Invitrogen). hImp4ACC was generated using 
oligonucleotides hImp4DCCFor and hImp4b and cloned into 
pCI-neo5’VSV and pEGFP-C3 using the XhoI and SmaI 
restriction sites. The hImp4Aa70 mutant was generated using 
oligonucleotides hImp4Aa70For, hImp4b and hImp4a via the 
megaprimer procedure as described above.
To generate the hImp4a70ERAA mutant, a PCR was per-
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Table I. Oligonucleotides used in this study.
4
mImp3A 5 ’-GCGAGATCTCTCGAGATGGTGCGGAAGCTTAAGTTC-3’
hImp3 5 ’-GCGAGATCTAGGCCTCTAGCTAGCGGCTTCTAGATCAAAGTCATC-3’
hImp4a 5 ’-GCGAGATCTCTCGAGATGCTGCGCCGCGAGGCCCGC-3’
hImp4b 5 ’-GCGAGATCTAGGCCTTCAGCTAGCCTCGGTGCTCAGGAAGCATCT-3’
hImp3DS4 5 ’-GCGAGATCTAGGCTTCTAGCTAGCGGCGGGGTCGGTGACCAC-3’
hImp3DCCRev 5 ’-CGAAGCGCGCACGCGGAACTGCAGCCGGTAACGCCGCAGCAC-3’
hImp4DCCFor 5 ’-GCGCTCGAGCGCCTGATTCCCACTGAGTTA-3’
hImp4Aa70For 5 ’-AAGAAGACAGACCACCGCAACCTGGGCACGCTGGAGCAGGAG-3’
hImp4a70ERAA 5 ’-GTGGAGCTCACTGCGGTCGGGCCCGCGTTTGAGCTGAAGCTGTACATG-3’
hImp4TFAAFor 5 ’-AGCCACCTGCCCTTTGGTCCTGCGGCCTACGCGACGCTGTGCAATGTGGTCATG-3’
hImp4TFAARev 5 ’-CATGACCACATTGCACAGCGTCGCGTAGGCCGCAGGACCAAAGGGCAGGTGGCT-3’
formed with oligonucleotides hImp4a70ERAA and hImp4b. 
The PCR product was subsequently cloned into pCR4-TOPO, 
isolated by SstI and StuI digestion and ligated into pCR4- 
TOPOhImp4 digested with the same enzymes. The 
hImp4TFAA mutant was generated using the oligonucleotides 
hImp4TFAAFor and hImp4TFAARev and the QuikChange 
mutagenesis kit according to the manufacturer’s procedure 
(Stratagene)
All mutant hImp3 and hImp4 constructs were subsequent­
ly digested with XhoI and StuI and cloned into pCI-neo5’VSV 
and pEGFP-C3 using the XhoI and SmaI restriction sites. The 
hImp3AS4 VSV and GFP-fusion constructs were generated by 
digesting pCR4TOPOhImp3AS4 with XhoI and EcoRI fol­
lowed by ligation o f the gel purified cDNA in the pCI- 
neo5’VSV and pEGFPC3 vectors digested with the same 
enzymes
To generate pCI-neoVSVhMpp10, pBS SK+ Mpp10 (45) 
a XhoI site was introduced by PCR upstream o f the translation­
al start codon and XbaI and SmaI sites at the 3 ’ end of the 
cDNA. A XhoI-SmaI digested cDNA was inserted into 
pCINeo5’VSV digested with the same enzymes. The resulting 
construct contained a VSV-G tag in frame with the hMpp10 
cDNA. The GFPhMpp10 deletion mutant construct were gener­
ated by digestion with with appropriate restriction sites The fol­
lowing internal restriction sites of the hMpp10 cDNA were 
used: BamHI (AN58); PvuII (AC567); N^eI (AC456); HinDIII 
(AC325); EcoRV  and HinDIII (A103-326). The integrity of 
each construct was verified by DNA sequencing.
Fluorescence microscopy
HEp-2 monolayer cells were grown to 70% confluency in
DMEM supplemented with 10% fetal calf serum (FCS). 2 x 106 
cells were transfected with 20 ^g of DNA in a total volume of 
800 ^l DMEM/10% FCS. Electroporation was performed at 
260 V at a capacity o f 950 ^F with a Gene Pulser II (Biorad). 
After electroporation, cells were resuspended in 5 ml 
DMEM/10% FCS, grown for 16 hours on coverslips before fur­
ther processing. Coverslips were washed twice with phosphate 
buffer saline (PBS), placed in methanol for 5 minutes at -20°C 
and rinsed with acetone at room temperature. GFP-fusion pro­
teins were visualised by fluorescence microscopy directly after 
cells were fixed and permeabilised. Images were obtained using 
an Olympus BH2  microscope in combination with an Olympus 
DP10 digital camera and analySIS software (Soft Imaging 
System GmbH).
Glycerol gradient sedimentation and immunoprecipitation 
experiments
A T150 flask with HEp-2 cells was grown to 70% conflu- 
ency using the conditions described above. Cells were harvest­
ed and disrupted in 1 ml gradient buffer (20 mM HEPES-KOH 
(pH 7.9), 150 mM NaCl, 0.5 mM DTT) by sonication (Branson 
microtip setting 2-3) for 3 times 20 seconds. Triton X-100 was 
added to 0 .2 % (v/v) and insoluble material was removed by 
centrifugation at 10,000 x g in a microcentrifuge. The super­
natant (1 ml) was loaded on a 10-30% glycerol gradient (v/v) 
prepared in gradient buffer containing 0.2% Triton X-100). 
Gradients were centrifuged in a Th674 rotor (Sorvall) for 15 
hours at 25,000 rpm. Gradients were manually fractionated in 
22 fractions each. Fractions were subjected to phenol:chloro- 
form:isoamylalcohol extraction and the RNA was isolated by 
ethanol precipitation. Proteins were precipitated by the addition
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o f 5 volumes of acetone to the organic phase. RNAs were 
resolved on 1 0 % denaturing polyacrylamide gels and trans­
ferred to Hybond N+ (Amersham). Hybridisation o f blots with 
anti-sense snoRNA probes was performed as described previ­
ously (31). The positions of the 18S and 28S rRNAs were deter­
mined by agarose gel electrophoresis and ethidium bromide 
staining.
For immunoprecip itati ons, antibodies were coupled to 
protein A agarose beads either directly (anti-hU3-55K, anti- 
hMpp10, anti-(tri)methylguanosine cap (H20)) or via rabbit- 
anti-chicken IgY antibodies (Jackson Immunoresearch) (anti- 
hImp3, anti-hImp4). Immunoprecipitations shown in Figure 2 
were performed using fresh HEp-2 cell lysates prepared in gra­
dient buffer as described above. After incubation with extracts 
(2 hours 4°C), beads were washed four times with gradient 
buffer and co-precipitated RNAs were isolated by phenol:chlo- 
roform:isoamylalcohol extraction and ethanol precipitation. 
RNAwas resolved on 6 % PAA/7 M urea gels. For the immuno- 
precipitation experiment shown in Figure 3, fractions 4-7 and 
16-20 o f the glycerol gradient were pooled and 450 ^l was 
incubated with the antibodies coupled to protein A beads or 
beads alone for 2  hours at 4°C. Wash steps and extraction of co­
precipitated RNAs was performed as described above and RNA 
was resolved on 10% PAA/7 M urea gel.
Expression and purification of GST-fusion proteins
GST-fusion proteins were expressed and purified essen­
tially as described previously (32). The proteins were eluted in 
the presence o f 0.2% Triton X-100 and stored at -70°C after the 
addition o f glycerol (1 0 %).
In  vitro transcription and translation
All pCI-neoVSV constructs were transcribed and 
tranaslated in reticulocyte lysate using either the TnT coupled 
transcription/translation kit (Promega), or by run-of transcrip­
tion and translation using manufacturers procedures (Promega). 
To generate hMpp10 deletion mutant translates, pCI- 
neoVSVhMpp10 was digested with the corresponding enzymes 
as described above.
GST pull-down experiments
GST-fusion protein (500 ng) was incubated with in vitro 
translated protein in buffer A (20 mM HEPES-KOH (pH 7.9), 
150 mM KCl, 0.2% Triton X-100, 1.5 mM MgCl2, 0.2 mM 
EDTA) in a final volume o f 20 ^l. Reactions were incubated for 
1 hour on ice. Subsequently, the reaction mixtures were diluted 
to 250 ^l with buffer A, 10 ^l o f glutathione-sepharose beads 
were added and the mixture was incubated by end-over-end 
rotation for two hours at 4°C. Beads were washed four times 
with Buffer A. Proteins were eluted from the beads by adding 
SDS sample buffer and heating for 5 min at 100°C. Co-precip­
itated proteins were separated by SDS-PAGE and visualised by 
autoradiography.
Generation of antisera
Female white chickens were immunised with 50 ^g of 
purified GST-fusion protein and boosted every two weeks with 
the same amount o f protein. Two chickens were used for immu­
nisation with GSThImp3 (006 and 007) and two for immunisa­
tion with GSThImp4 (008 and 009). The 007 and 008 bleeds 
showed significant reactivity on western blots with the corre­
sponding HeLa cell and recombinant proteins as well as in 
immunoprecipitation of the recombinant in vitro translated pro­
teins and thus were used for further experiments.
Affinity-purification of antibodies
Anti-hU3-55K antibodies (13) were affinity-purified using 
the peptide that was used for the immunisations coupled to 
Sulfolink resin as described by the manufacturer’s procedure 
(Pierce).
W estern blot analysis
Western blots loaded with gradient fractions were blocked 
in MP buffer (PBS, 5% non-fat milk powder, 0.1% NP-40 
(v/v)) for one hour at room temperature. Primary antibody was 
diluted in MP buffer and incubated for one hour at room tem­
perature. Blots were washed three times 10 minutes with MP 
buffer, followed by a one hour incubation with the secondary 
antibody. Antibodies used: chicken anti-hImp4, diluted 
1:10,000, chicken anti-hImp3, diluted 1:5,000, affinity purified
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4anti-hU3-55K antibodies 1:100, guinea pig anti-hMpp10 anti­
bodies, 1:2,000 (a kind gift from Dr. Larry Gerace) (45). As 
secondary antibodies, horse radish peroxidase conjugated rab­
bit anti-mouse (1:2,500), rabbit anti-guinea pig (1:2,500), swine 
anti-rabbit (1:2,500) or rabbit anti-chicken IgY (1:20,000) were 
used. Except for the rabbit anti-chicken antibodies (Jackson 
Immunoresearch), all secondary antibodies were purchased 
from Dako (Denmark).
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Abstract
The human U3 small nucleolar RNA (U3 snoRNA) is essential for processing at the first 
cleavage sites in the pre-rRNA and the production o f the 18S rRNA. The U3 snoRNA is 
associated with 12S and 60-80S ribonucleoprotein complexes o f which the latter might rep­
resent the U3 snoRNA associated with preribosomal particles. By transient expression of 
tagged U3 snoRNAs in human cells, we have investigated the involvement o f elements 
within the U3 snoRNA in the formation o f ribonucleoprotein complexes and in its subnu- 
cleolar localisation. The results indicate that the conserved box B/C motif is required for the 
formation o f 60-80S U3 snoRNA containing complexes. In addition we found that the 3’ 
hinge element, which has the potential to base-pair with a sequence element adjacent to the 
primary processing site in the pre-rRNA, is important for transport o f the U3 snoRNA from 
the dense fibrillar compartment to the surrounding granular compartment o f the nucleolus.
Introduction
Transcription of pre-ribosomal RNA (pre- 
rRNA) in mammalian cells takes place near the bor­
der of the dense fibrillar compartment and the fibril­
lar center in the nucleolus (reviewed in 20, 28, 36). 
The nascent pre-rRNA resides in dense fibrillar 
compartments and subsequently moves to the gran­
ular compartments where late processing events 
occur (7, reviewed in 16, 27). The processing of 
pre-rRNA not only involves a series of endo-and 
exonucleolytic cleavages of pre-rRNA but the rRNA 
also undergoes covalent, post-transcriptional modi­
fications. Both cleavages and chemical modifica­
tions are mediated by RNA-protein complexes 
called small nucleolar ribonucleoprotein complexes 
(snoRNPs). Most snoRNPs function in modification 
of the RNA in which the RNA component of the 
snoRNP (snoRNA) acts as a sequence specific guide 
to select the target sequence. The U3 snoRNA, a box 
C/D type snoRNA, mediates the early cleavage 
steps in both fungi and vertebrates through base- 
pairing with the pre-rRNA (22, 24, 43).
The U3 snoRNA is located throughout the 
nucleolus, although the highest concentration is 
present in punctate structures that resemble the 
dense fibrillar compartments. The presence of the
U3 snoRNA also in granular compartments strongly 
suggested that the pre-rRNA is accompanied by the 
U3 snoRNA when it moves from one compartment 
to the other (reviewed in 1, 15, 16, 39, 40).
The U3 snoRNA has two distinct functional 
domains (Figure 1). The 5’ domain contains the 
sequence elements that are important for base-pair­
ing with the pre-rRNA (GAC box, box A, box A’, 5’ 
hinge and 3’ hinge) (4-6, 9, 10, 21, 31, 44, 48). The 
3’ domain contains the conserved elements box B/C 
and the box C’/D (the latter is homologous to the 
box C/D motif, which is shared with other box C/D 
snoRNAs) (42, 53). In contrast to the box B/C, the 
box C’/D motif is required for nucleolar localisa­
tion, RNA stability and 5’ cap hypermethylation (41, 
45, 46).
In yeast, box A base-pairs with a region near the 
5’-terminus of the 18S rRNA. This interaction pre­
vents the formation of an evolutionarily conserved 
pseudoknot structure, a long-range interaction pres­
ent in the small ribosomal subunit (21). The 5’ hinge 
and 3’ hinge sequences of the human U3 snoRNA 
have the potential to base-pair with regions of the 5’ 
external transcribed spacer (5’ ETS) of the pre- 
rRNA and might function by correctly positioning 
the U3 snoRNA for base-pairing with the pre-rRNA
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(9). In Xenopus laevis oocytes, the sequence in the 
U3 snoRNA separating the 5’ hinge from the 3’ 
hinge also plays an important role in pre-rRNA pro­
cessing. The distance between these RNA elements, 
not the sequence itself, is important for 18S rRNA 
synthesis (9).
The U3 snoRNA is associated with proteins that 
are common to all box C/D snoRNPs: NOP56, 
NOP58 (Nop5p), fibrillarin (Nop1p in yeast) and 
15.5K (Snu13p in yeast). In addition, numerous pro­
teins have been identified that specifically interact 
with the U3 snoRNA: Rrp9p (hU3-55K in human), 
Imp3p, Imp4p, Mpp10p, Dhr1p, Rcl1p, Sof1p, and 
Lcp5p (reviewed in 47). In contrast to hU3-55K, 
most of these proteins have been shown to interact 
with the U3 snoRNA preferentially or exclusively in 
preribosomal particles (8, 12, 14, 18). Recent pro- 
teomic studies have identified a wide array of novel 
proteins that interact with the U3 snoRNA in preri- 
bosomal particles (12, 17). It has been postulated 
that these large complexes represent the terminal 
balls seen on chromatin spreads of nascent pre- 
rRNA (12, 32, 33).
The human U3 snoRNA is associated with 12S 
and 60-80S complexes (13, 25, 49). These findings, 
in combination with the increased knowledge on U3 
snoRNA associated proteins, have raised the ques­
tion which complex should be considered a U3 
snoRNP. We have recently proposed that the 12S 
complex represents a U3 snoRNP and that the 60­
80S complexes are composed of the U3 snoRNP 
associated with preribosomal particles (18).
By transient expression of tagged-U3 snoRNAs 
in human cells, we have analysed the involvement 
of functional elements of the U3 snoRNA in 12S 
and 60-80S complex formation in vivo and its nucle­
olar distribution. Our results suggest that the box 
B/C motif, together with the U3 snoRNP specific 
protein hU3-55K, is required for the association of 
the U3 snoRNP with 60-80S complexes. In addition,
we show that the 3’ hinge sequence in the 5’ domain 
of the U3 snoRNA is important for the transition of 
the U3 snoRNA from the dense fibrillar compart­
ment to the surrounding granular compartment of 
the nucleolus.
Results
Structural elements of the human U3 snoRNA
Based on RNA probing experiments with both 
naked U3 snoRNA and partially purified U3 
snoRNP, a secondary structure for the human U3 
snoRNA has been proposed in which box A, box A’ 
and the 5’ hinge are part of a hairpin structure and 
the conserved sequence elements in the 3’ domain of 
the U3 snoRNA (i.e. boxes B and C or boxes C’ and 
D) are pairwise adjacent to one another (31, 37). 
Recently, we proposed an alternative fold for the 
box B/C motif (Figure 1A) in which it adopts a sec­
ondary structure that resembles the 5’ stem-loop of 
the U4 snRNA (19, 35, 53). Figure 1A shows a sec­
ondary structure model for the human U3 snoRNA 
in which parts of the elements described above are 
included. In this structure, box A’ and box A ele­
ments are part of a hairpin structure, as suggested by 
previous studies in yeast and Xenopus laevis oocytes 
(9, 31), and the 5’ hinge, and 3’ hinge are single­
stranded (9). The sequence spacing the 5’-and 3’ 
hinge is often drawn as part of a short stem-loop 
structure (helix 1b’ in yeast) (9, 31). In the human 
U3 snoRNA this sequence element can also be fold­
ed as part of a small stem-loop structure, reminis­
cent of helix 1b’ in yeast (Figure 1A). For clarity this 
sequence element will be referred to as “hinge stem” 
in this manuscript.
The U3 msl2 RNA interacts with common box 
C/D snoRNP proteins and hU3-55K in vivo
The initial goal of this study was to set up a sys­
tem that would allow us to study the effect of muta­
tions on the association of U3 snoRNP proteins in
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Figure 1. A tagged U3 snoRNA assembles into 
a U3 snoRNP in HEp-2 cells
A) Sequence and secondary structure model for 
the human U3 snoRNA based on structures pro­
posed for the yeast, human and Xenopus U3 
snoRNA (9, 19, 24, 32, 38). The highly con­
served nucleotides in the box C’/D and box B/C 
motifs are depicted in white on a black back­
ground. Grey boxes mark the remaining 
nucleotides conserved in the individual sequence 
elements. The dotted lines indicate non-Watson- 
Crick base-pair interactions in the box B/C and 
C’/D motifs as has been proposed previously 
(19, 53). The boxed nucleotides represent 
sequences (5’ hinge and 3’ hinge) that have the 
potential to base-pair with the 5 ’ external tran­
scribed spacer (5’ETS) of the pre-rRNA. The 
arrow points to an alternative structure between 
the 5 ’ and 3’ hinge region (referred to as hinge 
stem in this manuscript), which is similar to 
helix 1b’ in the yeast U3 snoRNA (31, 57).
B) Secondary structure model for the tagged U3 
msl2 RNA. Only the region where the tag was 
inserted is shown. The box marks the nucleotides 
that are part o f the streptotag. Only the upper 
part of the 3’ domain is shown. The nucleotide 
numbering corresponds to the full-length wild­
type U3 snoRNA.
C) Expression of the U3 msl2 RNA in transient­
ly transfected HEp-2 cells. Total RNA isolated 
from transfected (lane 1 ) or untransfected (lane 
2 ) cells was analysed by northern blot and 
hybridisation using an anti-sense U3 snoRNA as 
probe. The positions o f the endogenous U3 
snoRNA and the U3 msl2 RNA are indicated on 
the left.
D) Total cell extracts prepared from cells trans­
fected with the U3 msl2 construct were subject­
ed to immunoprecipitation using anti-fibrillarin 
(lane 2 ), anti-hU3-55K (lane 3), anti-NOP56 
(lane 7) and anti-NOP58 (lane 8 ) antibodies. Co­
precipitated RNAs were analysed by northern 
blot and hybridisation using an anti-sense U3 
snoRNA as probe. Lanes 1 and 5, RNA isolated 
from 1 0 % of the material used for each immuno- 
precipitation. As a control for background pre­
cipitation, beads alone were used (lanes 4 and 6 ).
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vivo. For this purpose we generated expression con­
structs that encode tagged-U3 snoRNAs. U3 
snoRNA synthesis is tightly coordinated with pre- 
rRNA processing. Therefore, to avoid overexpres­
sion as much as possible, we decided to express the
tagged-U3 snoRNAs under the control of its own 
promoter.
A human U3 snoRNA gene (see 57) was cloned 
via PCR from HeLa genomic DNA libraries. This 
construct contains the minimal requirements for
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efficient expression of the RNA in vivo and accurate 
3’ end processing (57). We generated constructs that 
contained a streptotag sequence (2, 51) inserted into 
the coding sequence of the U3 snoRNA. RNAs 
expressed from these constructs contain a streptotag 
between nucleotides U135-C138 (Figure 1B; U3 
msl2) or U179-U181 (U3 msl3; data not shown)
To analyse expression of the tagged RNAs, 
HEp-2 cells were transiently transfected and cul­
tured for 16 hours. RNA prepared from cell extracts 
was analysed by gel electrophoresis and northern 
blot hybridisation using U3 snoRNA riboprobes. 
Figure 1C shows that HEp-2 cells expressed the U3 
msl2 RNA (Figure 1C, lane 1). In contrast, no 
detectable expression of the U3 msl3 RNA was 
observed (data not shown).
To determine if the U3 msl2 RNA associates 
with U3 snoRNP proteins in vivo, immunoprecipita- 
tion experiments were performed with anti-fibrillar- 
in, anti-hU3-55K, anti-NOP56 and anti-NOP58 
antibodies (19, 52) using extracts prepared from 
transfected cells. The results show the U3 msl2 
RNA co-precipitated with all antibodies (Figure 1D, 
lanes 2,3,7,8), demonstrating that the tag did not 
interfere with the association of these proteins.
The boxes C’ and D are essential for stable U3 
snoRNA production in HEp-2 cells.
To study the RNA regions that are required for 
the association of U3 snoRNP proteins in vivo, U3 
snoRNA mutants containing substitutions in func­
tional elements were generated (Figure 2A; mutA, 
mutA’,mutB, mutC, mutC’, mut D, mut 5’ hinge, 
mut 3’ hinge and mut stem). In each of these mutants 
the complete sequence of the element was substitut­
ed by an unrelated sequence. Similar mutants have 
been used in other studies on U3 snoRNA from var­
ious organisms (26, 30, 41, 45, 50, 56). The muta­
tions are shown in Figure 2A. Because these muta­
tions may affect the stability of the RNA, HEp-2
cells were transiently transfected with the mutant 
constructs and total RNA was isolated after 16 hours 
and analysed as described above. As evident in 
Figure 2B, the mutations in box C’ and D had the 
most dramatic effect on U3 msl2 expression levels. 
No detectable expression of mutC’ and mutD was 
observed (Figure 2B, lanes 7 and 8), suggesting that 
these elements are crucial for the stability of the U3 
snoRNA. The mutations in the hinge stem, box B 
and box C significantly reduced the expression level 
of the U3 msl2 RNA (Figure 2B, lanes 5,6,10). 
Mutations in the other elements did not affect the 
expression level or only slightly reduced it.
The box B/C motif is important for the associa­
tion of hU3-55K and hMpp10 but not NOP56, 
NOP58 and fibrillarin in vivo.
The expression of most mutant U3 snoRNAs in 
HEp-2 cells allowed us to study the effects of these 
mutations on the association of the U3 snoRNP 
associated proteins in vivo. In this study, we 
focussed on the common box C/D snoRNP proteins 
NOP56, NOP58 and fibrillarin and two proteins that 
specifically interact with the U3 snoRNA: hU3-55K 
and hMpp10. Monospecific antibodies against these 
proteins were used to immunoprecipitate associated 
RNPs from extracts prepared from transfected cells 
and co-precipitated RNAs were analysed by dena­
turing gel electrophoresis and northern blot hybridi­
sation using a probe specific for the U3 snoRNA. As 
a control for background precipitation, beads alone 
were used. Figure 3A shows the results of an exper­
iment with anti-NOP56, anti-NOP58, anti-fibrillarin 
and anti-hU3-55K antibodies. Figures 3B shows the 
results of an experiment with anti-hMpp10 antibod­
ies. The reproducibility of these results was substan­
tiated by several independent experiments (data not 
shown).
The results show that mutA and mutA’ were 
efficiently co-precipitated by all antibodies (Figure
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Figure 2. The box C ’/D m otif is essential for stable U3 snoRNA production.
A) Schematic representation o f the mutations introduced in the U3 msl2 RNA Each box illustrates the changes in a single mutant. 
The nucleotide numbering corresponds to the full-length wild-type U3 snoRNA.
B) HEp-2 cells were transiently transfected and grown for 18 hours before RNA isolation. Total RNA was analysed by northern 
blot and hybridisation using an anti-sense U3 snoRNA as probe. The mutant U3 constructs used in this experiment are indicated 
above each lane. On the left, the positions of the RNAs are indicated. Panel II shows a shorter exposure of the lower part o f panel 
I (endogenous U3 snoRNA).
3A-B, lanes 2 and 3). The mut 5’ hinge RNA was 
reproducibly less efficiently co-precipitated by the 
anti-NOP56, anti-NOP58, anti-fibrillarin and anti- 
hMpp10 antibodies than by the anti-hU3-55K anti­
bodies (Figure 3, lanes 6), suggesting that this
region might be important for stable association of 
these proteins. While the hinge stem mutation (mut 
stem) had a significant effect on the expression level 
of the RNA (Figure 2B, lane 10), this mutation did 
not markedly affect the association of the proteins
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Figure 3. The box B/C motif is im portant for hU3-55K and 
hM pp10 association but not for NOP56, NOP58 and fibril- 
larin  binding.
HEp-2 cells were transiently transfected with the tagged, 
mutant U3 snoRNA (indicated above each lane) and extracts 
from these cells were subjected to immunoprecipitation using 
anti-hU3-55K, anti-fibrillarin, anti-NOP56, anti-NOP58 (A) 
and anti-hMpp10 antibodies (B). Data shown in figures 3Aand 
3B are from separate experiments. 10% Input: RNA isolated 
from 1 0 % of the amount o f material used for the immunopre- 
cipitation experiments. As control for background precipita­
tion, beads alone were used. The U3 snoRNA panels represent 
shorter exposures of the blots than the upper panels (U3 msl2).
tested. (Figure 3, lanes 7). The 3’ hinge mutation had 
no noticeable effect on the association of the com­
mon box C/D snoRNP proteins and hU3-55K, but 
with anti-hMpp10 antibodies generally a less effi­
cient co-precipitation of this mutant RNA was 
observed (Figure 3, lanes 8).
The mutations in box B or box C only affected 
the association of the U3 snoRNA specific proteins 
hU3-55K and hMpp10 (Figure 3, lanes 4 and 5). 
Compared to the other U3 msl2 RNAs analysed, the 
mutB RNA was less efficiently co-precipitated by 
anti-hU3-55K antibodies, whereas hMpp10 associa­
tion did not appear to be affected (Figure 3, lanes 4).
No detectable interaction of hMpp10 and hU3-55K 
with the mutC RNA was observed (Figure 3, lanes 
5). Taken together, these results suggest that the 3’ 
domain is sufficient for the association of the com­
mon box C/D snoRNP proteins and the U3 snoRNA 
specific protein hU3-55K. The stable association of 
hMpp10 appears to require both box C and the 3’ 
hinge element. The association of the common box 
C/D snoRNP proteins was not significantly affected 
by mutations in the 5’ domain and in the box B/C 
motif, suggesting that the box C’/D motif and flank­
ing stems harbour the binding sites for these pro­
teins.
U3 m sl2
U3 snoRNA
U3 snoRNA U3 snoRNA
U3 m sl2 U3 m sl2
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Figure 4. The sedimentation behaviour of NOP56, NOP58, fibrillarin, hU3-55K and hM pp10 in density gradient centrifu­
gation experiments
A) HEp-2 cell lysates were loaded on a 10-30% (v/v) glycerol gradient, and the sedimentation o f U3 snoRNA, hU3-55K, hMpp10 
and the common box C/D snoRNP proteins was analysed by northern blot hybridisation and immunoblotting, respectively. The sed­
imentation o f the large ribosomal RNAs was determined by agarose gel electrophoresis and ethidium bromide staining and these 
were used as markers for 40S and 60S particles in the gradient. The U1 snRNA was used as a marker for 12S complexes.
B) The fractions containing either the 12S or 60-80S U3 snoRNP complexes (4-7 and 16-20) were pooled and used for immuno- 
precipitation with anti-NOP56 (lanes 3 and 11), anti-NOP58 (lanes 4 and 12), anti-fibrillarin (lanes 5 and 13), anti-hU3-55K (lanes 
6  and 14), anti-hMpp10 (lanes 7 and 15) and anti-m2,2 ,7G-cap (lanes 8  and 16) antibodies. RNAs isolated from the pooled fractions 
(5% Input, lanes 1 and 9) and co-precipitated RNAs were separated on denaturing polyacrylamide gels and analysed by northern 
blot hybridisation using a U3 snoRNA specific probe. As a negative control an immunoprecipitation was performed in the absence 
o f antibodies (beads, lanes 2  and 1 0 ).
96 Chapter 5
The box B/C motif is required for the assembly of 
60-80S U3 containing complexes
In mouse, human, yeast and plant cells the U3 
snoRNA is associated with 12S and 60-80S com­
plexes (12, 13, 17, 18, 25, 49). The 12S complex 
probably consists of the U3 snoRNA associated with 
the common box C/D snoRNP proteins and (some) 
U3-specific proteins like hU3-55K (18, 53), where­
as the 60-80S complexes probably represent the U3 
snoRNA associated with preribosomal particles (12,
13, 17, 18, 49).
The availability of the tagged-U3 snoRNA 
expression system prompted us to investigate the 
effects of the U3 snoRNA mutations on the forma­
tion of 60-80S U3 containing complexes by density 
gradient sedimentation. We first analysed the sedi­
mentation behaviour of the U3 snoRNP components 
in our experimental system. HEp-2 total cell extracts 
were fractionated by 10-30% glycerol gradient cen­
trifugation (Figure 4) and the fractions were 
analysed by northern blot analysis with probes spe­
cific for the U3 snoRNA and by western blot analy­
sis using anti-NOP56, anti-NOP58, anti-fibrillarin, 
anti-hU3-55K and anti-hMpp10 antibodies. 
Northern blotting revealed that the U3 snoRNA was 
indeed mainly found in the fractions corresponding 
to 12S and 60-80S. In agreement with previous 
observations (18), the distribution of hU3-55K in 
the gradient was similar to that of the U3 snoRNA. 
Both displayed a major peak at 12S and a minor 
peak at 60-80S. Interestingly, fibrillarin, NOP56 and 
NOP58 displayed a somewhat different sedimenta­
tion behaviour with a major peak at 60-80S and a 
minor peak at 12S. In contrast, hMpp10 predomi­
nantly co-sedimented with the U3 snoRNA at 60­
80S. In addition, hMpp10, fibrillarin, NOP56 and 
very low amounts of NOP58 also peaked at ~45S 
(fractions 10-12). These might represent processing 
complexes that are associated with 18S rRNA pre­
cursors, but have lost their association with the
remainder of the pre-rRNA due to cleavage in ITS1. 
The results of immunoprecipitation experiments 
show that the common box C/D snoRNP proteins 
and hU3-55K are associated with the U3 snoRNA in 
the 12S fractions (Figure 4B, lanes 3-6) and 60-80S 
fractions (Figure 4B, lanes 11-14), whereas hMpp10 
associated with the U3 snoRNA only in the 60-80S 
fractions (Figure 4B, compare lanes 7 and15)
Taken together, these results confirm previous 
observations (18) and show that the 12S U3 com­
plex is indeed associated with the common box C/D 
snoRNP proteins.
To determine the effect of U3 snoRNA muta­
tions on the assembly of 60-80S U3 containing com­
plexes, HEp-2 cells were transiently transfected 
with the tagged-U3 snoRNA encoding DNA con­
structs and after culturing for 18 hours total cell 
lysates were fractionated by 10%-30% glycerol gra­
dient centrifugation. RNA isolated from gradient 
fractions was analysed by northern blot hybridisa­
tion using a streptotag specific probe for the detec­
tion of U3 msl2 RNAs and a U3 snoRNA specific 
probe for the detection of endogenous U3 snoRNA. 
Endogenous U3 snoRNA served as a control for 
generation of 60-80S complexes in the transfected 
cells. The results of two independent experiments 
were quantified by phosphorimaging and the result­
ing data are summarised in Figure 5B. The relative 
amounts of U3 msl2 RNA and endogenous U3 
snoRNA in 60-80S complexes (fractions 16-19) 
were determined and used to calculate the relative 
efficiency of U3 msl2 RNA association with 60-80S 
complexes in comparison with endogenous U3 
snoRNA.
Mutations in sequence elements in the 5’ 
domain of the U3 snoRNA did not dramatically 
affect 60-80S association of U3 msl2 RNA (Figure 
5A; mutA, mutA’, mut 5’ hinge, mut stem, mut 3’ 
hinge). Quantification of the 60-80S association 
revealed that the mut 5’ hinge and mut 3’ hinge
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Figure 5. Effects of the U3 snoRNA m utations on the association with 60-80S particles.
A) Extracts from mutant U3 msl2 expressing HEp-2 cells (mutants indicated on top o f each panel) were fractionated by glycerol 
gradient sedimentation. RNAs were isolated from each fraction and analysed by northern blot and hybridisation. U3 msl2 RNAs 
were detected by hybridisation with a radiolabeled streptotag probe. The endogenous U3 snoRNA in the same fractions was detect­
ed by hybridisation with an anti-sense U3 snoRNA as probe.
B) The results of two independent experiments were quantified by phosphorimaging. The relative fractions o f U3 msl2 and endoge­
nous U3 snoRNA associated with 60-80S complexes were determined and the ratio between the fraction o f (mutant) U3 msl2 and 
endogenous U3 snoRNA was calculated. The average of the two experiments are depicted in the diagram. The error bars indicate 
the variation between the two experiments.
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RNAs were somewhat more efficiently incorporated 
into higher order complexes than the wild-type U3 
msl2 RNA (Figure 5B). Interestingly, the mutations 
in the hinge stem (Figure 5A; mut stem) resulted in 
the formation of complexes larger than 12S, where­
as the formation of higher order complexes did not 
appear to be affected (Figure 5B). The mutB RNA 
was reproducibly less efficiently associated with 60­
80S complexes than the wild-type U3 msl2 RNA 
and the other mutants (Figure 5). The most dramat­
ic effect, however, was observed for the mutC RNA, 
which was barely detectable in the 60-80S fractions 
(Figure 5).
Taken together, these data suggest that the box 
B/C motif is important for the association of the U3 
snoRNA with 60-80S complexes, and that box C is 
most important for this interaction.
The 3’ hinge and box C mutants predominantly 
localise to the dense fibrillar compartments of 
the nucleolus
In mammalian cells the U3 snoRNA is distrib­
uted throughout the nucleoli, although the highest 
concentration is present in subnucleolar punctate 
structures that resemble fibrillar centers and the sur­
rounding dense fibrillar compartments (reviewed in 
16). It has been postulated that the U3 snoRNA tra­
vels, together with the newly synthesised pre-rRNA 
from the dense fibrillar compartments to the sur­
rounding granular compartments, where the pre- 
rRNA is further processed and assembled into ribo­
somes (reviewed in 16, 20, 28, 36). To study the role 
of the conserved elements in the subcellular locali­
sation of the U3 snoRNA, fluorescence in situ 
hybridisation (FISH) experiments were performed 
using transiently transfected HeLa cells expressing 
the tagged-U3 snoRNA (mutants) using a fluores­
cent tag-specific probe (Figure 6B; strep-Cy3). As a 
marker for the dense fibrillar compartments, FISH 
was performed using a Cy3-labeled U8 snoRNA
probe (Figure 6A; U8-Cy3). For each sample, the 
distribution of endogenous U3 snoRNA was deter­
mined in parallel using a FITC-labeled U3 probe 
(Figure 6; U3-FITC). The results show that all the 
U3 msl2 mutants accumulated in the nucleoli, and 
that for most mutants extensive co-localisation was 
observed with the endogenous U3 snoRNA (Figure 
6B, overlay panels). The distribution of the wild­
type U3 msl2 RNA was very similar to that of the 
endogenous U3 snoRNA. Strikingly, the distribution 
of the mutC RNA and the mut 3’ hinge RNA was 
markedly different from that of the wild-type U3 
msl2 and the other mutant U3 msl2 RNAs. MutC 
and mut 3’ hinge were predominantly detected in 
punctate regions, reminiscent of dense fibrillar com­
partments. The mutB RNA and the mut stem RNA 
also appeared to be more concentrated in the punc­
tate regions compared to the endogenous U3 
snoRNA and the wild-type U3 msl2 RNA. With 
these mutants, however, also staining throughout the 
nucleolus was observed.
Taken together, our results strongly suggest that 
box C and the 3’ hinge are critical for transition of 
the U3 snoRNA from dense fibrillar compartments 
to granular compartments, whereas box B and the 
hinge stem play a less crucial role in this process.
Discussion
In this study we have addressed the role of func­
tional elements of the human U3 snoRNA in the for­
mation of U3 ribonucleoprotein complexes and its 
subcellular localisation. We provided evidence that 
the box B/C motif is required for the formation of 
60-80S U3 snoRNA containing complexes. In addi­
tion, we showed that box C and the 3’ hinge play a 
crucial role in the localisation of the U3 snoRNA to 
the granular compartment of the nucleolus. The 
results are summarised in Table I
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A
B
U3-FITC strep-Cy3 overlay U3-FITC strep-Cy3 overlay
Figure 6 . Effects of U3 snoRNA mutations on subnucleolar localisation.
A) Nucleolar distribution o f endogenous U3 and U 8  snoRNAs in HeLa cells determined by FISH using FITC-or Cy3-labeled 
probes. Images were obtained using a confocal laser scanning microscope.
B) Nucleolar distribution of the U3 msl2 (mutant) RNAs determined by FISH using a Cy3-labeled streptotag probe (strep-Cy3). 
The distribution o f the endogenous U3 snoRNA was determined in parallel (U3-FITC) and the overlay o f the U3-FITC and Cy3- 
strep signal is shown as indicated.
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Table I. Summary of the results
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The functional elements in the 5 ’ domain of the 
U3 snoRNA are not essential for the association 
of the U3 snoRNA with 60-80S complexes
The hairpin structures in the 5’ domain of the 
U3 snoRNA have been proposed to exist only in the 
free U3 snoRNP (9, 31). When base-paired with the 
pre-rRNA, the 5’ domain might be unfolded. 
Interestingly, the mutations in the hinge stem, which 
disrupt the putative base pairing in this region, 
resulted in the appearance of complexes larger than 
12S (~18S), in parallel with a reduction in the 
amount of 12S complexes. Its association with 60­
80S complexes did not appear to be affected, so that 
it may be assumed that the mutation generated a 
binding site for one or more (unrelated) RNA bind­
ing proteins. As a consequence, the stem structure 
flanked by the 5’ and 3’ hinge (reminiscent of helix 
1b’ in yeast (31)) might be required to prevent the 
association of such additional and as yet unknown 
(pre-rRNA processing) factors with the U3 
snoRNA.
It has been postulated that interactions between 
the 5’ hinge, 3’ hinge and the pre-rRNA are required 
to correctly position box A (and A’) of the U3 
snoRNA for base pairing with the 5’ terminal region 
of the 18S rRNA (9). However, the results of the
glycerol gradient analyses show that these sequence 
elements are not required for the association of the 
U3 snoRNA with 60-80S complexes, suggesting 
that base-pairing interactions between these ele­
ments and the pre-rRNA are not essential for higher 
order complex formation.
Interestingly, the 3’ hinge mutations significant­
ly reduced the association of hMpp10. Recent stud­
ies in yeast suggest that the role of Mpp10p in pre- 
rRNA processing is somehow linked to the base 
pairing interactions between box A and the 5’ termi­
nus of the 18S pre-rRNA, which is essential for pro­
cessing at sites Aj and A2 (21, 29, 44, 54). In 
Xenopus laevis oocytes, the 3’ hinge and box A are 
essential for processing at the 5’-and 3’ termini of 
the 18S rRNA (9, 10). Taken together these data lead 
to the interesting hypothesis that the association of 
hMpp10 with the U3 snoRNA requires a 3’ hinge- 
pre-rRNA duplex and that this interaction is neces­
sary to allow base-pairing of box A with the pre- 
rRNA. Box A itself is not required for Mpp10 asso­
ciation (Figure 3) (56).
While the 3’ hinge is essential for 18S rRNA 
synthesis in Xenopus laevis oocytes, the 5’ hinge 
element is important though not essential (9). 
Indeed, our results are consistent with a model in
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which the 3’ hinge is of primary importance for U3 
snoRNA function. Thus, the function of this RNA 
element in pre-rRNA processing appears to be con­
served between Xenopus laevis and human. In con­
trast, in yeast the 5’ hinge is absolutely essential for 
pre-rRNA processing (5), whereas the role of the 3’ 
hinge element has not been investigated yet.
The 3’ hinge element is required for transition of 
the U3 snoRNA from the dense fibrillar compart­
ment to the granular compartment of the nucleo­
lus
Processing of pre-rRNA in nucleoli takes place 
in a spatially organised manner. Cleavages at the 
primary processing site in the 5’ ETS most likely 
occur in the dense fibrillar compartments, whereas 
late processing steps presumably occur in the gran­
ular compartments ((7, 27) and references therein). 
Thus, the transition of pre-rRNA from the dense fib­
rillar compartment to the granular compartment is 
correlated with the various steps of processing. The 
presence of U3 in both dense fibrillar and granular 
compartments led to the idea that the U3 snoRNA 
moves together with the pre-rRNA from the dense 
fibrillar compartment to the granular compartment 
(16). However, it is unclear at which particular stage 
during pre-rRNA processing this transition occurs.
The broad subnucleolar distribution of the mutA 
and mutA’ RNAs suggests that the processing events 
mediated by these elements are not essential for 
transition of the U3 snoRNA to the granular com­
partment of the nucleolus. These results even sup­
port a model in which these processing events occur 
in the granular compartment. Interestingly, the 3’ 
hinge mutant RNA was retained in dense fibrillar 
compartments, suggesting that this element is essen­
tial for granular compartment localisation. In 
humans the 3’ hinge has the potential to base-pair 
with a sequence element in the 5’ ETS adjacent to 
the primary processing site (9). It is tempting to
speculate that the 3’ hinge in human cells is required 
for cleavage at the primary processing site and that 
inhibition of this step prevents the translocation of 
the U3 snoRNA, still associated with pre-rRNA 
intermediates, to the granular compartment of the 
nucleolus.
The box B/C motif and the box C’/D motif repre­
sent distinct functional domains
The data described here provide further evi­
dence that the U3 box B/C and box C’/D motifs are 
functionally distinct. Previously, the box C’/D motif 
has been demonstrated to be required for 5’-cap 
hypermethylation, snoRNA stability and nucleolar 
localisation, in contrast to the box B/C motif (41, 45, 
46). In agreement with this, the mutC’ and mutD 
RNAs were not detectably expressed, whereas the 
mutations in box B and box C did not prevent 
expression nor nucleolar accumulation. These dif­
ferences might be attributed to distinct subsets of 
proteins that interact with these two motifs. While 
15.5K binds to both the box B/C and box C’/D motif 
in vitro, hU3-55K only interacts with the box B/C 
motif (19, 30, 53). In addition, the results of the 
immunoprecipitation experiments suggest that the 
box C’/D motif contains the binding site for NOP56, 
NOP58 and fibrillarin, because none of the other 
mutations affected the association of these proteins. 
The interaction of these proteins with the snoRNA 
box C/D region has been demonstrated both in vivo 
and in vitro (11, 34, 52). One of the stems flanking 
the internal loop in the box C/D region plays an 
important role in the protein binding specificity to 
these motifs (52). While the overall structure and the 
binding of 15.5K are conserved in both the box B/C 
motif and the box C’/D motif of the U3 snoRNA, 
the sequence of the conserved stem in the box B/C 
motif is different, which may explain why NOP56, 
NOP58 and fibrillarin do not require this element 
for their association with the U3 snoRNA (19).
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Nevertheless, it has been reported that fibrillarin 
association with the U3 snoRNA in HeLa total cell 
extracts requires the box C sequence of the box B/C 
motif (3). These data thus suggest that fibrillarin 
may interact with both box C and box C’/D motif.
The box B/C motif is required for the formation 
of 60-80S U3 snoRNA containing complexes and 
is important for subnucleolar localisation
The glycerol gradient sedimentation data 
strongly suggest that the 12S U3 complex consti­
tutes the “free” U3 snoRNP complex composed of 
the U3 snoRNA, the common box C/D snoRNP pro­
teins and the U3-specific protein hU3-55K. In this 
respect, the human U3 snoRNP particle is probably 
similar to its yeast counterpart, because a purified 
yeast U3 snoRNP complex contained Nop56p, 
Nop58p, Nop1p, Snu13p and Rrp9p, the yeast coun­
terpart of hU3-55K (53).
Our results strongly suggest that the box B/C 
motif plays an important role in the association of 
the with 60-80S complexes, which presumably rep­
resent the U3 snoRNP associated with preribosomal 
particles. Recently, we have shown that the associa­
tion of hU3-55K with the U3 snoRNA in vitro 
requires 15.5K binding to the box B/C motif (19). 
This strongly suggests that hU3-55K and possibly 
other proteins associated with the box B/C motif are 
required for the interaction of U3 with 60-80S parti­
cles. hMpp10 association with the U3 snoRNA also 
seems to be abrogated by mutations in box C. 
Furthermore, hMpp10 predominantly associates 
with U3 in 60-80S complexes. It is likely that asso­
ciation of hMpp10 with 60-80S complexes is (in 
part) mediated by protein-protein interactions 
between hMpp10 and proteins stably associated 
with the box B/C region, e.g. hU3-55K. The reten­
tion of the mutC RNA in dense fibrillar compart­
ments suggests that these interactions occur close to 
the site of rDNA transcription. In agreement with
this model, hMpp10 has not been detected in Cajal 
bodies and a high concentration has been reported in 
punctate regions of the nucleolus that resemble 
dense fibrillar compartments (55)
The association of the human U3 snoRNP with 
60-80S complexes appears to depend primarily on 
protein-protein interactions rather than RNA base- 
pairing interactions. This association appeared to be 
relatively instable because it is disrupted by moder­
ate NaCl (200 mM) or MgCl2 (1 mM) concentra­
tions (our unpublished results)
In conclusion, the results obtained in this study 
provide more insight in the assembly of higher order 
U3 containing complexes and suggest a possible 
role of the box B/C motif in this process. The tran­
sition of the U3 snoRNA from the dense fibrillar 
compartment to the granular compartment may 
require cleavage of the pre-rRNA at the primary 
processing site. We are currently investigating in 
detail how translocation of U3 to the granular com­
partment is regulated.
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Table II. Oligonucleotides used in this study
5’-ATGCGAGATCTCTGCAGCTTTGAACTCAG-3’
5’-ATGCGAGATCTCCCGAGATCGCGCCACTG-3’
5’-GGCGTTGCTTGGATCGCATTTGGACTTCTGCCCAGGGTGGCACCACGGTCGGATCCCTG
CAACTGCCGTCA-3’
5 ,-TTAAGACTATACTTTCAGCCTAGTACCATATAGTGTGTTACTAGAG-3’
5’-AGGAGGCCGTTAAGACTAATGAAACAGGGATCATTTCTATAG-3’
5’-TCATTTCTATAGTGTGTTAGATCTCTTCTTTCTCTGAACGTGTAG-3’
5’-TGTGTTACTAGAGAAGAAAGAGAAGGCCAGTAGAGCACCGAAAA-3’
5’-GTTTCTCTGAACGTGTTCTCGTCCGAAAACCACGAGGAAG-3’
5’-AGGTAGCGTTTTCTCCTCTAGA ACTTGCCGGCTTTCTGGCGTTG-3'
5 ’-CAACGCCAGAAAGCCGGCAAGTTCTAGAGGAGAAAACGCTACCT-3’
5’-ACTGCCGTCAGCCATACTGCTAGCTTCTTCTCTCCGTATTGG-3’
5’-CCAATACGGAGAGAAGAAGCTAGCAGTATGGCTGACGGCAGT-3’
5’-AGCACCGAAAACCACGTCCTTCTCGAGTAGCGTTTTCTCCTG-3’
5’-CAGGAGAAAACGCTACTCGAGAAGGACGTGGTTTTCGGTGCT-3’
5’-CATGAAGGAAAAACCACCATATGGGCGTTCTCTCCCTCT-3’
5’-Cy3-GCAGGGATCCGACCGTGGTGCCACCCTGGGCAGAAGTCAAATGCGATCCAAGC-3’
5 ,-fluoresceine-CGGTGCTCTACACGTTCAGAGAAACTTCTCTAGTAAC
ACACTATAGAAATGATCCCTGAA-3’
5’-Cy3-CAATCATCATGTTCTAATCTGCCCTCCGGAAGGAGGAAACAGGAAACAGGTAAGGAT
TATCCCACCTG-3’
5’-TCCGACCGTGGTGCCACCCTGGGCAGAAGT-3’
U3Forw
U3Rev
U3msl2For
MutboxA
MutboxA’
M ut5’Hinge
MutStem
M ut3’Hinge
MutboxBa
MutboxBb
MutboxCa
MutboxCb
MutboxC’a
MutboxC’b
MutboxDa
MutboxDb
strep-Cy3
U3-FITC
U8-Cy3
streptotag
oligonucleotide
Materials and Methods
Cloning of hum an U3 snoRNA gene and construction of 
mutants
The HU3-1 DNA sequence (57) was PCR amplified from 
HeLa genomic DNA using oligonucleotides U3Forw and 
U3Rev (see Table II). PCR products were gel purified and 
cloned into pCRII TOPO (Invitrogen) according to manufactur­
ers procedures. To generate U3 msl2, PCR was performed with 
the U3msl2For oligonucleotide in combination with U3Rev 
(see Table II). PCR products were gel purified and used as 
megaprimer in a second PCR reaction in combination with 
U3Forw oligonucleotide. PCR products were gel purified and 
cloned into pCR4 TOPO (Invitrogen). The U3 msl2 mutants 
mutA, mutA’, mut 5’ hinge, mut stem and mut 3’ hinge were 
generated using the corresponding oligonucleotides (Table II) 
in combination with the U3Rev oligonucleotide. PCR products 
were gel purified and used in a second round PCR reaction in 
combination with the U3Forw oligonucleotide. The resulting 
products were cloned into pCR4 TOPO (Invitrogen). The U3 
msl2 mutants mutB, mutC, mutC’ and mutD were generated 
using the corresponding oligonucleotides listed in Table I and
the Stratagene QuickChange site-directed mutagenesis kit 
according to the manufacturers procedures. In some cases, 
enzyme restriction sites were introduced into the oligonu­
cleotides to be able to distinguish mutant constructs from wild­
type (Table II, underlined sequence). The integrity o f all con­
structs was verified by DNA sequencing.
Transfection experim ents, im m unoprecipitation experi­
ments and glycerol gradient analysis
HEp-2 monolayer cells were grown to 70% confluency in 
DMEM supplemented with 10% fetal calf serum (FCS). For 
immunoprecipitation experiments, 2  x 1 0 6 HEp- 2  cells were 
transfected with 20 ^g o f DNA by electroporation with a Gene 
Pulser II (Biorad) at 260 V a t a capacity of 950 ^F in a total vol­
ume o f 800 ^l DMEM/10% FCS. After electroporation, cells 
were resuspended in 10 ml DMEM/10% FCS, cultured for 18 
hours and harvested. Cells were disrupted in 500 ^l lysis buffer 
(25 mM Tris pH 7.5, 0.2 mM EDTA, 0.2% Triton X-100 (v/v), 
150 mM NaCl). Insoluble materials were pelleted by centrifu­
gation at 13,000 rpm in a microcentrifuge. 
Immunoprecipitation experiments were performed essentially
104 Chapter 5
as described (30). Co-precipitated RNAs were isolated by phe- 
nol/chloroform/isoamylalcohol (25:24:1) extraction and 
ethanol precipitation. The anti-NOP56, anti-NOP58, anti-hU3- 
55K and anti-hMpp10 antibodies used in the experiments have 
been described previously (19, 52, 55). For the glycerol gradi­
ent analysis, 5 x 106 cells were transfected with 40 ^g of DNA 
in a total volume of 1.6 ml DMEM/10% FCS. Cells were dis­
rupted by sonication in 1 ml gradient buffer (20 mM HEPES 
KOH pH7.9, 150 mM NaCl, 0.5 mM DTT). Triton X-100 was 
added to 0 .2 % (v/v) and insoluble material was pelleted by cen­
trifugation at 13,000 rpm in a microcentrifuge. Supernatant was 
loaded on a 10-30% glycerol gradient (v/v) prepared in gradi­
ent buffer containing 0.2% Triton X-100. Gradients were cen­
trifuged in a Th674 rotor (Sorvall) for 15 hours at 25,000 rpm. 
Gradients were manually fractionated in 20 fractions. RNA was 
isolated by phenol/chloroform/isoamylalcohol (25:24:1) 
extraction and ethanol precipitation. RNA was resolved on 6 % 
polyacrylamide/7 M urea gels and blotted to Hybond N+ 
(Amersham). Hybridisation o f blots with anti-sense U3 
snoRNA probes was performed as described previously (38). 
The U3 msl2 RNA in the gradient fractions (Figure 5) was 
detected using a 32P-labeled streptotag oligonucleotide (Table
II).
Affinity-purification of antibodies
Anti-hU3-55K, anti-NOP56 and anti-NOP58 antibodies 
(19, 52) were affinity-purified using the peptides that were used 
for the immunisation coupled to Sulfolink resin as described by 
the manufacturer’s procedure (Pierce).
W estern blot analysis
Western blots loaded with gradient fractions (100 ^l of 
each fraction) were blocked in MP buffer (1xPBS, 5% non-fat 
milk powder and 0.1% NP-40 (v/v)) for one hour at room tem­
perature. Primary antibody was diluted in MP buffer and incu­
bated for one hour at room temperature. Blots were washed 
three times 10 minutes with MP buffer, followed by a one hour 
incubation with the secondary antibody. Blots were washed two 
times 10 minutes with MP buffer and once with PBS and pri­
mary antibody was visualised by chemiluminescence.
Antibodies used: affinity-purified anti-hU3-55K (1:100); affin­
ity purified anti-NOP56 (1:1000); affinity-purified anti-NOP58 
(1:1000); anti-hMpp10 (1:2000), anti-fibrillarin P2G3 mono­
clonal antibody (1:5000). Secondary antibodies used: horserad­
ish peroxidase conjugated swine-anti-rabbit, rabbit-anti-mouse 
and rabbit-anti-guinea pig (1:2500). All conjugated secondary 
antibodies were purchased from Dako (Glostrun, Denmark).
In  situ hybridisation experiments
HeLa monolayer cells were grown to 70% confluency in 
DMEM supplemented with 10% fetal calf serum (FCS). 1 x 105 
HeLa cells were transfected with 100 ng o f DNA using 
Lipofectamine 2 0 0 0  (Invitrogen), according to the manufactur­
ers procedure. After 16 hours o f culturing, cells were washed 
twice with PBS and then incubated for 20 minutes in PBS con­
taining 4 % PFA. The cells were then washed 2 x 5 minutes in 
70% ethanol and then re-hydrated for 5 minutes in PBS with 5 
mM MgCl2.The PBS was removed and the cells covered in 25 
^l o f pre-hybridisation buffer (15% formamide; 2 x SSC; 10 
mM sodium phosphate pH 7.0) and incubated for 1 hour or 
more at 37°C in the humidified incubator. The pre-hybridisation 
buffer was removed and replaced with 1 0  ng of the oligonu­
cleotide probe, 10 ^g o f tRNA, and 10 ^g of denatured salmon 
sperm DNA in hybridisation buffer (10 mM sodium phosphate 
pH 7.0; 15% formamide; 2 x SSC, 10% dextran sulphate) and 
incubated for a further 4 hours at 37° C. The coverslips were 
then washed twice with 2 x SSC, 15% formamide, 10 mM sodi­
um phosphate (pH 7.0) for 30 minutes at 37°C and then washed 
twice with 1 x SSC, 0.1% Triton X-100 (v/v) at room tempera­
ture. Finally, the cells were washed twice with 1 x SSC, 0.1% 
Triton X-100 (v/v) at room temperature and then mounted and 
then viewed.
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The human Sof1 protein interacts with fibrillar­
in in a 12S complex, that does not contain the 
U3 snoRNA
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Abstract
In yeast, the Soflp protein has been demonstrated to be involved in the early endori- 
bonucleolytic cleavages of pre-rRNA processing. Sof1p interacts with Nop1p (the yeast 
counterpart of fibrillarin) and specifically associates with the U3 snoRNP complex. Here we 
describe the cDNA cloning and characterisation of a human Sof1p homologue. The human 
hSof1 cDNA encodes a polypeptide of 67 kDa, which harbours 7 putative WD40 repeats. 
The hSof1 protein interacts with fibrillarin in vivo, but, in contrast to the yeast protein, does 
not appear to be associated with the human U3 snoRNA and is not stably associated with 
higher order pre-rRNA processing complexes. The results indicate that hSof1 may be asso­
ciated with a different box C/D snoRNP complex that, in contrast to the situation in yeast, 
is not the U3 snoRNP.
Introduction
The U3 small nucleolar ribonucleoprotein com­
plex (U3 snoRNP), a box C/D snoRNP, is required 
for the synthesis of 18S rRNA. The RNA compo­
nent of the U3 snoRNP, the U3 snoRNA, is associ­
ated with the common box C/D proteins fibrillar- 
in/Nop1p, Nop56, Nop58 and 15.5K/Snu13p (3, 14, 
15, 21, 27, 30, 32). In addition, immunoprecipitation 
experiments have demonstrated that the yeast U3 
snoRNA associates with Sof1p, Rcl1p, Dhr1p, 
Rrp9p, Mrd1p, Imp3p, Imp4p and Mpp10p (2, 4, 7, 
11, 13, 16, 19, 29, 31) and with numerous other pro­
teins in higher order processing complexes (5, 8). 
However, little is known about the structural organ­
isation of these complexes and how they function in 
pre-rRNA processing.
One of the most highly conserved and most 
extensively studied box C/D snoRNP proteins is fib­
rillarin. The amino acid sequence of human fibrillar- 
in is 70% identical to that of its yeast counterpart 
Nop1p (12). ANop1p deficient yeast strain can be 
complemented by human fibrillarin, although this 
strain displays a temperature-sensitive phenotype 
and is impaired in pre-rRNA processing (12). The 
yeast Sof1p protein was identified as a dominant, 
allele specific suppressor that restored the pre-rRNA 
processing and growth defects of this strain (11).
However, in contrast to Nop1p, which is associated 
with all box C/D snoRNPs, Sof1p was found to 
associate only with the U3 snoRNA and genetic 
depletion experiments demonstrated that Sof1p is 
essential for viability and required for 18S rRNA 
synthesis (11). Recently, almost ten years after its 
first description, Sof1p was reported to be associa­
ted with a large pre-rRNA processing complex 
termed the small subunit (SSU) processome (5)
The yeast Sof1p protein contains 7 WD40 
repeats, a structural element that has been proposed 
to mediate protein-protein interactions (11, 20, 22, 
24, 26, 29). The number of WD40 repeats in a par­
ticular protein may vary from four to eight. For 
example, ß-transducin contains seven WD40 repeats 
which fold into a propeller like structure (26). In 
addition to their involvement in protein-protein 
interactions (26), WD40 repeats may also be 
involved in direct interactions with RNA (10).
One of the major goals of our studies is to learn 
more about the composition and the architecture of 
the human U3 snoRNP complex. We have previous­
ly described the cloning and characterisation of 
hU3-55K, hImp3, and hImp4 and we have shown 
that these proteins are associated with the U3 
snoRNA (9, 20, 24). In this Chapter, the cloning and 
characterisation of the human Sof1 homologue is
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Figure 1. Amino acid sequence alignment of Soflp homologues
Amino acid sequences derived from cDNAs encoding Sof1 homologues o f Homo sapiens (hs), Drosophila melanogaster (dm), 
Caenorhabditis elegans (ce), Arabidopsis thaliana (at) and Saccharomyces cerevisiae (sc) were aligned by ClustalW and conserved 
residues were highlighted using Boxshade. Identical amino acids (in at least three o f the sequences) are marked by black boxes and 
similar amino acids are marked by gray boxes. Accession numbers of the corresponding cDNAs: hsSof1, BAB55377; ceSof1, 
AAA83580; atSof1, AAL32701; scSof1, P33750; dmSof1, AAF49638. The 7 WD40 domains are boxed and the putative NLS 
sequences are underlined.
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Figure 2. The hSof1 ORF encodes a polypeptide of 62kDa
In vitro translated 35S-labeled hSof1 protein and a HeLa total 
cell extract were separated by 10% SDS-PAGE. Radiolabeled 
hSof1 (lane 1) was visualised by autoradiography, whereas the 
HeLa protein was detected by immunoblotting using the S63 
anti-hSofl antibody (lane 3). Lane 2 shows the result for the 
corresponding pre-immune rabbit serum. The molecular mass 
o f the marker proteins is indicated on the left o f the panel.
described. Like the yeast protein, hSof1 localises to 
nucleoli and interacts with fibrillarin in vivo. 
However, our results strongly suggest that hSof1 is 
not associated with the U3 snoRNA but instead with 
another box C/D snoRNP particle.
Results
Identification and cloning of a cDNA encoding 
the human Sof1p homologue
Database searches performed with the yeast 
Sof1p amino acid sequence revealed a series of 
cDNA sequences from different organisms that 
shared a high degree of sequence homology. Since 
the yeast Sof1p protein contains WD40 repeats only 
cDNA sequences were selected that shared also sig­
nificant homology outside the WD40 domain. 
Several human sequences remained and the largest 
of these contained an open reading frame (ORF) of 
597 amino acids (accession numbers: BAB55377, 
XP_005229, BAC11163, Q96JY7). These cDNAs 
contain an in-frame stop codon 51 nucleotides
Figure 3. hSof1 localises to nucleoli in HEp-2 cells
The subcellular localisation o f hSof1 was determined by indi­
rect immunofluorescense using affinity purified antibodies 
from serum S63 (D). As a reference for nucleolar staining, the 
subcellular localisation o f fibrillarin was visualised by a mono­
clonal anti-fibrillarin antibody (B). Figure A and C show the 
corresponding phase contrast pictures.
upstream of the putative translational start codon, 
indicating that they encode the complete putative 
human Sof1p homologue (data not shown).
A cDNA corresponding to the putative hSof1 
protein was isolated from a teratocarcinoma cDNA 
library by a PCR approach using a primer derived 
from the database entries in combination with vec­
tor primers (for details see Materials and Methods). 
Sequence analysis of the resulting clones showed 
that a significant portion of the 5’ part was missing. 
Several attempts to obtain a cDNA fragment corre­
sponding to the 5’ region by RT/PCR failed (data not 
shown). To obtain a complete clone, PCR products 
were generated using HeLa genomic DNA in com­
bination with hSofl specific primers. Sequencing of 
several independent cloned PCR products revealed 
that their sequence was identical to the missing 5’ 
end. It should be noted that no intron sequences are 
contained within the amplicon of the genomic DNA. 
The putative hSof1 DNA fragments derived from 
genomic DNA and cDNA libraries were subsequent-
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ly combined in a single construct to obtain a full- 
length ORF.
In addition to the putative human Sofl sequence 
the database searches led to the identification of 
Soflp homologues from several other species. A 
multiple alignment of Sof1p homologues from 
Homo sapiens, Drosophila melanogaster, 
Caenorhabditis elegans, Arabidopsis thaliana, and 
Saccharomyces cerevisiae is shown in Figure 1. The 
human sequence is 45% identical and 63% similar 
to the yeast protein and has a predicted molecular 
mass of 67.5 kDa and a theoretical pi of 9.4. A strik­
ing difference between the putative hSofl and the 
other Sof1 polypeptides studied is the 152 amino 
acid extension at the N-terminus. Blast and Motif 
searches revealed no sequence similarity between 
the hSof1 N-terminus and other known proteins and 
no sequence motifs were identified in this part of 
hSofl (data not shown). Motif searches did identify 
seven putative WD40 repeats in the open reading 
frame of hSof1 (Figure 1, boxed sequences), which 
cover the middle section of the protein. 
Furthermore, two putative nuclear localisation sig­
nals (NLS) were identified near the C-terminus 
(Figure 1, underlined sequences).
To investigate the expression of hSofl in human 
cells, polyclonal antibodies were generated by 
immunising rabbits with synthetic peptides derived 
from the hSof1 sequence. Serum S63 efficiently 
immunoprecipitated recombinant, in vitro translated 
hSofl (data not shown). The reactivity of serum S63 
with HeLa cell proteins was assessed by 
immunoblotting. The results in Figure 2 show that 
this serum specifically recognised a HeLa protein 
migrating at approximately 62 kDa (Figure 2, lane
3). Importantly, the electrophoretic mobility of this 
protein appeared to be the same as that of the radio­
labeled, in vitro translated hSofl polypeptide. Taken 
together, these data strongly suggest that the cloned 
hSofl sequence represents the full-length protein
and that this protein is indeed expressed in HeLa 
cells.
The hSof1 protein localises to nucleoli
To determine the subcellular localisation of the 
hSofl protein, indirect immunofluorescence experi­
ments were performed using affinity-purified anti­
bodies from serum S63 (Figure 3). As a reference 
for nucleolar staining, cells were immunostained in 
parallel with anti-fibrillarin antibodies. These results 
show that the anti-hSofl antibodies predominantly 
stained nucleoli, indicating that hSofl accumulates 
in this compartment. Thus, its nucleolar localisation 
is consistent with a role in pre-rRNA processing.
In HeLa cells the hSof1 protein is associated with 
fibrillarin but not with the U3 snoRNA
The yeast Soflp specifically interacts with the 
U3 snoRNA, which is also associated with Noplp 
(the yeast orthologue of fibrillarin) ( l l) . Several 
experiments were performed to determine whether 
hSofl is a functional counterpart of Soflp. We first 
investigated whether hSofl is associated with fibril- 
larin in vivo. Immunoprecipitations were performed 
with affinity-purified anti-hSofl antibodies using 
HeLa total cell extracts. Another rabbit serum (S64) 
was used as a negative control. The co-precipitated 
proteins were subsequently analysed by SDS-PAGE 
and western blotting using a monoclonal anti-fibril- 
larin antibody (Figure 4A). The results show that 
fibrillarin was indeed co-precipitated by the anti- 
hSofl antibodies.
To establish if hSofl, like its yeast counterpart, 
associates with the U3 snoRNA, RNAs were isola­
ted from immunoprecipitated material from HeLa 
total cell extracts and analysed by northern blot 
hybridisation using several RNA probes (Figure 
4B). As a reference for U3 snoRNA associated pro­
teins, immunoprecipitations were performed in pa­
rallel with anti-hU3-55K and anti-fibrillarin anti­
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Figure 4. hSofl interacts with fibrillarin but is not associated with the U3 snoRNA in vivo.
A) HeLa total cell extract was subjected to immunoprecipitation using affinity purified anti-hSofl antibodies isolated from serum 
S63 (lane 2) or the S64 serum (control serum; lane 3) and co-precipitated proteins were analysed by 10% SDS-PAGE and western 
blotting using anti-fibrillarin antibodies (P2G3). The position of fibrillarin on the blot is indicated. 10% Input: 10% o f the materi­
al used for immunoprecipitation.
B) HeLa total cell extracts were subjected to immunoprecipitation using anti-hU3-55K, anti-fibrillarin (27B9) and affinity-purified 
anti-hSof1 antibodies (lanes 3-5). Co-precipitated RNAs were isolated and separated on a 6% denaturing polyacrylamide gel and 
analysed by northern blot hybridisation using riboprobes specific for U1 snRNA, U3 snoRNA and U8 snoRNAs. In lane 1, RNA 
isolated from the total cell extract was loaded (5% o f the amount used for immunoprecipitation) and as a negative control an 
‘immunoprecipitation’ was performed in the absence o f antibodies (beads, lane 2).
C) Cell lystates prepared from Jurkat cells labeled in vivo with [32P]-orthophosphate, were subjected to immunoprecipitations using 
anti-hU3-55K (lane 1), anti-fibrillarin (72B9; lane 3), affinity-purified anti-PM/Scl-100 antibodies (lane 4) and affinity-purified 
anti-hSofl antibodies (lanes 5 and 7; 500 ^l; lanes 6 and 8; 1 ml). Lanes 7 and 8 show the results o f immunoprecipitations with 
affinity-purified anti-hSof1 antibodies performed at a higher salt concentration (300 mM KCl). The arrow points to an RNAthat is 
specifically co-precipitated by the anti-hSof1 antibodies, most cleary seen in lane 6.
bodies. As is evident from Figure 4B, no detectable 
U3 snoRNA co-precipitation was observed in the 
immunoprecipitate of the anti-hSof1 antibodies 
(Figure 4B, lane 5). As expected, hU3-55K specifi­
cally and efficiently co-precipitated the U3 
snoRNA, and both box C/D snoRNAs analysed, U3 
and U8 snoRNA, were co-precipitated with the anti- 
fibrillarin antibodies. Similar experiments with
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Figure 5. hSof1 sediments a t 12S 
in glycerol gradients
HEp-2 cell lysates were loaded on 
10-30% (v/v) glycerol gradients, 
and the sedimentation o f U8 
snoRNA, U14 snoRNA, U3 
snoRNA, hU3-55K, fibrillarin and 
hSof1 was analysed by northern 
blot hybridisation and immuno- 
blotting, respectively. The sedi­
mentation of the large ribosomal 
RNAs (as an indication of the 
position of the 40 and 60S com­
plexes) was determined in a sepa­
rate analysis by agarose gel elec­
trophoresis and ethidium bromide 
staining. The U1 snRNA was used 
as a marker for 12S complexes.
8
8
8
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other antisera, which were generated using soluble 
recombinant hSof1 protein, all failed to demonstrate 
an interaction between hSof1 and the U3 snoRNA 
(data not shown). Taken together, these results 
strongly suggest that hSof1 is not associated with 
the U3 snoRNA. Therefore, the observation that 
anti-hSof1 antibodies co-precipitated fibrillarin 
indicated that hSof1 might be associated with anoth­
er box C/D snoRNP complex. To investigate the 
potential association of hSof1 with RNA, immuno- 
precipitations were performed using extracts pre­
pared from metabolically [32P]-labeled cells (Figure 
4C). As controls, anti-hU3-55K and anti-fibrillarin 
antibodies were used. Immunoprecipitations with 
anti-hSof1 antibodies were performed with increas­
ing amounts of affinity purified anti-hSof1 antibo-
dies and and with different stringencies (100 and 
300 mM KCl). While the anti-hU3-55K and anti- 
fibrillarin antibodies efficiently co-precipitated the 
U3 snoRNA (Figure 3C, lanes 1 and 3), also in this 
experiment no detectable interaction was observed 
between hSof1 and the U3 snoRNA (Figure 4C, 
lanes 5-8). However, with the anti-hSof1 antibodies 
we did detect co-precipitation of a small RNA 
migrating in a region close to the tRNAs (indicated 
by an arrow; Figure 4C). As controls for background 
precipitation, beads alone (Figure 4C, lane 2) and 
unrelated affinity-purified rabbit antibodies (direct­
ed to the PM/Scl-100 protein) (25) were used. These 
results suggest that hSof1 may indeed be associated 
with another RNA, possibly a box C/D snoRNA. 
The efficiency of co-precipitation of this RNA was
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significantly reduced when the immunoprecipita- 
tions were performed at 300 mM KCl (Figure 4C, 
lanes 7 and 8). This suggests that the interaction of 
hSof1 with this RNA is not very stable.
The hSof1 protein sediments at 12S in glycerol 
gradients
The association of hSof1 with a fibrillarin con­
taining nucleolar ribonucleoprotein particle, sug­
gested by the experiments described above, promp­
ted us to investigate the sedimentation behaviour of 
hSof1 in density gradients. A HEp-2 total cell 
extract was fractionated by centrifugation in a 10­
30% glycerol gradient and the distribution of hSof1 
was determined by western blot analysis. The results 
showed that hSof1 was only detectable in fractions 
corresponding to 12S (Figure 5). In addition to 
hSof1, the distribution of other box C/D snoRNP 
components, fibrillarin, hU3-55K, U3 snoRNA, U8 
snoRNA and U14 snoRNA, was determined by 
immunoblotting and northern blot hybridisation, 
respectively. Like U3 snoRNA, both the U8 and 
U14 snoRNAs are involved in the biogenesis of 18S 
rRNA (6, 17, 18, 23). In agreement with previous 
observations (Chapters 4 and 5), the distribution of 
hU3-55K in the gradient was similar to that of the 
U3 snoRNA. Both displayed a major peak at 12S 
and a minor peak at 60-80S. Fibrillarin displayed a 
more complex sedimentation behaviour with a 
major peak at 60-80S, an intermediate peak at 
approximately 45S and a minor peak around 12S, 
coinciding with the hSof1 peak. The sedimentation 
of U8 snoRNA was similar to that of the U3 
snoRNA, although the relative amount associated 
with higher order complexes seemed to be some­
what lower. In contrast, the U14 snoRNA predomi­
nantly sedimented at 12S in the glycerol gradient 
(Figure 5). Taken together, these gradient fractiona­
tion data are consistent with the hypothesis that 
hSof1 is associated with 12S complexes, which con­
tain fibrillarin and possibly also a box C/D snoRNA 
which is not U3 or U8 snoRNA.
Discussion
In this manuscript we describe the cloning and 
characterisation of the human Sof1p homologue, a 
protein that in yeast has been shown to be involved 
in 18S rRNA maturation and to be associated with 
the U3 snoRNP. We have shown that hSof1 localis­
es to nucleoli and that it is associated with fibrillar- 
in in vivo . In agreement with these data, hSof1 was 
identified in a direct proteomic analysis of nucleolar 
proteins (1). These data support a role for hSof1 in 
human pre-rRNA processing, in agreement with the 
reported function for its yeast counterpart. However, 
we failed to demonstrate an association of hSof1 
with the U3 snoRNA, which suggests that hSof1 
interacts with fibrillarin in a U3 snoRNA indepen­
dent manner. Indeed, the analysis of co-immunopre- 
cipitated 32P-labeled RNAs indicated that hSof1 
associates with a small RNA that most likely repre­
sents a box C/D snoRNA. The association of hSof1 
with this RNA was significantly reduced when 
immunoprecipitations were performed under more 
stringent conditions. The fact that the association of 
fibrillarin with most snoRNPs is also salt-sensitive 
(28) suggests that the association of hSof1 with this 
small RNA may be mediated, at least in part, by fib- 
rillarin. The association of hSof1 with fibrillarin 
suggests that this 12S complex represents a snoRNP 
involved in either 2’-O-methylation or cleavage of a 
precursor to 18S rRNA.
The results of the gradient fractionation experi­
ment indicate that hSof1 is not associated with 60­
80S complexes. However, we cannot exclude the 
possibility that hSof1 transiently interacts with these 
complexes. In contrast to the U3 and U8 snoRNAs, 
the U14 snoRNA was barely detectable in the 60­
80S fractions. In addition, the U14 and other 
snoRNAs involved in modification of pre-rRNA are
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not stably associated with the yeast 90S preriboso- 
mal particles / SSU processome (5, 8). These results 
suggest that many snoRNPs, and perhaps also the 
12S hSof1 containing complex, transiently interact 
with pre-rRNA processing complexes. Alternatively, 
they might interact with the pre-rRNA prior to pre­
ribosome assembly.
The yeast Sof1p protein was initially identified 
as an allele-specific supressor of a yeast strain 
expressing human fibrillarin. Sof1p, a protein essen­
tial for yeast viability, interacts specifically with the 
U3 snoRNA and is associated with preribosomal 
complexes / SSU processome (5, 11, 12). A purified 
yeast U3 snoRNP complex was shown to contain the 
common box C/D snoRNP proteins and Rrp9p 
(yeast orthologue of hU3-55K), suggesting that 
Sof1p exclusively associates with the yeast U3 
snoRNA in preribosomal particles. In contrast, the 
human Sof1 interacts with fibrillarin in a 12S com­
plex which does not contain detectable amounts of 
U3 snoRNA. In addition, the human protein does 
not complement a yeast Sof1p knock-out strain (our 
unpublished results). Taken together, these data 
raise the question whether hSof1 is indeed a func­
tional homologue of the yeast protein. The use of the 
RNA interference technique, followed by the analy­
sis of pre-rRNA processing intermediates will allow 
us to determine the role of hSof1 in human pre- 
rRNA processing.
Materials and Methods
Oligonucleotides used in this study
hSof7 5 ’ -GCGGATCCCCCGGGTCATCTAGATTTTA- 
CAACTGCCACTACGTG-3’
GNPCR1 5 ’-GCGAGATCTCACGCGTTGCTCGAGATG- 
GAGGGGAGGTCCCAGCCT-3’
GNPCR2 5 ’-AAGTCCAACTTGGTTTCGCGG-3’
Cloning of hSof1 cDNA
Database searches revealed cDNA sequences (accession 
numbers: BAB55377, XP_005229, BAC11163, Q96JY7) of 
which the amino acid sequence shared significant sequence 
homology with the yeast Sof1p protein. Using a primer derived 
from these cDNA sequences (hSof7) in combination with lamb­
da gtl1 vector primers, a partial hSof1 cDNA was isolated by a 
PCR approach from a teratocarcinoma cDNA library, as 
described previously (24). The hSof7 primer introduced BamHI 
and SmaI restriction sites immediately downstream o f the stop- 
codon and an XbaI site immediately upstream o f the stopcodon. 
PCR products were cloned in the pCR2 TOPO vector 
(pCR2hSof1) (Invitrogen). The remaining 5’ end of the hSof1 
ORF was PCR amplified from HeLa genomic DNA using 
oligonucleotides GNPCR1 and GNPCR2. The GNPCR1 
oligonucleotide introduced in-frame BglII and XhoI restriction 
sites upstream o f the ATG. A full-length ORF was generated by 
inserting the PCR product derived from genomic DNA into a 
NotI-NdeI digested pCR2hSof1 plasmid. The resulting con­
struct, pCR2hSof1FL, contains a XhoI site in frame with the 
ATG at the 5 ’ end and SmaI, XbaI and BamHI sites at the 3’ end.
pCI-neo5’VSVhSof1 was created using the XhoI and SmaI 
restriction sites (24). The resulting construct encodes hSof1 
with a 5’VSV tag.
In  vitro transcription and translation
The pCI-neo5’VSVhSof1 was linearised with NotI, and 
transcribed with T7 RNApolymerase in a final volume o f 20 ^l. 
Two microliter o f the transcription reaction was used for in 
vitro translation in rabbit reticulocyte lysates (Promega) 
according to the manufacturers procedure.
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Generation of anti-hSof1 rabb it antibodies
Two synthetic peptides CRETKLDLQRVPRNYD and 
CREKAAKDYNQKLKEK were coupled to KLH via the N- 
terminal cysteine of the peptides and a mixture of both KLH- 
peptide conjugates was used to immunise a rabbit (S63) 
(Eurogentec, Belgium). Note that the N-terminal cysteine of 
both peptides is not derived from the sequence encoded by the 
hSof1 cDNA. The serum from rabbit S63 recognised radiola­
beled in vitro translated hSof1 (data not shown).
Affinity purification of anti-hSof1 antibodies
Two milligrams o f peptide (1 mg o f each of the peptides 
used for immunisation) was crosslinked to 8 mg of BSA 
(Sigma) using glutaraldehyde (0.02%) and the mixture (1 ml) 
was incubated for one hour at room temperature. Then 400 
o f 1 M glycine, pH 7.2 was added followed by another hour of 
incubation at room temperature. The mixture was subsequently 
dialysed in coupling buffer (0.1 M NaHCO3, pH 8.3, 0.5 M 
NaCl) overnight. Coupling o f the BSA-peptide conjugate to 
CNBr activated Sepharose 4B (Pharmacia) was perfomed as 
described by the manufacturer. Two milliliters o f crude rabbit 
serum (S63) were diluted 10 fold with PBS and applied to a col­
umn containing the immobilised BSA-peptide conjugate. The 
column was washed with 30 ml o f Buffer A (0.5 M NaCl, 
0.05% NP-40 (v/v) in PBS) and bound antibodies were eluted 
with Buffer B (100 mM glycine-HCl, pH 2.5, 0.5 M NaCl,
0.05% NP-40). After elution, the column fractions were imme­
diately neutralised by 1 M Tris base.
W estern blotting and glycerol gradient analysis
Western blotting was performed as described previously 
(9). Antibodies used for immunodetection were affinity purified 
rabbit antibodies to hU3-55K (9), dilution 1:100; anti-hSof1 
serum (S63), dilution 1: 500; monoclonal anti-fibrillarin anti­
bodies (P2G3), dilution 1:5000. Alkaline phosphatase conjuat- 
ed secondary antibodies: swine-anti-rabbit immunoglobulins, 
dilution 1:2500; rabbit-anti-mouse immunoglobulins, dilution 
1:2500. All secondary antibodies conjugates were purchased 
from Dako (Denmark).
Glycerol gradient analysis was performed as described
previously (9).
Indirect immunofluorescence
Indirect immunofluorescence was performed as described 
previously (20). Images were obtained using an Olympus BH2 
microscope in combination with an Olympus DP10 microscope 
digital camera system and analySIS sofware (Soft Imaging 
System GMBH, Münster, Germany).
Im m unoprecipitation experiments
For each experiment antibodies were coupled to 10 ^l of 
protein Aagarose beads in IPP150 (150 mM NaCl, 0.2% Triton 
X-100 (v/v), 25 mM Tris-HCl, pH 7.5), either overnight at 4°C 
or one hour at room temperature. Immunoprecipitations were 
performed using 10 ^l o f anti-hU3-55K rabbit antiserum (10), 
500 ^l or 1 ml of affinity purified anti-hSof1 and 750 ^l o f anti- 
fibrillarin (72B9) hybridoma supernatant. 
Immunoprecipitations, RNA isolation, and northern blot 
hybridisation were performed as described previously (20, 24). 
Metabolic labeling of Jurkat cells with 32P-labeled orthophos­
phate was performed essentially as described (28).
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Chapter 7
General Discussion
Introduction
The human U3 snoRNP complex functions in the early cleavage steps in pre-rRNA pro­
cessing, which are required for the synthesis of the 18S rRNA and thus the production of the 
small ribosomal subunit. The RNA component of the U3 snoRNP complex transiently base- 
pairs with the pre-rRNA and this interaction most likely renders the cleavage sites accessi­
ble to endonucleases.
The aim of the project underlying this thesis was to elucidate the composition and the 
architecture of the human U3 snoRNP complex. Questions to be answered were which pro­
teins are specifically associated with this complex, which regions of the U3 snoRNA are 
involved in protein-RNA interactions and how do certain proteins interact with the U3 
snoRNA? In addition to these aspects (addressed in Chapters 2-4), also the incorporation of 
the U3 snoRNP complex into pre-rRNA processing complexes was studied (Chapter 5). In 
Chapter 6, I make clear that “looks can be deceiving”. Although the amino acid sequence of 
the human Sof1 protein is highly similar to the yeast Sof1p protein, the mechanism by which 
these proteins associate with pre-rRNA processing complexes appears to be different.
In this Chapter the results presented in this thesis are summarised and the contribution 
of these data to our knowledge on the structure and function of the human U3 snoRNP com­
plex are discussed.
To be or not to be a U3 snoRNP
The U3 snoRNA is associated with both com­
mon box C/D snoRNP proteins and a large number 
of proteins that specifically interact with U3. The 
results of density gradient analyses have shown that 
most of the U3-specific proteins predominantly or 
exclusively interact with the U3 snoRNA in higher 
order complexes (Chapters 4 and 5) (5, 6, 10). The 
common box C/D snoRNP proteins and the U3-spe- 
cific hU3-55K also interact with the smaller 12S U3 
snoRNA complex (Chapters 4 and 5) (30). The pres­
ence of the U3 snoRNA in multiple complexes has 
raised the question whether the term “U3 snoRNP” 
is still valid. In view of the stability and relatively 
well-defined composition of the 12S U3 complex 
we propose to refer to this complex as the U3 
snoRNP particle, and to consider the 60-80S U3 
containing complexes as assemblies of the U3 
snoRNP with preribosomal particles (Chapter 4).
U3 snoRNP biogenesis and subcellular 
trafficking
The biogenesis of the human U3 snoRNP is spa­
tially organised and involves the production of 3’- 
extended U3 snoRNA precursors. Maturation of the 
human U3 snoRNA requires a specific nuclear com­
partment, the Cajal bodies (reviewed in 7)). Cajal 
bodies are found in the proximity to or even within 
(the DFC of) the nucleolus (2, 20). Maturation of the 
human U3 snoRNA is tightly coupled to the associ­
ation of U3 snoRNP proteins. After transcription by 
RNA polymerase II in the nucleoplasm, the 3’- 
extended U3 snoRNA precursors are bound by 
15.5K (Figure 1A) and move to the Cajal bodies 
where they are processed and associate with a com­
plete set of core box C/D snoRNP proteins, and pre­
sumably also hU3-55K (Figure 1B) (27). The U3 
complex assembled in Cajal bodies most likely rep­
resents the 12S U3 snoRNP. Subsequently, the 
mature U3 snoRNP travels to the nucleolus and
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Nucleoplasm
Figure 1. Model for U3 RNP biogenesis and subcellular trafficking
The 3 ’-extended U3 snoRNA precursor is bound by 15.5K in the nucleoplasm (A) and moves to Cajal bodies where it is processed 
and associates with a complete set o f box C/D snoRNP proteins (hU3-55K, NOP56, NOP58 and fibrillarin; as indicated). This 
results in the formation of the 12S U3 complex (B). The 12S U3 complex is subsequently transported to the DFC in the nucleolus 
(C) where it associates with additional pre-rRNA processing factors, like Mpp10, Imp3 and Imp4 and where it base-pairs with the 
pre-rRNA, as indicated. The complexes that are formed at this stage most likely represent the 60-80S complexes (D). After cleav­
age at the primary processing site o f the pre-rRNA, the 60-80S complex moves, together with the pre-rRNA, to the GC where the 
cleavages at the 5 ’-and 3 ’ termini o f the 18S pre-rRNA (site 1 and site 3, respectively) take place (E). After these cleavage events, 
the 60-80S complexes are released from the pre-rRNA and return to the DFC or are disassembled (F).
probably accumulates in the dense fibrillar compart­
ment (DFC) (Figure 1C). Here, the U3 snoRNP 
associates with the nascent pre-rRNA and other pre- 
rRNA processing factors, like Mpp10, Imp3 and 
Imp4, leading to the formation of 60-80S complex­
es (Figure 1D).
The relationship between nucleolar substruc­
tures and different steps in ribosome biogenesis is 
not well understood. After the formation of preribo-
somal complexes the U3 snoRNA moves to the 
granular compartment (GC) (9). However, little is 
known on the regulation of this transition. The 
results presented in Chapter 5 suggest that this tran­
sition is triggered by the U3 mediated cleavage at 
the primary processing site. In Xenopus laevis 
oocytes, box A and box A’ are required for cleavages 
at the 5’ and 3’ termini of the 18S rRNA as well as a 
cleavage event in the 5’ ETS downstream of the pri-
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mary processing site. We showed that substitution of 
box A and box A’ sequences does not prevent the GC 
localisation of the U3 snoRNA, suggesting that 
these processing events are not required for transi­
tion of the U3 snoRNA to the GC. The nascent pre- 
rRNA is predominantly detected in the fibrillar 
region, whereas 5’ETS regions downstream of the 
primary processing site and ITS1 are detected 
throughout the nucleolus (13). Thus, it is conceiv­
able that the box A and box A’ mediated cleavage 
steps take place in the GCs, explaining the ubiqui­
tous nucleolar distribution of these mutant RNAs 
(Chapter 5).
In 1997, Gerbi and Borovjagin (9) proposed that 
the U3 snoRNP returns to the DFC after the pre- 
rRNA has been processed, where it awaits participa­
tion in another round of pre-rRNA processing 
(Figure 1F). This model is largely based on the 
observation that inhibition of rDNA transcription by 
actinomycin D treatment does not deplete the U3 
snoRNA from the DFC (23). Alternatively, the U3 
snoRNP dissociates and the individual components 
return to the DFC (Mpp10, and the Imps) or to the 
Cajal bodies (box C/D proteins, hU3-55K, U3 
snoRNA)
Structure and function of the box B/C 
motif
15.5K binding to the box B/C motif mediates the 
assembly of U3 snoRNP specific proteins
The hU3-55K, a WD40 repeat protein, is a spe­
cific U3 snoRNP protein that requires the box B/C 
motif for its interaction with the U3 snoRNA (16) 
(Chapter 2). The observation that the 15.5K protein, 
the primary box C/D RNA binding protein, directly 
binds the box B/C motif prompted us to investigate 
the interaction of hU3-55K with the box B/C motif 
in more detail (Chapter 3) (30). In 1987, Parker and 
Steitz proposed a secondary structure model for the 
human U3 snoRNA, in which the boxes B and C
were drawn juxtaposed to each other in an internal 
loop (Figure 2A) (22). However, the box B/C 
domain can also be folded into a secondary structure 
that is very similar to the 15.5K binding site in the 
U4 snRNA and the nucleotides essential for 15.5K 
binding are conserved in this structure (30) (Figure 
2B). We have provided evidence that this structure 
indeed exists in the U3 snoRNP (Chapter 3). In addi­
tion, we showed that 15.5K binding to the box B/C 
motif and a structurally conserved element flanking 
the box B/C motif are essential for hU3-55K bind­
ing to the U3 snoRNA in vitro (Figure 2B and C). 
This structural element, which is flanked by a stem 
that consists of only two base-pairs (Figure 2C; 
Stem I) is probably not formed in the free U3 
snoRNA, explaining why hU3-55K does not effi­
ciently interact with the free U3 snoRNA (Chapter 
2). Thus, 15.5K binding to the box B/C motif of the 
U3 snoRNA generates a high-affinity binding site 
for hU3-55K. It is very likely that hU3-55K makes 
several contacts with the U3 snoRNA, but this struc­
turally conserved region appears to be the primary 
determinant for this interaction (Chapter 3). Taking 
into account that this region is adjacent to the 15.5K 
binding site, it is likely that hU3-55K also interacts 
with 15.5K in the complex (Figure 2C).
This hierarchical assembly has also been 
demonstrated for the common box C/D snoRNP 
proteins and for U4/U6 snRNP complexes in vitro 
(19, 21, 29). 15.5K binding to the box C/D motif sta­
bilises the base-pairing of highly conserved 
nucleotides in the structure referred to as Stem II 
(Figure 2D and E). It has been shown that both the 
structure and the nucleotide composition are essen­
tial for the association of NOP56, NOP58 and fibri- 
larin in vitro (29). UV crosslinking experiments 
demonstrated that NOP56 and NOP58 directly bind 
the snoRNA in a sequence specific manner (3).
In the box B/C structure, some of the highly 
conserved nucleotides can adopt a stem similar to
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Figure 2. 15.5K mediates the assembly of RNP specific proteins
(A) Secondary structure model o f the box B/C motif and flanking stems as proposed by Parker and Steitz (22). The nucleotides cor­
responding to box B and C are boxed.
(B) Secondary structure model of the box B/C m otif when bound by 15.5K. The conserved nucleotides essential for 15.5K binding 
are marked by black boxes. Binding o f 15.5K to the box B/C m otif leads to the formation of a small internal loop which is essen­
tial for subsequent binding of hU3-55K to the U3 snoRNA. The dots indicate non-Watson-Crick base-pairing interactions.
(C) Model for the interaction between hU3-55K and the box B/C structure. In this model hU3-55K contacts the small internal loop 
that is formed after 15.5K binding. Possible interactions between hU3-55K and other regions of the box B/C structure are not inclu­
ded in this model. The dots indicate non-Watson-Crick base-pairing interactions.
(D) Schematic representation of a box C/D snoRNA fragment. The consensus sequence of boxes C and D are boxed. R represents 
a purine.
(E) Secondary structure model o f a box C/D snoRNA fragment bound by 15.5K. Binding of 15.5K to the box C/D motif results in 
a structural rearrangement which brings conserved nucleotides of boxes B and C together in a stem (Stem II). The conserved nucleo­
tides essential for 15.5K binding are marked by black boxes. The remaining conserved nucleotides are marked by grey boxes. R  is 
a purine, N is any nucleotide. The positions o f Stem I and Stem II are indicated. The dots indicate non-Watson-Crick base-pairing 
interactions.
(F) Proposed secondary structure model of a box C/D snoRNA fragment associated with NOP56, NOP58, 15.5K and fibrillarin. In 
this model, base-pairing interactions between the box C/D snoRNA and pre-rRNA are included. R is a purine, N is any nucleotide, 
m represents a 2 ’-0-methylated nucleotide. The predicted position o f fibrillarin, the putative methyltransferase, in the box C/D 
snoRNP is shown. The dots indicate non-Watson-Crick base-pairing interactions. The conserved nucleotides required for 15.5K bin­
ding are marked by black boxes. The remaining conserved nucleotides are marked by grey boxes.
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Figure 3. Various models for the archi­
tecture of the 3 ’ dom ain of the U3 
snoRNP
(A) Schematic representation of a fragment 
o f the 3 ’ domain o f the human U3 
snoRNA. The proposed secondary structu­
res of the box B/C motif and the box C ’/D 
motif when bound by 15.5K are included. 
The positions o f Stem I and Stem II o f the 
box B/C and the box C’/D motifs are indi­
cated. The dots indicate non-Watson-Crick 
base-pairing interactions. The conserved 
nucleotides required for 15.5K binding are 
marked by black boxes. Grey boxes mark 
the remaining conserved nucleotides.
(B) A model for protein-RNA interactions 
in the 3’ domain o f the U3 snoRNA. In this 
model, the box B/C motif is associated 
with 15.5K and hU3-55K. Stem II o f the 
box B/C structure is predicted to be a bin­
ding site for additional pre-rRNA proces­
sing factors (X). The box C ’/D motif is 
associated with the common box C/D 
snoRNP proteins.
(C) Alternative model for protein-RNA 
interactions in the 3 ’ domain o f the U3 
snoRNA. In this model, fibrillarin interacts 
with both the box C’/D and box C o f the 
U3 snoRNA. The interactions o f NOP56, 
NOP58, 15.5K and hU3-55K with this 
fragment are as depicted in B).
(D) Alternative model for protein-RNA 
interactions in the 3 ’ domain o f the U3 
snoRNA. In this model, two molecules of 
both fibrillarin and NOP56 are present in 
the 3’ domain, each pair interacting with a 
specific motif.
Stem II of the box C/D motif (Figure 2B and C). 
Interestingly, the nucleotide composition of this 
stem is partially different.
15.5K directly binds the 5’ stem-loop structure 
of the U4 snRNA and the U4atac snRNA (18). In the 
U4/U6, U4atac/U6atac snRNPs, 15.5K binding is
essential for the association of 61K (hPrp31), and a 
hetero-trimeric complex consisting of the 20K, 60K 
and 90K proteins (19). Interestingly, the central 
region of the 61K protein, which is involved in RNA 
binding, shares significant sequence homology with 
the box C/D proteins NOP56 and NOP58 (8, 19).
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Moreover, the 60K protein contains WD40 repeats, 
like the hU3-55K protein ((19) and references there­
in). The assembly of the 61K protein and the 
20/60/90K hetero-trimeric complex with the cog­
nate snRNP complexes also appears to require struc­
tural RNA elements. The data summarised above 
strongly suggest that the association of 15.5K with 
these RNAs generates a nucleation center for the 
association of other proteins that specifically inter­
act with the respective RNAs. The specificity of this 
interaction is determined by the identity of 
nucleotides/base-pairs and/or structural features 
adjacent to the 15.5K binding site. Since the 
sequence of Stem II in the box B/C motif (Figure 2B 
and C) is not important for both 15.5K and hU3-55K 
binding (Chapter 3), it is tempting to speculate that 
this element may play a role in the binding of other 
U3 snoRNA associated proteins.
Architecture of the human U3 complex 
The 3’ domain
Figure 3A shows a schematic representation of 
a fragment of the U3 snoRNA comprising the box 
B/C motif, the box C’/D motif and flanking stems. 
The data described above indicate that the box B/C 
motif is associated with 15.5K and hU3-55K and 
possibly other proteins that interact with Stem II of 
the box B/C motif (Figure 3B). The box C’/D is both 
structurally and functionally homologous to the 
common box C/D motif (24, 30). Thus NOP56, 
NOP58 and fibrillarin most likely associate with this 
part of the U3 snoRNA. In agreement with this 
model, the B and C elements are not essential for the 
association of these proteins in vivo, neither in yeast 
nor in humans (Chapter 5) (34). In view of the 
nucleotide composition of Stem II of the box B/C 
motif, we predict that NOP56, NOP58 and fibrillar­
in do not interact with this region of the RNA. 
Indeed, fibrillarin, NOP56 and NOP58 did not 
detectably interact with an RNA comprising the box
B/C motif and flanking stems (our unpublished 
results). However, in HeLa total cell extracts, the 
association of fibrillarin with the U3 snoRNA has 
been reported to require box C (1) (Figure 3C). In 
Xenopus laevis oocytes NOP56 and fibrillarin can 
interact with the box C’ and box D’ elements of a 
methylation snoRNA in a 15.5K independent man­
ner (3). As mentioned in the General Introduction of 
this thesis (Chapter 1), box C’/D’ elements are often 
found in methylation snoRNAs next to box C/D 
motifs and also represent box C/D like elements. 
The nucleotides in the C’/D’ motif that are contac­
ted by these proteins are conserved in the box B/C 
motif of the human U3 snoRNA (30). Thus, it is pos­
sible that NOP56 and fibrillarin also interact with 
the box B/C motif of the U3 snoRNA (Figure 3D), 
although there is no experimental evidence to sup­
port this model.
15.5K binding to the 5’ stem-loop of the U4 
snRNA results in a kink of 150° in the structure, con­
verging the stems that flank the internal loop at an 
angle of 30° (28). If the binding of the two 15.5K 
molecules to the 3’ domain of the U3 snoRNA leads 
to similar structural changes in the RNA, this would 
have significant implications for the structure of this 
part of the U3 snoRNA. The binding of 15.5K to the 
box B/C and C’/D motif might result in an S-shaped 
structure, converging stem I and stem II of each 
motif at an angle of 30°.
The hetero-trimeric Imp3-Mpp10-Imp4 complex 
interacts with the 5’ domain U3 snoRNA in the 
DFC of the nucleolus
In Chapter 4 we describe the cloning and char­
acterisation of the human Imp3 and Imp4 proteins. 
We have shown that hImp3 and hImp4 form a het- 
ero-trimeric complex with hMpp10 in vitro. The 
nucleolar localisation of hImp3, hImp4 and hMpp10 
appeared to correlate with the capacity to form this 
hetero-trimeric complex. In agreement with this,
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depletion of Mpp10p in yeast led to destabilisation 
of Imp3p and Imp4p, suggesting that formation of 
the ternary complex is required for their function 
(32). Recently it has been shown that the interaction 
of this complex with the U3 snoRNA is mediated by 
Imp3p (32). The fact that this complex interacts with 
the U3 snoRNA in higher order complexes (Chapter
4) (5) suggests that either Imp3 binds the U3 
snoRNA when this is base-paired with the pre- 
rRNA, or that this interaction is required to dock the 
U3 snoRNA on the pre-rRNA. The observation that 
mutant RNAs that failed to stably associate with 
hMpp10 were retained in the DFC and the fact that 
hImp3, hImp4 and hMpp10 are not detected in Cajal 
bodies (33) (our unpublished results), suggest that 
this interaction takes place in the DFC of the nucle­
olus (Chapter 5).
Figure 4 shows a schematic representation of 
the U3 snoRNA base-paired with part of the 5’ ETS 
of the pre-rRNA. hMpp10 association with the U3 
snoRNA requires the 3’ hinge element suggesting 
that hImp3 contacts the 3’ hinge/pre-rRNA duplex. 
Deletion of 109 amino acids of yeast Mpp10p led to 
processing defects at sites A1 and A2, indicating that 
its role in pre-rRNA processing in yeast might be 
linked to base-pairing interactions between the U3 
snoRNA and 18S rRNA sequences in the pre-rRNA 
(11, 14, 32). Since this C-terminal region contains 
coiled-coil domains, which are often involved in 
protein-protein interactions (17), it is conceivable 
that this deletion might have affected the stable 
binding of proteins with Mpp10. It has been postu­
lated that Imp4p directly interacts with the pre- 
rRNA via its o 70-like RNA binding motif (31, 32). 
Therefore, the hImp3-hMpp10-hImp4 complex may 
be involved in the stabilisation of the interactions 
between the U3 snoRNA and the 18S pre-rRNA 
(Figure 4). The C-terminal truncation of Mpp10 
may also have resulted in less efficient association 
of additional pre-rRNA processing factors that are
required for this event. A candidate for such an inter­
acting protein is Dhr1p, a putative RNA helicase (4). 
Genetic depletion of Dhr1p led to processing defects 
at sites A1 and A2 (4). Like Mpp10, Dhr1p predom­
inantly associates with the U3 snoRNA in higher 
order complexes (6). Although, these proteins do not 
directly interact with each other in the yeast two- 
hybrid assay (32), it is possible that this interaction 
only takes place when Mpp10 is associated with the 
U3 snoRNP in higher order complexes.
The proteins stably associated with the box B/C 
motif mediate the association of hImp3-hMpp10- 
hImp4 hetero-trimeric complex with the U3 
snoRNA
In Chapter 5 we proposed that the box B/C 
motif might be required for the in vivo association of 
the U3 snoRNP with 60-80S complexes, which most 
likely represent pre-rRNA processing complexes. In 
addition, the association of U3 with these complex­
es appears to be correlated with hU3-55K binding to 
the box B/C region. Thus, the macromolecular 
assembly on the box B/C region might provide bind­
ing platform for yet other pre-rRNA processing fac­
tors and this may mediate the assembly the U3 
snoRNP into higher order complexes. Interestingly, 
the hMpp10 association with the U3 snoRNA also 
requires an intact box C (Chapter 5). It is therefore 
possible that interactions between the Imp3-Mpp10- 
Imp4 complex with proteins stably associated with 
the box B/C motif may be required to dock the U3 
snoRNA on the pre-rRNA or stabilise U3 
snoRNA-pre-rRNA base-pairing interactions 
(Figure 4).
Future perspectives
Many questions still await further clarification. 
For example, as mentioned in the General 
Introduction of this thesis, it is not entirely clear 
where certain processing steps take place in the sub-
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o7Figure 4. The proteins stably associated with the box B/C m otif mediate the association of hImp3-hM pp10-hImp4 hetero- trim eric complex with the U3 snoRNASchematic representation o f the U3 snoRNAbase-paired to a fragment o f the 5’ ETS of the pre-rRNA and the association o f Mpp10, 
Imp3 and Imp4. The structure of the 3 ’ domain is drawn as in Figure 3. The interaction hU3-55K, 15.5K and other putative pro­
cessing factors (indicated by an X) with the box B/C motif and the common box C/D proteins with the box C’/D motif is includ­
ed. The upper arrow depicts possible protein-protein interactions between the Imp3-Mpp10-Imp4 complex and the protein complex 
assembled on the box B/C motif. Arrows indicate the possible interaction between Dhr1 and hMpp10. The positions o f box A, box 
A’, 5 ’ hinge, 3’ hinge, box B, box C, box C ’ and box D in the U3 snoRNA are indicated by boxes. The trimethyl cap at the 5 ’-end 
o f the U3 snoRNA is indicated by m2,2,7G. The primary processing site in the pre-rRNA is indicated by PPS.
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nucleolar compartments and what triggers the tran­
sition of the U3 snoRNA and the pre-rRNA from the 
DFC to the GC in the nucleolus? In addition, it is 
still completely unclear which molecules are direct­
ly involved in the catalysis of the cleavages in the 
pre-rRNA. And if the U3 snoRNA is only involved 
in cleavages during processing, why is it associated 
with fibrillarin, the putative methyltransferase 
shared by all box C/D snoRNPs? The results pre­
sented in Chapter 5 provide some insight in the tran­
sition of the U3 snoRNA from the DFC to the GC. 
The use of a tagged-rRNA system, in combination 
with the tagged-U3 snoRNA will allow us to pre­
cisely determine the processing steps required for 
transition and determine where in the nucleolus cer­
tain processing steps take place. In such a system, 
the base-pairing interactions involved can be sys­
tematically determined in a mammalian cell system, 
by the mutation of presumptive base-pairing ele­
ments and compensatory mutations in the interact­
ing molecule. In addition, cleavage sites can be dis­
rupted and the effects on the movement of both 
RNAs can be studied. Finally, the processing of the 
transiently expressed rRNA can be analysed by 
northern analysis using a tag-specific probe.
It would be very interesting to know if the com­
mon box C/D snoRNP proteins are indeed asymmet­
rically distributed in the human U3 complex (Figure 
2), as has been suggested for the U25 box C/D 
snoRNP (3). Unfortunately, mutations in the box 
C’/D of the U3 snoRNA render the RNA unstable in 
human cells (Chapter 5) making it difficult to study 
the effect of mutations in this region on the associa­
tion of the common box C/D snoRNP proteins. One 
possible way to overcome this problem is to express 
a U3 snoRNA / box H/ACA fusion RNA. The box 
H/ACA motif might stabilise box C’/D mutant 
RNAs in vivo and target the RNA to the DFC of the 
nucleolus (see 26). Such a chimera has been suc­
cessfully used to study the sequence and structural 
elements of box C/D snoRNAs required for 2’-0- 
methylation (12).
Studies in Xenopus laevis oocytes have demon­
strated that the U3 snoRNA box C’/D motif in com­
bination with its flanking stems is sufficient to 
localise the RNA to the nucleolus (25). This leads to 
the following question: can the functionally but not 
structurally related box H/ACA motif replace the 
box C’/D motif without affecting the function of the 
U3 snoRNP? This would, in theory, allow stable 
RNA production and target the RNA to the DFC of 
the nucleolus (see 26). It is conceivable that the box 
C’/D motif, together with the proteins that associate 
with this element, may simply be required to sta­
bilise the RNA and for correct localisation.
The telomerase RNA is a core component of the 
telomerase enzyme and is required for telomere for­
mation at chromosome ends. Interestingly, the 3’ 
domain of the vertebrate telomerase RNA harbours 
a box H/ACA motif and is associated with the pro­
teins common to box H/ACA snoRNAs. Like the 
box C’/D element of the U3 snoRNA, the box 
H/ACA motif of the telomerase RNA targets the 
RNA to Cajal bodies and nucleoli and is essential for 
stability (reviewed in 26). Although we can only 
speculate why the telomerase RNA associates with 
these compartments, it is an example of another 
non-coding RNA that utilises a snoRNA motif and 
snoRNA proteins for nuclear trafficking.
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Summary
The synthesis and processing of pre-ribosomal 
RNA takes place in a specialised nuclear compart­
ment, called the nucleolus. This process requires 
extensive chemical modification and cleavage of the 
pre-rRNA, which are mediated by small nucleolar 
ribonucleoprotein complexes (snoRNP). The 
snoRNPs consist of proteins and an RNA compo­
nent, called the snoRNA, which acts as a sequence 
specific guide to direct the RNP complex to the site 
of modification or cleavage. Based on secondary 
structure features o f the snoRNA, conserved 
sequence elements and the protein components con­
tained in the snoRNP, these complexes can be devi- 
ded in two major groups: the box C/D snoRNPs and 
the box H/ACA snoRNPs. The box C/D snoRNPs 
mediate the cleavage and 2’-O-methylation of 
rRNA, whereas the box H/ACA are involved in 
pseudouridine formation. The U3 snoRNP complex, 
a member of the box C/D snoRNP family, is requi­
red for early cleavage steps in pre-rRNA processing 
leading to the formation of the 18S rRNA. The U3 
snoRNA is associated with proteins that are com­
mon to all box C/D snoRNPs: NOP56, NOP58, 
fibrillarin and 15.5K. In addition, numerous proteins 
have been identified that specifically interact with 
the U3 snoRNA.
The goal of the research underlying this thesis 
was to elucidate the composition and architecture of 
the human U3 snoRNP complex. In Chapter 1, the 
structural and functional organisation of the nucleo­
lus and the function and complexity of the snoRNP 
complexes with emphasis on the U3 snoRNP, are 
introduced. Using in vivo and in vitro reconstitution 
systems, we analysed in detail how the U3 snoRNP 
specific protein hU3-55K interacts with the U3 
snoRNA (Chapters 2 and 3). We showed that hU3- 
55K directly binds a fragment of the U3 snoRNA 
containing the conserved box B/C motif and flan
king stems. We found that efficient binding of hU3- 
55K to this fragment in vitro needs two important 
requirements: binding of a trans-acting factor, pro­
tein 15.5K, to the box B/C motif and a structurally 
conserved element that flanks the 15.5K binding 
site. Chapter 4 describes the cloning and characteri­
sation of the human Imp3 and Imp4 proteins. The 
results presented in this chapter strongly suggest 
that hImp3, hImp4 and hMpp10 form a relatively 
stable complex that predominantly is associated 
with the U3 snoRNA in larger 60-80S ribonucleo- 
protein complexes. Furthermore, analyses of hImp3, 
hImp4 and hMpp10 mutants indicated that forma­
tion of the hetero-trimeric complex is required for 
nucleolar localisation of the individual components.
In Chapter 5 we showed that the box B/C motif 
of the U3 snoRNA, together with the proteins that 
interact with this motif, plays an important role in 
the incorporation of the 12S U3 complex into 60­
80S complexes in vivo. Furthermore, our data sug­
gest that the association of the hImp3-hMpp10- 
hImp4 with the U3 snoRNA most likely takes place 
in the dense fibrillar compartment of the nucleolus 
and may (in part) require interactions with proteins 
that are stably associated with the box B/C motif. In 
addittion, by fluorescent in situ  hybridisation 
(FISH) we have mapped the regions in the U3 
snoRNA required for its accumulation in specific 
subnucleolar compartments (Chapter 5).
Although most of the yeast U3 snoRNP proteins 
are well conserved in humans, the mechanism in 
which they function in pre-rRNA processing does 
not always appear to be the same. In Chapter 6 we 
describe the cloning and characterisation of the 
human Sof1 protein. The human Sof1p protein inter­
acts with fibrillarin in a 12S complex, that, to our 
surprise, did not contain the U3 snoRNA.
In Chapter 7, the results presented in this thesis 
are summarised and discussed.
134 Summary
Samenvatting
De synthese van pre-ribosomaal RNA (pre- 
rRNA) en haar verwerking tot rRNA vinden plaats 
in een gespecialiseerde kernstructuur, genaamd de 
nucleolus. Tijdens dit proces ondergaat het pre- 
rRNA vele chemische modificaties en klievingen, 
die door de zogenaamde small nucleolar ribonucleo- 
protein complexen (snoRNP’s) worden uitgevoerd. 
De snoRNP’s bestaan uit eiwitten en een RNA com­
ponent, het snoRNA, dat het RNP complex stuurt 
naar de plaats op het pre-rRNA dat gemodificeerd of 
gekliefd moet worden. Gebaseerd op secundaire 
structuur gegevens van de snoRNA component, de 
geconserveerde sequentie elementen, en de eiwitten 
die ermee geassocieerd zijn, worden deze com­
plexen vaak in twee groepen verdeeld: de box C/D 
snoRNP’s en de box H/ACA snoRNP’s. De box C/D 
snoRNP’s zijn betrokken bij de klievingstappen en 
bij de 2’-O-methylering van het pre-rRNA, terwijl 
de box H/ACA snoRNP’s betrokken zijn bij de 
pseudouridinylering. Het U3 snoRNP complex, 
behorend tot de familie van box C/D snoRNP’s, is 
nodig voor vroege klievingstappen van het pre- 
rRNA, die leiden tot de rijping van het 18S rRNA. 
Het U3 snoRNA is geassocieerd met eiwitten die in 
alle box C/D snoRNP’s aanwezig zijn: NOP56, 
NOP58, fibrillarine en 15.5K. Daarnaast is er nog 
een reeks eiwitten geïdentificeerd die specifiek een 
interactie aangaan met het U3 snoRNA.
Het doel van het onderzoek beschreven in dit 
proefschrift was om de samenstelling en de architec­
tuur van het humane U3 snoRNP complex op te hel­
deren. Hoofdstuk 1 geeft een kort overzicht van 
onze huidige kennis over de structuur en de organi­
satie van de nucleolus en de functie en complexiteit 
van snoRNP complexen, met de nadruk op het U3 
snoRNP. Door gebruik te maken van zowel in vitro 
als in vivo reconstitutie systemen hebben wij in 
detail bestudeerd hoe het U3-specifieke eiwit hU3- 
55K een interactie aangaat met het U3 snoRNA
(Hoofdstukken 2 en 3). In deze hoofdstukken laten 
we zien dat hU3-55K direct bindt aan het deel van 
het U3 snoRNA dat het box B/C motief en flanke­
rende structuren omvat. We hebben aangetoond dat 
binding van hU3-55K aan dit RNA fragment afhan­
kelijk is van binding van het eiwit 15.5K aan het box 
B/C motief en van een structureel geconserveerd 
RNA element in de directe nabijheid van dit motief.
De klonering en de karakterisatie van de huma­
ne Imp3 en Imp4 eiwitten, twee eiwitten die speci­
fiek met het U3 snoRNA associëren, worden 
beschreven in Hoofdstuk 4. De resultaten gepresen­
teerd in dit hoofdstuk geven sterke aanwijzingen dat 
hImp3, hImp4 en hMpp10 samen een relatief stabiel 
complex vormen wat alleen in 60-80S complexen 
met het U3 snoRNA een interactie aangaat. Uit ana­
lyses van hImp3, hImp4 en hMpp10 mutanten is ook 
gebleken dat deze eiwitten met elkaar een complex 
moeten vormen om naar de nucleolus te kunnen 
gaan.
In Hoofdstuk 5 laten we zien dat het box B/C 
motief van het U3 snoRNA, samen met de eiwitten 
die hiermee associëren, een belangrijke rol speelt bij 
de associatie van het 12S U3 snoRNP met 60-80S 
complexen in vivo. Onze resultaten geven ook aan 
dat het hImp3-hMpp10-hImp4 complex associeert 
met het U3 snoRNA in het “dense fibrillar” compar­
timent van de nucleolus en dat dit zeer waarschijn­
lijk (gedeeltelijk) afhankelijk is van interacties met 
eiwitten die stabiel geassocieerd zijn met het box 
B/C motief. Verder hebben we via fluorescente in 
situ hybridizatie aangetoond welke RNA elementen 
in het U3 snoRNA nodig zijn voor zijn accumulatie 
in specifieke subnucleolaire compartimenten.
Hoewel de meeste U3 snoRNP eiwitten evoluti­
onair sterk geconserveerd zijn in eukaryoten, lijkt de 
wijze waarop ze hun rol vervullen in pre-rRNA pro­
cessing mogelijk niet altijd hetzelfde te zijn. In 
Hoofdstuk 6 beschrijven we de klonering en karak-
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terisatie van het humane hSof1 eiwit. In gist is aan­
getoond dat het ortholoog van dit eiwit (Sof1p) 
geassocieerd is met het gist U3 snoRNA. Het hSof1 
eiwit blijkt weliswaar samen met fibrillarine bij een 
12S complex voor te komen, maar verassenderwijs 
bleek dit complex geen U3 snoRNA te bevatten.
In Hoofdsstuk 7 van dit proefschrift worden de 
resultaten kort samengevat en bediscussieerd.
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